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Abstract 
Myosins establish a superfamily of cytoskeleton-associated motor proteins, which are encoded in the 
genome of virtually all eukaryotic organisms. As molecular motors powered by the hydrolysis of ATP, 
myosins are capable of translocating along filamentous actin. The transduction of chemical into 
mechanical energy enables myosins to fulfill a plethora of different functions, as for example muscle 
contraction, cell-cell adhesion, protein transport, or membrane trafficking. 
In this context, myosin-XXI plays an extraordinary role. The motor protein, which has recently been 
described in the literature, is the only myosin the expression of which could thus far be verified in the 
parasite Leishmania donovani. For the parasite, myosin-XXI is a vital motor protein mediating the 
important cellular processes of endocytosis, exocytosis, vesicular trafficking, and flagellum 
formation. 
In the present work, the molecular bases underlying the function of this essential multifunctional 
motor protein were aimed to be further elucidated. 
For this purpose, the full-length myosin as well as individual myosin-XXI domains were characterized 
using in vivo and in vitro methods. In mammalian cell transfection experiments, functionality and 
cellular distribution of myosin-XXI were examined in a physiological environment devoid of 
endogenously expressed myosin-XXI. With the help of gliding filament assays and lipid bilayer binding 
experiments, directionality of myosin-XXI translocation along F-actin was determined and membrane 
attachment of the molecular motor was investigated. 
The transfection studies indicated that myosin-XXI is capable of performing processive movement in 
mammalian cells, and that the motor protein most probably promotes actin polymerization within 
the filopodia of transfected cells. These processes depended on the presence of the N-terminal 
portion of myosin-XXI (aa 1 to 800) comprising an SH3-like domain, the complete motor domain, and 
part of the adjacent neck and tail region. Gliding filament assays verified for the first time that 
myosin-XXI, like the vast majority of myosins known to date, is a plus end-directed molecular motor. 
The analysis of myosin-XXI´s association with membranes demonstrated that the motor protein´s 
attachment to lipid bilayers requires positive bilayer curvature. In addition, it was shown that 
myosin-XXI exhibits at least two separate curvature sensitive lipid binding sites. 
The results obtained in the present study give evidence that the N-terminal domains of myosin-XXI 
are of great importance for the motor protein´s functionality, though they are known not to be 
involved in the localization of myosin-XXI within Leishmania donovani. A potential function of the 
N-terminal parts of myosin-XXI might include the regulation of actin polymerization in membrane 
protrusions, a process that could possibly play a role in the myosin-XXI-mediated formation of the 
Leishmania donovani flagellum. From the results of the membrane binding studies, it can be 
concluded that membrane curvature has a regulatory effect on the spatial distribution of myosin-XXI. 
Abstract 
Accordingly, myosin-XXI is the first myosin described to bind to membranes depending on membrane 
geometry. The existence of several separate curvature sensitive lipid binding motifs within the motor 
protein might in fact guarantee maintenance of the myosin-XXI-membrane association during the 
conformational changes occurring when myosin-XXI passes through its catalytic cycle. 
 
Kurzfassung 
Myosine bilden eine Superfamilie Cytoskelett-assoziierter Motorproteine, die im Genom nahezu aller 
eukaryotischen Organismen kodiert sind. Angetrieben durch die Hydrolyse von ATP können sich 
Myosine als molekulare Motoren entlang von filamentösem Aktin fortbewegen. Die Umwandlung 
chemischer in mechanische Energie ermöglicht es Myosinen, eine Vielzahl verschiedener Funktionen, 
wie zum Beispiel Muskelkontraktion, Zell-Zell-Adhäsion, Proteintransport oder membran-
verlagernden Transport zu erfüllen. 
Myosin-XXI nimmt hierbei eine besondere Stellung ein. Dieses in der Literatur beschriebene 
Motorprotein ist das bislang einzige Myosin, dessen Expression in dem Parasiten Leishmania 
donovani nachgewiesen werden konnte. Für den Parasiten stellt Myosin-XXI ein lebensnotwendiges 
Motorprotein dar, welches die wichtigen zellulären Prozesse Endozytose, Exozytose, Vesikeltransport 
und Flagellenbildung vermittelt. 
Ziel der vorliegenden Arbeit war es, die molekularen Grundlagen der Funktion dieses essenziellen 
multifunktionalen Motorproteins weiter aufzuklären. 
Hierzu wurden sowohl das vollständige Myosin als auch einzelne seiner Domänen mit Hilfe von 
in-vivo- und in-vitro-Methoden charakterisiert. In Transfektionsexperimenten an Säugetierzellen 
wurden die Funktionalität und die zelluläre Verteilung von Myosin-XXI in einer physiologischen 
Umgebung untersucht, in der kein endogen exprimiertes Myosin-XXI vorhanden war. Mittels 
Gleitfilamentversuchen und Experimenten zur Bindung an Lipiddoppelschichten wurde die Richtung 
der Myosinbewegung entlang von F-Aktin bestimmt sowie das Membranbindeverhalten des 
molekularen Motors genauer erforscht. 
Die Transfektionsversuche zeigten, dass Myosin-XXI in Säugetierzellen in der Lage ist, sich prozessiv 
zu bewegen und dass es sehr wahrscheinlich die Aktinpolymerisation in den Filopodien der 
transfizierten Zellen verstärkt. Für diese Prozesse ist der N-terminale Abschnitt des Myosin-XXI-
Moleküls (Aminosäuren 1 bis 800) erforderlich, welcher eine SH3-ähnliche Domäne, die vollständige 
Motordomäne und einen Teil der anschließenden Hals- und Schwanz-Region umfasst. In 
Gleitfilamentversuchen wurde erstmalig nachgewiesen, dass sich Myosin-XXI wie die überwiegende 
Mehrheit der bisher bekannten Myosine in Richtung des Plus-Endes von F-Aktin bewegt. Die 
Untersuchungen zum Membranbindeverhalten von Myosin-XXI verdeutlichten, dass die Anlagerung 
des Motorproteins an Lipiddoppelschichten eine positive Oberflächenkrümmung der 
Doppelschichten voraussetzt. Ferner konnte gezeigt werden, dass das Motorprotein mindestens zwei 
eigenständige krümmungssensitive Lipidbindungsstellen aufweist. 
Die Ergebnisse der vorliegenden Arbeit belegen, dass die N-terminalen Domänen von Myosin-XXI von 
hoher Wichtigkeit für die Funktionalität des Motorproteins sind, auch wenn sie bekanntermaßen bei 
der Lokalisation von Myosin-XXI in Leishmania donovani keine Rolle spielen. Eine mögliche Funktion 
Kurzfassung 
des N-terminalen Abschnitts von Myosin-XXI könnte die Regulation der Aktinpolymerisation in 
Membranausstülpungen sein, ein Prozess, der möglicherweise bei der Myosin-XXI-vermittelten 
Bildung des Leishmania-donovani-Flagellums von Bedeutung ist. Aus den Ergebnissen der 
Membranbindungsstudien lässt sich schlussfolgern, dass die Oberflächenkrümmung von Membranen 
regulatorisch auf die räumliche Verteilung von Myosin-XXI wirkt. Hierbei ist Myosin-XXI das erste 
Myosin, für das eine Abhängigkeit der Membranbindung von der Membrangeometrie beschrieben 
wird. Das Vorhandensein mehrerer eigenständiger krümmungssensitiver Lipidbindemotive innerhalb 
des Motorproteins könnte dabei gewährleisten, dass die Membranbindung von Myosin-XXI 
aufrechterhalten werden kann, während das Motorprotein seinen katalytischen Zyklus und die damit 
einhergehenden Konformationsänderungen durchläuft. 
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1 
1 Introduction 
1.1 The Eukaryotic Cytoskeleton 
The cytoskeleton of eukaryotic cells is composed of a filamentous network of proteins that fulfills a 
multitude of tasks essential for proper cell function and thus survival. Not only does the cytoskeleton 
define and stabilize cellular shape, it is also involved in the interaction of the cell with its 
environment, and is the fundamental structure in the internal spatial organization of eukaryotic cells 
(Alberts et al., 2007). 
To adapt to the plethora of different functions of the cytoskeleton, different types of cytoskeletal 
filaments evolved. These filament types comprise actin filaments, microtubules, and intermediate 
filaments. As the present study is concerned with the actin-based motor protein myosin-XXI, actin 
filaments will be described in greater detail. 
 
 Actin Filaments 1.1.1
In eukaryotes, spatial structures formed by actin play important roles in various processes including 
muscle contraction, cell division, cell motility, and vesicle transport. Further, actin filaments define 
cell shape of animal cells (Pollard and Cooper, 2009). In conjunction with cell motility and changes in 
cell shape, actin forms and stabilizes membrane protrusions (Nambiar et al., 2010). A prominent 
example of actin-based membrane protrusions are filopodia, which will be described in 
subsection 1.5.7. Actin is highly abundant in eukaryotes accounting for 1 % to 10 % of a cell´s total 
protein content depending on the cell type. 
In its monomeric form, called globular actin or G-actin, it is a protein of a molecular weight of 42 kDa, 
a length of 5.5 nm and a width of 3.5 nm. Each actin monomer consists of two subunits and exhibits 
an ATP/ADP (ADP: adenosine diphosphate) binding pocket between these subunits (Figure 1; 
Kabsch et al., 1990; Graeve and Müller, 2014). 
Actin monomers bind to each other by forming non-covalent bonds resulting in the formation of 
double-stranded filaments called filamentous actin or F-actin. Actin filaments are flexible helices 
composed of two so-called protofilaments, linear strings of end-to-end associated monomers. 
Helices exhibit a diameter of 5 to 9 nm and a 36 nm helical repeat. One twist of an F-actin helix 
consists of 13 G-actin units (Figure 1; Holmes et al., 1990; Alberts et al., 2007). The formation of actin 
polymers starts with a nucleation process of slow kinetics, which is the rate limiting step of the 
polymerization reaction and causes a lag phase prior to the beginning of filament assembly. Nuclei of 
actin are expected to be trimeric (Sept and McCammon, 2001). At a constant G-actin concentration, 
the lag phase is followed by a phase of elongation until the rates of monomer attachment and 
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detachment are equal. At this point, an equilibrium or steady state is reached, at which filament 
length remains constant (Figure 2). The concentration of free G-actin in solution in the steady state is 
called critical concentration (cc). As actin monomers always attach to F-actin in the same head-to-tail 
orientation, actin filaments display a polar architecture. This polarity is associated with divergent 
rates of polymerization and depolymerization at the distinct ends of a filament. The end exhibiting 
higher assembly and disassembly rates is called the plus end, whilst the filament end showing slower 
monomer attachment and detachment is referred to as the minus end. Originating from the 
appearance of myosin-decorated actin filaments in electron microscopy images, plus ends are also 
termed barbed ends and minus ends are called pointed ends (Alberts et al., 2007). Within eukaryotic 
cells, actin filaments are arranged with their barbed ends facing the cell periphery (Mooseker and 
Tilney, 1975; Tilney et al., 1981). 
 
 
Figure 1 Atomic models of G-actin and F-actin. (A) G-actin consists of two subdomains (blue, grey) enclosing an ATP/ADP 
binding pocket. Here, conformation of an ADP-bound (red) actin monomer is shown. (B) F-actin is a polar helical polymer 
resulting from the assembly of actin monomers in a head-to-tail fashion. One twist of the helix (indicated by arrows) 
contains 13 monomers and is 36 nm long. Here, the middle G-actin (∗) is two-colored for comparison with (A), all other 
monomers are single-colored. Figure taken from Holmes (2009). 
 
The occurrence of polymerization and depolymerization at the plus and minus ends is determined by 
the concentration of free actin monomers in solution. Above the critical concentration cc G-actin 
binds to the filament ends, while filaments disassemble as soon as the monomer concentration drops 
below cc. In a simple association reaction, cc would be determined by the rate kon of monomer 
association and koff of monomer dissociation 
 
𝑐𝑐 =
𝑘𝑜𝑓𝑓
𝑘𝑜𝑛
 
  
 (1) 
and would be equal for both filament ends. However, actin hydrolyzes ATP resulting in the release of 
energy. Soon after actin monomers get incorporated into a filament, ATPase activity is induced and 
the released energy is stored within the polymer lattice. As a consequence, detachment of an ADP-
bound monomer is energetically more favorable than dissociation of an ATP-bound monomer. 
Hence, the rate of monomer addition to the filament end determines whether this end is formed by 
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ADP-bound or ATP-bound monomers. Accordingly, the slowly growing minus end is more likely 
occupied by ADP-bound G-actin and hence the average dissociation rate at the minus end is higher 
than the one at the plus end of a filament. Thus, as cc can still be approximated by equation (1), the 
critical concentration cc(-) of the minus end is higher than cc(+) of the plus end. In consequence, a 
concentration regime exists in between cc(-) and cc(+) where filament growth proceeds at the plus end 
while G-actin detaches from the minus end: 
 𝑐𝑐(−) > 𝑐 > 𝑐𝑐(+). (2) 
At a defined concentration cTM within this regime, monomer association and dissociation balance and 
actin filaments exhibit a behavior called treadmilling characterized by a constant filament length 
(Figure 2; Hill and Kirschner, 1982; Mitchison, 1995). 
 
 
Figure 2 Kinetics of actin polymerization. (A) Time course of the polymerization reaction. The vertical axis depicts the 
percentage of monomeric actin which is incorporated into the filament, i.e. removed from solution. Assembly of G-actin 
(pink) into filaments is initiated by the formation of a trimeric nucleus (green). This first step is of slow kinetics thus causing 
a lag time in the polymerization process. Once a trimer has formed, monomers associate with this nucleus resulting in the 
formation of a filament and subsequent elongation. However, G-actin association proceeds faster at the so-called plus end, 
while the minus end grows more slowly. As soon as the concentration of free monomeric actin left in solution reaches the 
critical concentration (cc), the polymerization process reaches a steady state, at which G-actin attachment and detachment 
rates are equal. Importantly, in vivo kinetics of filament assembly are modified by the action of various accessory proteins. 
(B) Polymerization rates at the plus (+) and minus (-) ends of filamentous actin as functions of free G-actin concentration (c). 
At a negative polymerization rate a filament end disassembles, at a positive rate a filament end elongates. Resulting from 
G-actin´s capability to hydrolyze ATP, the plus ends and minus ends of filamentous actin exhibit differing critical 
concentrations, denoted as cc(+) (for plus ends) and cc(-) (for minus ends) here. At a G-actin concentration 𝒄 < 𝒄𝒄(+) < 𝒄𝒄(−), 
filaments cannot be formed. As c exceeds cc(+), filament growth at the plus end begins. Initially, merely unstable filaments 
form as depolymerization rate at the minus end is higher than polymerization rate at the plus end. At a defined 
concentration 𝒄𝒄(+) < 𝒄𝑻𝑴 < 𝒄𝒄(−), assembly and disassembly rates at the two ends are equal and treadmilling occurs, 
which is characterized by the constancy of filament length. The treadmilling process is depicted in the cartoon above the 
diagram. As soon as c increases beyond cTM, the overall filament length grows until finally, when c exceeds cc(-), filament 
elongation advances at both the plus and the minus end. Cartoons taken from Graeve and Müller (2014). 
 
In vivo, formation of actin polymers is additionally regulated by further proteins, e.g. capping 
proteins, which bind to the barbed ends of filaments thus inhibiting attachment of G-actin. One of 
these capping proteins is gelsolin, which in addition exhibits an actin filament severing activity. The 
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actin-depolymerizing factor ADF/cofilin represents another important regulator of filament assembly 
as it depolymerizes F-actin (Weber et al., 1991; Carlier, 1998; Pantaloni et al., 2001). Arrangement of 
filamentous actin into higher structures is mediated by further accessory proteins like fascin, which 
aggregates F-actin into bundles, or the ARP2/3 complex, which organizes F-actin into branched 
meshworks (Otto, 1994; Pollard and Cooper, 2009). 
 
1.2 Molecular Motors 
Molecular motors are enzymes which convert energy provided by electrochemical gradients or by 
the hydrolysis of nucleoside triphosphates into mechanical work or chemical energy (von Delius and 
Leigh, 2011). The cytoskeleton of eukaryotes is associated with molecular motors belonging to the 
superfamilies of myosins, kinesins, and dyneins. Force generation and transport mediated by 
cytoskeleton-associated motor proteins play an essential role in many cellular processes ranging 
from muscle contraction, to movement of cilia and flagella, or transport of organelles, proteins, and 
RNA (Schliwa and Woehlke, 2003). 
Motors of the myosin, kinesin and dynein superfamilies possess a catalytic motor domain, also 
termed head domain, which binds to a specific type of filament and hydrolyzes ATP into ADP and a 
free inorganic phosphate (Pi). This chemical cycle of ATP cleavage is coupled to a mechanical cycle in 
which small conformational changes in the head domain are amplified and translated into movement 
(von Delius and Leigh, 2011). Throughout the resulting chemo-mechanical cycle, strength of the 
interaction between the head domain and the filament changes enabling the motor to detach and 
reattach thus allowing the molecule to move along its filament track (Alberts et al., 2007). During this 
movement, loss of track is guaranteed by different mechanisms: processive molecular motors stay 
attached to the filament at all times, as for example in the case of dimeric processive motors, where 
one head stays attached to the track while the second motor domain is translocated. Non-processive 
motors, which completely detach from the filament, can for instance perform processive movement 
by forming motor ensembles such as thick filaments formed by skeletal muscle myosin-II. The 
translocation of cytoskeletal motor proteins along polar filaments proceeds with a defined 
directionality. 
Protein domains outside the head regulate the enzymatic activity of cytoskeletal motors, and 
mediate oligomerization and the interaction with cargo (Schliwa and Woehlke, 2003; von Delius and 
Leigh, 2011). 
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1.3 Myosins 
Molecular motors of the myosin superfamily are involved in a broad range of processes, including 
contractile processes like muscle contraction and cell motility, establishment of cell-cell and cell-
substrate adhesion, membrane trafficking processes (i.e. organelle transport, exocytosis, 
endocytosis), and protein and RNA transport (Krendel and Mooseker, 2005). Due to their important 
functional role, myosins are expressed in most eukaryotic cells, and thus far, only three unicellular 
eukaryotes have been reported not to possess any myosin gene (Odronitz and Kollmar, 2007; 
Bloemink and Geeves, 2011). 
Myosins are characterized by their capability to translocate along filamentous actin thus either 
moving along F-actin or powering gliding of actin filaments. This actin-based movement is directed 
toward the barbed end of actin filaments for nearly all myosins. To date, only one full-length myosin, 
namely myosin-VI, and a tail-less myosin-IX construct have been shown to perform pointed end-
directed movement (Sellers, 1999; Wells et al., 1999; Inoue et al, 2002). 
Myosins are multimeric proteins consisting of one or two heavy and several light polypeptide chains 
(Figure 3). Their heavy chains consist of at least three structurally and hence functionally different 
domains, namely the head, neck, and tail domain (Sellers, 1999; Lodish et al., 2000). The head 
exhibits a molecular weight of approximately 80 kDa and its basic structural motifs like the ATP/ADP 
binding pocket, the actin binding site, switch I, switch II, and the relay loop are highly conserved. 
Switch I and II are flexible loop regions which regulate the conformational state of the motor domain 
thereby modulating its catalytic activity and its interaction with actin filaments (Cheney et al., 1993; 
Cope et al., 1996; Geeves and Holmes, 1999). The relay loop is located C-terminal of the nucleotide 
binding site and translates conformational changes in the ATP/ADP binding pocket into a 
repositioning of the so-called converter domain, which in turn results in the movement of the myosin 
neck (Sasaki et al., 2003; Fischer et al., 2005). A detailed description of the myosin chemo-mechanical 
cycle is given in section 1.4. Occasionally, additional motifs precede the head domain at the myosin 
N-terminus. For instance, N-terminal SH3 (SRC homology 3) or SH3-like domains, which could 
mediate interactions with other proteins or interact with the motor domain itself, have been 
identified in several myosins including myosin-XXI (Foth et al., 2006; Mooseker and Foth, 2008; 
Batters et al., 2014). At its C-terminus, the motor domain is followed by a neck domain primarily 
composed of α-helices. The neck functions as a lever arm amplifying the amplitude of the movement 
generated by the head and is mechanically stabilized by the binding of myosin light chains. The 
number and type of light chains associated with the heavy chain varies between different myosins 
(Sellers, 1999; Mooseker and Foth, 2008). Association of light chains is mediated by IQ motifs, which 
are composed of approximately 24 amino acids (aa) and display a core sequence of IQxxxRGxxR 
(I: isoleucine, Q: glutamine, x: arbitrary aa, R: arginine, G: glycine). The maximum number of IQ 
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motifs has thus far been discovered in the neck of a Phytophthora ramorum myosin, which contains 
17 such motifs. Myosin light chains comprise calmodulin and calmodulin-related proteins (Cheney 
and Mooseker, 1992; Mooseker and Foth, 2008). Calmodulin, which is activated upon the binding of 
Ca2+, has been shown to be capable of modulating the function of several myosins, for example by 
increasing the stiffness of the neck region, by regulating the molecular conformation of myosin, or by 
controlling dimerization (Lin et al., 2005; Alberts et al., 2007; Batters et al., 2014, 2016). 
The far C-terminal part of myosins is formed by the tail domain, which is the most variable part of the 
molecule concerning primary sequence, structure and function. However, within a given class of 
myosins, apart from the head the combined neck and tail domain is generally conserved as well 
indicating a coevolution of head, neck, and tail. The myosin tail contains binding sites for additional 
binding partners hence determining myosin cargo and localization. Furthermore, the tails of several 
myosins form coiled coil domains mediating dimerization, i.e. the formation of two-headed motors. 
In class II myosins, the tail actually enables self-association into filaments. Together with the 
biochemical kinetic properties defined by the motor domain, the tail specifies myosin function 
(Sellers, 1999; Korn, 2000; Krendel and Mooseker, 2005). 
 
 
Figure 3 Structure of selected members of the myosin superfamily. Myosins are molecular motors consisting of one or 
two heavy polypeptide chains. Each heavy chain consists of at least three distinct structural domains: the head, also called 
motor domain, the neck, and the tail. The highly conserved motor domain (blue) binds to F-actin und hydrolyzes ATP. 
Within the neck domain, light chain binding IQ motifs (black) are located. The tail region is the most variable part, which in 
different myosins contains different structural motifs, e.g. coiled coil regions (green), which can mediate dimerization, 
membrane binding domains (orange), or other cargo binding domains like FERM (4.1/ezrin/radixin/moesin, yellow), MyTH4 
(myosin tail homology 4, red), or PH (pleckstrin homology, purple) domains. The SH3 domain (brown) in myosin-VII is 
proposed to regulate the orientation of the tail (Wang et al., 2007). Class VI and class VII myosins might exist in both a 
monomeric or dimeric form. (A) Scheme of the domain sequences of selected vertebrate myosins. (B) Respective 
illustration of the protein structure. Figure taken from Krendel and Mooseker (2005). 
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Figure 4 Unrooted phylogenetic tree of the myosin superfamily. Based on the genetic sequence of their motor domains, 
Odronitz and Kollmar (2007) grouped myosins into 35 distinct classes. In the above illustration, branches demonstrate the 
evolution of myosins within each class. Time scale indicates 10
3
 years. Orphan sequences are sequences of myosins which 
could not be assigned to one of the defined classes. Figure taken from Odronitz and Kollmar (2007). 
 
The subfamily of myosins is divided into classes according to the homology of their motor domain 
nucleic acid sequences or aa sequences respectively (Figure 4). As more and more myosins are 
identified, the number of established classes has been continuously growing throughout the past 
years: while in 1993, merely 7 myosin classes were defined (Cheney et al., 1993), in 2000, 17 classes 
were described (Hodge and Cope, 2000). In 2007, a phylogenetic analysis by Odronitz and Kollmar 
grouped myosins into 35 distinct classes. In humans, genome analysis revealed the existence of 39 
genes encoding myosins from 12 distinct classes (Berg et al., 2001). 
The first myosins to be described were skeletal muscle myosins of class II (see subsection 1.3.1), thus 
class II myosins are also referred to as conventional myosins. The first so-called unconventional 
myosin was isolated from Acanthamoeba. As this myosin turned out to be a single-headed motor, it 
was named myosin-I, while double-headed conventional myosins were now called myosin-II. 
Subsequently identified myosins were assigned a Roman numeral according to the chronology of 
their discovery (Alberts et al., 2007; Mooseker and Foth, 2008). 
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 Skeletal Muscle Myosin-II 1.3.1
Class II skeletal muscle myosins were the first myosins to be discovered. As they have been intensely 
studied throughout the past decades, a profound knowledge of their structure and function exists. In 
the present work, a proteolytic fragment of rabbit skeletal muscle myosin-II was used as control in 
experiments investigating the directionality of the actin-based movement of myosin-XXI (see 
section 4.4). For these reasons, a brief introduction on skeletal muscle myosins-II is given here. 
Class II skeletal muscle myosins are dimeric motor proteins composed of two heavy chains 
and four light chains (Figure 5). Each heavy chain contains two IQ motifs mediating the association of 
the heavy chain with one regulatory (also termed phosphorylatable) light chain and one essential 
(also called alkali) light chain. Light chains belong to the calmodulin/troponin-C superfamily. The tail 
of skeletal muscle myosin-II is an extended α-helical domain acting as dimerization site by forming a 
coiled coil structure. In addition to dimer formation, the tail mediates the self-assembly of dimeric 
myosin-II into thick filaments at low ionic strength, and serves as binding site for proteins which 
stabilize filament structure and interlink filaments (Sellers, 1999; Reggiani and Bottinelli, 2008). 
 
 
Figure 5 Structural properties of skeletal muscle myosin-II. (A) Dimeric skeletal muscle myosin-II. The myosin dimer is 
formed by two heavy and four light polypeptide chains. Dimerization of heavy chains is mediated by coiled coil formation 
along the alpha-helical tail domains. With the help of controlled tryptic digestion, myosin-II dimers can be separated into 
distinct functional fragments: HMM contains both motor domains, the neck region, and approximately one third of the 
dimeric tail, and is capable of translocating along filamentous actin. This fragment can be further digested into 
subfragments S1, i.e. two monomeric fragments each containing a motor and neck domain, and subfragment S2, i.e. the 
respective tail segment. LMM is composed of the C-terminal part of the myosin-II tail, and unlike HMM, it aggregates into 
paracrystalline-like structures at low ionic strength. Figure taken from Holmes (2008). (B) Structure of the sarcomere, the 
basic structural unit of skeletal muscles. Under conditions of low ionic strength, the tail-mediated assembly of myosin-II 
molecules results in the formation of bipolar thick filaments with a head-free central zone. Together with actin-based thin 
filaments, thick filaments form the basic structural unit of skeletal muscles. The sliding of myosin-II heads along surrounding 
oppositely oriented thin filaments causes a contraction of the sarcomere. Importantly, sarcomere formation also requires 
the presence of accessory proteins like α-actinin, which crosslinks thin filaments, or myosin binding proteins, e.g. titin and 
MYBP-C (myosin binding protein-C), which stabilize and interlink thick filaments. Figure taken from Hwang and Sykes 
(2015). 
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Within thick filaments, myosin tails position parallel to the filament axis. The staggered 
arrangement of myosin molecules in the filaments results in the periodic emergence of myosin-II 
heads at the surface. Importantly, thick filaments, which contain several hundreds of myosin heads, 
exhibit a bipolar architecture characterized by a central head-free zone, referred to as bare zone. The 
bipolarity of skeletal muscle myosin-II filaments enables them to slide surrounding actin-based thin 
filaments past each other thus driving muscle contraction (Figure 5; Cooke, 1986; Reggiani and 
Bottinelli, 2008). 
Noteworthily, skeletal muscle myosin-II can be cleaved into separate functional fragments by 
controlled proteolysis (Figure 5). Digestion with trypsin produces two fragments called heavy 
meromyosin (HMM) and light meromyosin (LMM). HMM contains the catalytic motor domains and a 
segment of the myosin tail sufficiently long for dimerization. It is capable of translocating F-actin but 
does not aggregate into filaments. HMM can be further tryptically digested into two single-headed 
subfragments S1, each consisting of head and neck, and a dimeric subfragment S2, merely 
comprising the remaining tail segment. LMM, which consists of the C-terminal approximate two 
thirds of the myosin-II tail, dimerizes and assembles into paracrystalline-like aggregates at low ionic 
strength (Cooke, 1986; Sellers, 1999). 
 
1.4 Chemo-Mechanical Transduction in Myosins 
The catalytic cycle of myosins, in which chemical energy released during ATP hydrolysis is converted 
into mechanical force, seems to be a highly conserved process occurring in all myosins characterized 
so far (De La Cruz and Ostap, 2004; El-Mezgueldi and Bagshaw, 2008). 
This process is composed of a defined sequence of biochemical reactions involving the attachment to 
and detachment from F-actin, nucleotide binding, and release of hydrolysis products (Lymn and 
Taylor, 1971; Eisenberg and Greene, 1980). However, significant variations in the rates of transition 
between different states of myosin in the ATPase cycle allow for an efficient adjustment of myosin 
kinetic properties to specific physiological tasks. In accordance with differing myosin functions, these 
variations even exist within a given class of myosins (De La Cruz and Ostap, 2004; Sweeney and 
Houdusse, 2010). 
The initially proposed model of chemo-mechanical energy transduction, the swinging crossbridge 
model, was originally postulated by Huxley (1957) and later further developed by Huxley and 
Simmons (1971). In this model, force generation by myosins was hypothesized to solely result from 
conformational changes within the myosin motor domain. Today, the swinging lever arm hypothesis 
is widely accepted, which states that the performance of mechanical work is a consequence of small 
conformational changes in the ATP binding pocket being translated into a large swinging motion of 
the lever arm, i.e. the myosin neck (Spudich, 1994; Holmes, 1997; Sweeney and Houdusse, 2010). 
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Figure 6 The myosin ATPase cycle. In a conserved cycle of biochemical reactions, myosin (three-part multicolored symbol) 
converts chemical energy provided by the hydrolysis of ATP into mechanical force. Force is transmitted to F-actin (yellow 
spheres) via a swinging motion of the lever arm (light blue), the so-called power stroke. In short, nucleotide-free actin-
associated myosin (1) binds ATP (2), and subsequently detaches from the actin filament (3). The lever arm position required 
for force transmission is then restored in the recovery stroke (4), followed by the hydrolysis of ATP (5) and the rebinding of 
myosin to F-actin (6). Once Pi is released from the motor domain (7-8), myosin performs a two-step power stroke, during 
which small conformational changes in the nucleotide binding pocket are translated into a swinging lever arm motion of 
significantly larger amplitude (9-10). Concomitant with the power stroke, myosin´s affinity for ADP markedly decreases 
resulting in the dissociation of ADP and thus in the transition of actomyosin back into the initial rigor conformation (11). For 
a detailed description of the myosin catalytic cycle see text. Figure taken from Sweeney and Houdusse (2010). 
 
 The Myosin ATPase Cycle 1.4.1
In 1971, a cyclic scheme for the ATP-dependent force generation by myosins was introduced by Lymn 
and Taylor (1971) for the first time. Accordingly, the myosin catalytic cycle is also referred to as 
Lymn-Taylor cycle. 
In the years following the proposal of cyclic force generation, more detailed information on the 
myosin ATPase cycle was obtained, for example by the determination of myosin and actomyosin 
crystal structures, single-molecule mechanical studies of myosins, or kinetic studies in aqueous 
solution (Sweeney and Houdusse, 2010). 
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A simplified kinetic scheme of the myosin catalytic cycle as summarized by Sweeney and Houdusse 
(2010) is depicted in Figure 6. In general, intermediate states of the myosin catalytic cycle are 
categorized according to the affinity of myosin for actin binding. States of low (i.e. micromolar) 
affinity comprise actin detachment, the recovery stroke i.e. the repositioning of the lever arm, ATP 
hydrolysis, and reattachment to actin. High (i.e. submicromolar) affinity states are intermediate 
states involved in the generation of force, including the power stroke, during which the movement of 
the myosin lever arm transmits force to the actin filament (Geeves and Holmes, 1999). 
In the presence of load and under saturating concentrations of actin and ATP, the ATPase cycle 
proceeds as follows (Sweeney and Houdusse, 2010): 
1. At the end of the preceding enzymatic cycle, nucleotide-free myosin is tightly bound to actin 
in the so-called rigor state. At this stage, the actomyosin complex is also denoted as AM 
(A…actin, M…myosin). 
 
Transition to low affinity states of myosin: 
2. Subsequently, myosin rapidly rebinds ATP resulting in a conformational change transferring 
myosin into its post-rigor states. This conformational change significantly weakens the 
association of myosin with actin. Initially, myosin is still weakly attached to actin (AM.ATP 
conformation). 
3. In the following post-rigor state, myosin has dissociated from the actin filament, thus 
adopting the ATP-bound M.ATP conformation. Detachment from actin enables myosin to 
execute the recovery stroke, during which the myosin lever arm swings back into the position 
required for force transmission. 
4. By performing the recovery stroke, myosin reaches its pre-power stroke states, the first of 
which is characterized by the hydrolysis competence of myosin. 
5. Upon the hydrolysis of ATP, myosin remains associated with the respective reaction 
products, ADP and Pi (M.ADP.Pi conformation). 
6. In the succeeding transition into AM.ADP.Pi, reattachment of myosin to the actin filament 
presumably initiates conformational changes of myosin required for later Pi release. 
 
Transition to high affinity (i.e. force-generating) states of myosin: 
7. In the next step, myosin actin association tightens thus likely stabilizing further 
conformational changes which result in the creation of a Pi escape route alternative to the 
ordinary exit from the nucleotide binding pocket. The structural basis of this escape route, 
which is commonly called back door, is yet unknown. 
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8. Following phosphate release, i.e. the transition into the AM.ADP conformation, closure of the 
presumed back door prevents rebinding of Pi. 
9. In conjunction with back door closure, the lever arm carries out the first swing of the power 
stroke. 
10. In a second swinging motion of the lever arm, the myosin power stroke is completed. During 
the power stroke, small conformational changes in the motor´s nucleotide binding pocket are 
translated into a lever arm motion of considerably larger amplitude allowing for an effective 
transmittance of force to the actin filament. Concomitant with the terminal second step of 
the power stroke, the strength of myosin´s association with ADP is significantly reduced. 
11. In the final state transition of the ATPase cycle, ADP is released from the nucleotide binding 
pocket, transferring myosin back into its rigor state (1.). 
 
 Myosin Kinetic Properties 1.4.2
In accordance with the diverse physiological functions of distinct myosins, these cytoskeletal 
molecular motors exhibit differing kinetic properties. 
An important kinetic parameter for the characterization of myosins is the duty ratio, which is defined 
as the fraction of the ATPase cycle a myosin spends in its high affinity states, i.e. tightly bound to the 
actin filament track. 
Accordingly, high duty ratio motors like myosin-V and myosin-VI remain strongly attached to F-actin 
throughout a substantial portion of their catalytic cycle. Importantly, a high duty ratio is a 
prerequisite for processivity, i.e. the capability of a motor protein to translocate along filaments in 
multiple consecutive interactions without detaching from the filamentous track (De La Cruz and 
Ostap, 2004; El-Mezgueldi and Bagshaw, 2008). In the case of myosin-V, processivity was 
demonstrated to enable this motor protein to continuously translocate along actin over distances of 
up to several μm in vitro (Sakamoto et al., 2000). The minimum number of consecutive myosin-V-
actin interactions in vitro was estimated to range between 40 and 50 steps (Mehta et al., 1999). For 
high duty ratio myosins, ADP release was identified as the rate-limiting step of the ATPase cycle. 
In turn, low duty ratio myosins merely populate the high affinity states throughout a small 
part of their catalytic cycle (De La Cruz and Ostap, 2004). For instance, skeletal muscle myosin-II 
remains strongly associated with F-actin for less than 20 % of the duration of its ATPase cycle 
(Guilford et al., 1997). This enables fast skeletal muscle myosin-II to generate sarcomere contractions 
of maximum speed and maximum power output (Sweeney and Houdusse, 2010). In consequence of 
the proportionally short time low duty ratio myosins remain in the strong binding states, these motor 
proteins dissociate from actin filaments after passing through a single catalytic cycle. Hence, low duty 
motors are non-processive. However, when non-processive motors form large assemblies or are 
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spatially constraint by cytoskeletal structures, they too can effectively perform processive movement 
(El-Mezgueldi and Bagshaw, 2008). Further, certain monomeric non-processive myosins might as well 
employ a second tail-located actin binding site in order to translocate without detaching from their 
filament track (Les Erickson et al., 2003). The rate-limiting transition in the catalytic cycle of low duty 
ratio myosins is the release of Pi (De La Cruz and Ostap, 2004). 
 
1.5 Biomembranes 
Similar to the cytoskeleton, the eukaryotic membranous system plays a crucial role in determining 
cell shape and function (Sackmann, 1995). Moreover, the interplay between membranes, 
cytoskeletal filaments and filament-associated motor proteins has been shown to drive essential 
cellular processes like cell movement, endocytosis, or vesicular transport (Schliwa and Woehlke, 
2003; Soldati and Schliwa, 2006; Keren, 2011). 
As within the current work, membrane association of the motor protein myosin-XXI was one of the 
aspects elucidated, the molecular constituents and the architecture of biomembranes will be 
introduced in this section. 
 
 Functions of Biomembranes 1.5.1
Biological membranes, also termed biomembranes, constitute the boundaries of cells and 
intracellular compartments thus spatially separating the molecular contents of cellular organelles, 
the cytoplasm, and the cell´s environment. This spatial separation reduces the number of molecules 
accessible for direct interactions within the cytoplasm and the intracellular compartments. 
Furthermore, it allows for the establishment of compartment-specific conditions regarding protein 
content, pH, and ionic composition. The resulting gradients give rise to electrochemical potentials 
and the directed flow of constituents. In addition, ionic composition and pH of the distinct subspaces 
regulate the activity of specialized proteins thereby enabling the inner compartments of a cell to 
fulfill specific, well-defined functions (Sackmann, 1995; Goñi, 2014). 
Importantly, biomembranes do not only serve the purpose of spatial separation, but also allow for 
interactions with a cell´s or an organelle´s surroundings, as for instance during the formation of cell-
cell contacts or during signal uptake by receptor proteins (Alberts et al., 2007). Moreover, 
membrane-associated transport processes like endocytosis, exocytosis or transport via membrane 
proteins enable the exchange of material, e.g. nutrients, metabolic waste, or ions. Additionally, 
membrane proteins enable biomembranes to fulfil a multitude of further tasks like ATP synthesis, 
regulatory functions, or tethering of the cytoskeleton (Lodish et al., 2000). 
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 Membrane Lipids 1.5.2
Lipids are organic molecules which share two common characteristics: insolubility in water and high 
solubility in organic solvents like chloroform or isopropanol (Lottspeich and Engels, 2012). In 
biomembranes, they are arranged in a 6 nm to 10 nm thick double layer forming the structural basis 
of membrane architecture (see subsection 1.5.4). Membranes of eukaryotic cells are composed of 
three major classes of lipids: phospholipids, glycolipids, and cholesterol. 
 
 
Figure 7 Chemical structures of lipid constituents of eukaryotic membranes. (A) Examples of phospholipids contained in 
eukaryotic biomembranes. Phospholipids are amphipathic molecules consisting of a polar head group and at least one 
hydrophobic hydrocarbon tail. The head group contains an alcohol, a phosphate, and glycerol or sphingosine. Here, several 
phospholipids derived from glycerol are depicted. The structure of these lipids differs in the alcohol moiety linked to the 
phosphate group. The complete structure shown on the left is the one of PC. By substitution of the boxed choline group 
with other alcohol residues, structures of different phospholipids are obtained. The names of the respective phospholipids 
are parenthesized. In phosphatidic acid, which is not shown here, choline is replaced by a hydroxyl group. As the glycerol 
moiety of cardiolipin joins two phosphatidic acid molecules, cardiolipin is also referred to as diphosphatidylglycerol. Figure 
taken from Dowhan et al. (2016). (B) Structure of cholesterol. Cholesterol is composed of four interlinked hydrocarbon 
rings, to which a hydroxyl group and a hydrocarbon tail are bound. While the hydroxyl group constitutes the polar part of 
the amphipathic molecule, the hydrophobic moiety is formed by the hydrocarbon rings and tail. Figure taken from 
Palmer (2004). 
 
Phospholipids, which are abundant in all biomembranes, consist of a hydrophilic head group and at 
least one hydrophobic tail. The polar head is composed of an alcohol, a phosphate, and a glycerol or 
sphingosine, whilst each tail is formed by a fatty acid (Figure 7; Berg et al., 2012). Cis-double bonds 
within the fatty acid carbon chain influence the lateral space required by a tail. Together with the 
overall length of the lipid molecule and the cross-sectional area of the hydrophilic head, the spatial 
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extent of the hydrophobic tails determines the molecular geometry of a phospholipid (Marsh, 1996; 
Alberts et al., 2007; McMahon and Boucrot, 2015). Due to their molecular structure, phospholipids 
are generally depicted using the following shorthand: the hydrophilic head is pictured as a circle, and 
the hydrophobic tails are represented by straight or wavy lines connected with this circle. 
Examples of phospholipids contained in eukaryotic membranes include phosphatidylethanolamine 
(PE), phosphatidylcholine (PC), phosphatidylserine (PS), sphingomyelin, and phosphatidylinositol (PI) 
(Table 1; Berg et al., 2012). Commonly, PC and PE account for more than 50 % of the total 
phospholipid content of eukaryotic membranes hence playing a major role in determining structural 
properties of biomembranes (Gibellini and Smith, 2010). PS is the most abundant negatively charged 
membrane phospholipid in eukaryotes thus being an important mediator of electrostatic interactions 
between membranes and proteins (Lee et al., 2006; Leventis and Grinstein, 2010). Sphingomyelin, 
which colocalizes with cholesterol in biomembranes, is assumed to be a regulator of cholesterol 
distribution (Slotte and Ramstedt, 2007). PI, despite representing only a minor component of 
biomembranes, has a unique role within eukaryotic cells. Its phosphorylated forms, called 
phosphoinositides, can be rapidly modified by phosphorylation and dephosphorylation of their head 
group (Figure 8), thereby activating or deactivating their function as protein binding sites. Therefore, 
phosphoinositides have regulatory functions in many cellular processes, e.g. intracellular signaling, 
membrane trafficking, or membrane adhesion of the cytoskeleton (Lemmon, 2003; Scrimgeour and 
Harwood, 2007). 
 
Table 1 Lipid composition of various eukaryotic membrane systems. Data summarize the lipid constituents of the human 
erythrocyte plasma membrane (Tanford, 1980), the overall membranous system of Chinese hamster ovary (CHO) cells 
(Ohtsuka et al., 1993), the inner and outer mitochondrial membrane of Saccharomyces cerevisiae (Zinser et al., 1991), and 
the endoplasmic reticulum (ER) of murine L-cells (Murphy et al., 2000). Numbers are expressed in mol% of total lipid. Blanks 
indicate that the respective lipid species was not analyzed. As exemplified below, phospholipids represent a group of lipid 
species abundant in all biomembranes. 
 
       
Erythrocyte CHO Cells 
Mitochondria 
ER     Outer Inner 
      
      PC 19 51 46 38 46 
            PE 18 21 33 24 21 
            PI 1 8 10 16 2 
            PS 9 7 1 4 2 
            Sphingomyelin 18 9 - - 9 
            Cholesterol 25 - 0 0 20 
            Glycolipids 10 - - - - 
            Others 0 4 10 18 - 
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Figure 8 The phosphoinositide cycle in mammalian cells. Phosphatidylinositol (PI), a phospholipid constituent of 
biomembranes, can be phosphorylated at the 3, 4, and 5 position of its inositol ring. The resulting phosphorylated forms, 
called phosphoinositides, serve as protein binding sites and thereby regulate membrane functionality. Thus, the rapid 
activation and deactivation of these binding sites by phosphorylation and dephosphorylation play important regulatory 
roles within eukaryotic cells. The above scheme depicts the PI phosphorylation/dephosphorylation cycle in mammalian 
cells. The respective reactions are catalyzed by phosphatidylinositol kinases (K, the number behind the lipid name 
designates the position of phosphorylation/dephosphorylation), phosphatase and tensin homolog (PTEN), or SH2 domain-
containing inositol 5’-phosphatase (SHIP). Gray arrows indicate paths which are less well-characterized or generate only a 
minor proportion of the respective phosphoinositide. Figure taken from Lemmon (2003). 
 
The class of glycolipids comprises a heterogeneous group of lipids conjugated to one or more 
monosaccharide units. Like phospholipids, they are composed of at least one hydrophobic 
hydrocarbon tail and a polar head group, however with the hydrophilic head linked to sugar residues. 
In vivo, glycolipids are exclusively found in the non-cytosolic leaflet of lipid membranes. In addition to 
their importance in membrane stabilization and cell surface rigidization, they are also involved in 
cellular processes like cell-cell adhesion or signal transduction (Alberts et al., 2007; Holst, 2008). One 
group of glycolipids comprises lipids called cerebrosides. These glycolipids solely contain one sugar 
unit and are a key component of the insulating myelin sheaths of nerve cells (Linington and Rumsby, 
1977; Berg et al., 2012). 
Cholesterol, which constitutes up to 25 % of the lipids forming a eukaryotic biomembrane, consists 
of four interlinked hydrocarbon rings, which at one site of the molecule are attached to a 
hydrocarbon tail and at the opposite site carry a hydroxyl group. The hydrophilic hydroxyl group 
interacts with the head domains of adjacent membrane lipids, while the hydrophobic rings and tail 
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are embedded within the membrane core (Karp, 2005; Berg et al., 2012). In biomembranes, 
cholesterol decreases the permeability for small water-soluble molecules and reduces membrane 
fluidity. Furthermore, it prevents crystallization of the hydrocarbon chains of phospholipids and 
glycolipids (Shin and Freed, 1989; Alberts et al., 2007). Together with sphingomyelin, cholesterol is 
involved in the formation of membrane domains assumed to be a favorable location of certain 
membrane proteins (Slotte and Ramstedt, 2007; Goñi, 2014). 
 
 Self-Aggregation of Membrane Lipids 1.5.3
The common feature of all membrane lipids is their amphiphilicity, i.e. their composition of a 
hydrophilic and a hydrophobic moiety. In consequence, in an aqueous environment membrane lipids 
self-assemble into 3D structures shielding their hydrophobic parts from contact with water 
(Berg et al., 2012).  
In the course of self-assembly, membrane lipids can adopt distinct phases. Phases are defined as 
states of uniform physical properties, and the main phases of membrane lipids in water can be 
grouped into lamellar, micellar, inverse hexagonal, and inverse cubic phases (Figure 9). 
 
 
Figure 9 Main phases of membrane lipids dispersed in water. Due to their amphiphilicity, membrane lipids spontaneously 
self-assemble in an aqueous environment, thereby adopting distinct phases, i.e. states of uniform physical properties. Self-
assembly is driven by hydrophobic interactions, thus lipids position with their polar moieties facing the lipid-water 
interface. The four major membrane lipid phases comprise lamellar, inverse hexagonal, micellar, and inverse cubic. In 
lamellar phases, membrane lipids form bilayers. Inverse hexagonal phases are characterized by the formation of water-
filled tubes arranged in a hexagonal lattice. Micelles are spherical monolayer structures. Membrane lipids adopting inverse 
cubic phases arrange in diverse types of cubic lattices enclosing aqueous channels or cavities. Illustrations of lamellar, 
inverse hexagonal, and inverse cubic phases taken from, micellar phase redrawn in accordance with Squires et al. (2009). 
 
Introduction 
18 
Lamellar phases are characterized by the assembly of two layers of lipid molecules into a bilayer with 
the bilayer core harboring the hydrophobic moieties. Micelles display a spherical architecture with 
the hydrophobic carbohydrate chains buried in the interior. Inverse hexagonal phases consist of 
water-filled lipid tubes forming a hexagonal lattice. The lipid-water interface within the tubes is 
established by the hydrophilic lipid heads. In inverse cubic phases, lipids are organized in a cubic 
lattice enclosing aqueous cavities or channel. As in the case of inverse hexagonal phases, hydrophilic 
lipid heads face the water-filled space. 
The phase spontaneously adopted by lipids is determined by various external factors including 
temperature, pressure, and the amount of surrounding water. Changes in these factors can result in 
a transition to another lipid phase. Temperatures at which such phase transitions occur are called 
phase transition temperatures. In addition to external conditions, the molecular geometry of lipids is 
a critical factor determining the lipid phase. 
Phases commonly adopted by the majority of phospholipids and glycolipids are of lamellar nature. 
However, different lamellar phases exist each differing in the freedom of lipid movement. In general, 
biomembranes adopt the so-called liquid crystalline phase characterized by unhindered translational 
and rotational lipid movement (Goñi, 2014). 
 
 
Figure 10 Vesicle formation by membrane lipids in the lamellar phase. To prevent contact of the hydrophobic bilayer core 
with water at bilayers edges, lipids in the lamellar phase form closed, self-healing compartments. In vitro, compartment 
formation enables the preparation of synthetic vesicles. Depending on the preparation technique applied, unilamellar, 
multilamellar, or multivesicular vesicles are obtained. While unilamellar vesicles consist of a single lipid bilayer, 
multilamellar and multivesicular vesicles are composed of several concentric or non-concentric spherical bilayers 
respectively. Figure taken from van Swaay and deMello (2013). 
 
As the self-assembly of membrane lipids is predominantly driven by hydrophobic interactions, lipids 
in the lamellar phase, i.e. lipid bilayers, tend to form closed, self-healing compartments. Due to the 
absence of bilayer edges in these structures, the energetically unfavorable exposure of the 
hydrophobic bilayer core to the aqueous surroundings is avoided. In vivo, lipid self-assembly into 
closed structures enables the generation of sealed plasma membranes and the formation of distinct 
intracellular compartments (Berg et al., 2012). In vitro, it is exploited to prepare synthetic vesicles 
with diameters ranging from 25 nm to 100 μm. Depending on the applied preparation technique, 
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vesicles can be unilamellar, i.e. be formed by a single bilayer, multilamellar, i.e. be composed of 
several concentric spherical bilayers, or multivesicular, i.e. contain several non-concentric spherical 
bilayers (Figure 10; van Swaay and deMello, 2013; Stano and Luisi, 2016). 
 
 The Fluid Mosaic Model of Biomembrane Structure 1.5.4
The structure and functional properties of biomembranes have been subject of intensive scientific 
research already beginning in the 1920s and still pursued today. 
One of the early models of biomembrane architecture was proposed by Danielli and Davson (1935). 
According to their hypothesis, biomembranes are double layers of amphipathic lipid molecules with 
the polar parts of the lipids oriented towards the lipid-water interface and the hydrophobic lipid 
moieties embedded in the bilayer core. Additionally, the authors proposed the existence of a 
continuous protein film covering both faces of the membrane. 
Based on the idea of a lipid bilayer forming the fundamental structure of biomembranes, Singer and 
Nicolson (1972) developed the fluid mosaic model, which to date is commonly utilized to explain 
biomembrane architecture. Unlike Danielli and Davson, Singer and Nicolson hypothesized 
biomembranes to be fluid bilayers composed of both lipids and integral proteins. They proposed 
lipids to be the major constituent of bilayers, forming a matrix in which integral proteins are either 
embedded or which these proteins completely span. The latter type of integral protein is termed 
transmembrane protein today. Similar to membrane lipids, integral membrane proteins can be 
glycosylated, i.e. biomembranes contain glycoproteins. In addition to the existence of integral 
proteins, Singer and Nicolson pointed out that peripheral membrane proteins are locally associated 
with the hydrophilic outer surfaces of biomembranes. In the fluid mosaic model, protein and lipid 
constituents of biomembranes are not expected to exhibit a lateral long-range order, i.e. a lateral 
order over distances of several 100 nm. 
The characteristic feature of the model membrane proposed by Singer and Nicolson is the dynamic 
behavior of its constituents: lipid molecules and integral proteins perform unhindered 2D 
translational diffusion giving the membrane properties comparable to a 2D oriented viscous solution. 
Additionally, lipids and proteins freely rotate around axes perpendicular to the membrane plane. 
Importantly, the fluid mosaic model predicts that transbilayer rotations of membrane constituents 
do not proceed at significant rates. Thus, no substantial exchange of lipid and protein molecules 
between the two bilayer leaflets occurs, resulting in an asymmetry of the composition and structure 
of the distinct membrane leaflets. 
Singer and Nicolson also speculated about a potential influence of protein-protein and protein-lipid 
interactions on biomembrane properties, for example due to the formation of aggregates. Further, 
they suggested the possibility of varying bilayer thickness at membrane areas surrounding large 
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integral proteins, and considered the potential existence of membrane lipid fractions not organized 
in a bilayer structure. 
Following its publication, the fluid mosaic model has been complemented and partially modified by 
findings obtained through the scientific research of the past decades (Figure 11). 
 
 
Figure 11 Adapted fluid mosaic model of the structure of eukaryotic membranes. Amphipathic membrane lipids form a 
bilayer in which a high density of integral proteins is embedded. Both membrane lipids and integral proteins can carry 
covalently linked carbohydrate chains. Peripheral membrane proteins transiently or irreversibly bind to the hydrophilic 
outer surfaces of the biomembrane. Due to the high spatial density of membrane proteins, protein-protein and protein-
lipid interactions cause a restriction of lateral diffusion. Moreover, areas of specific chemical composition exist throughout 
the membrane plane. These so-called membrane domains presumably fulfill specific functions. Cholesterol is one of the 
constituents of biomembranes known to be involved in domain formation. In the above illustration, a 
glycosylphosphatidylinositol-anchored (GPI-anchored) protein, i.e. a protein covalently linked to a glycolipid, is shown to be 
associated with such a membrane domain. Figure taken from Dowhan et al. (2016). 
 
One of the novel aspects of biomembrane architecture was the finding that in fact, integral 
membrane proteins are inserted into membranes at such high densities that hardly any membrane 
area is left unperturbed. In addition, the existence of bulky extra-bilayer membrane protein domains 
was discovered. As a consequence of this high spatial density of proteins, protein-protein and 
protein-lipid interactions cause a pronounced restriction of lateral diffusion within biomembranes 
(Engelman, 2005). Resulting diffusion coefficients were determined to range between 10-13 m2·s-1 and 
10-12 m2·s-1 in the case of lipids, and between 10-15 m2·s-1 and 10-13 m2·s-1 for integral proteins 
(Edidin, 1974). Furthermore, it could be verified that the presence of large integral membrane 
proteins leads to variations in bilayer thickness. However, spatial and temporal fluctuations in 
membrane thickness occur rather frequently due to the high incidence of integral proteins (Holt and 
Killian, 2010; Goñi, 2014). Another finding complementing the fluid mosaic model was the discovery 
of transiently attached peripheral membrane proteins: depending on the prevailing physiological 
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conditions, certain proteins reversibly bind to biomembranes and return to the aqueous 
environment after detachment (Nicolson, 1976; Burn, 1988). 
In addition to an impact of high membrane protein density, dynamics of biomembrane constituents 
are also altered in areas of different lipid phase. While the liquid crystalline phase is the phase 
primarily adopted by membrane lipids, further lipid phases, which exhibit different degrees of 
translational and rotational freedom, have been shown to be of physiological importance as well 
(de la Serna et al., 2004; Zhang et al., 2009). The combined effect of varying lipid phases, protein-
protein interactions, and protein-lipid interactions gives rise to the formation of membrane domains, 
areas of specific chemical composition which presumably fulfill particular functions. These domains 
exist in a variety of sizes, with diameters supposably starting at less than 100 nm and reaching up to 
several μm. In contrast to the initial fluid mosaic model, the presence of such long-range order is now 
actually assumed to be a common feature of biomembranes (Pike, 2006; Goñi, 2014). 
Apart from its importance in domain formation, the coexistence of different lipid phases within 
biomembranes is also thought to enable the transient generation of non-bilayer intermediate 
structures arising during processes like membrane fusion or fission (Chernomordik and Zimmerberg, 
1995; Yang and Huang, 2003; Goñi, 2014). 
Importantly, research of the past decades also elucidated geometric aspects of biomembrane 
architecture. Today, biomembranes are not considered plane objects but structures exhibiting 
dynamically modulated curvature (Goñi, 2014). The induction and sensing of bilayer curvature is an 
important aspect of the interaction of numerous proteins with biomembranes and will be described 
in greater detail in subsection 1.5.6. 
Another modification of the fluid mosaic model is the fact that in biomembranes transbilayer 
rotations, so-called flip-flops, of lipids occur at significant rates. Occurrence of flip-flops is locally 
restricted and the resulting exchange of lipids between the bilayer leaflets is of transient nature. 
Transbilayer rotations can happen spontaneously or can be catalyzed by specific proteins 
(Contreras et al., 2003, 2010). 
 
 Phospholipid Binding by Peripheral Membrane Proteins 1.5.5
Biomembranes are complex mixtures of manifold lipid and protein species and their constituents are 
involved in a wide range of intermolecular interactions (Goñi, 2014). As the present study is 
concerned with the binding of the motor protein myosin-XXI to phospholipid bilayers, the association 
of peripheral membrane proteins with membrane-embedded phospholipids will be addressed in this 
subsection. 
Peripheral membrane proteins associate with membrane phospholipids via lipid binding domains. 
These domains are attracted to and bind to lipids by non-covalent forces, mainly electrostatic, van 
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der Waals, and hydrophobic interactions and hydrogen bonds. Frequently, membrane binding 
involves not a single type but a combination of these interactions. Phospholipid binding domains of 
peripheral membrane proteins exhibit various structures ranging from structurally defined globular 
domains to unstructured domains (Lemmon, 2008; Goñi, 2014). 
 
Table 2 Globular phospholipid binding domains of peripheral membrane proteins. At present, globular phospholipid 
binding domains can be grouped into a minimum of 11 distinct classes. In the overview given below, general properties of 
the majority of domains of a specific class are summarized. Within some of these classes, variations concerning preferred 
ligands and ligand specificity exist. If not stated otherwise, lipid binding generally exhibits little or no target specificity or 
stereospecific lipid binding is limited to certain representatives of the respective domain class. Note that PX and FYVE 
domains primarily target PI(3)P with high stereospecificity. C1 domains, the targets of which do not belong to the class of 
phospholipids, are commonly considered as phospholipid binding domains as one of their targets, diacylglycerol, is only one 
phosphate group short of being classified as phospholipid (Lemmon, 2008). Abbreviations: ANTH: AP180 N-terminal 
homology; BAR: Bin-amphiphysin-Rvs; C1: protein kinase C conserved region 1; C2: protein kinase C conserved region 2; 
ENTH: epsin N-terminal homology; FERM: 4.1/ezrin/radixin/moesin; FYVE: Fab1/YOTB/Vac1/EEA1; PDZ: PSD-95/Dlg/ZO-1; 
PH: pleckstrin homology; PX: phox homology; PS: phosphatidylserine; PI(4,5)P2: phosphatidylinositol 4,5-bisphosphate; 
PI(3)P: phosphatidylinositol 3-phosphate; PI(3,4,5)P3: phosphatidylinositol 3,4,5-trisphosphate; PI(3,4)P2: 
phosphatidylinositol 3,4-bisphosphate.  
 
     Domain Typical Size [aa] Structure Preferred Lipid Target References 
     
     
ANTH ~280 α-helical solenoid phosphoinositides 
Ford et al. (2001), 
Itoh and De Camilli 
(2006) 
          
BAR ~250-280 
extended α-helical 
bundle 
acidic phospholipids Ren et al. (2006) 
          
C1 ~50 Zn2+ finger 
diacylglycerol, phorbol 
esters 
Zhang et al. (1995),  
Colón-González and 
Kazanietz (2006) 
          
C2 ~130 β-sandwich PS, phosphoinositides 
Sutton et al. (1995),  
Cho and Stahelin (2006) 
          
ENTH ~140 α-helical solenoid PI(4,5)P2 
Kay et al. (1999),  
Itoh et al. (2001) 
          
FERM ~300 
clover-shaped 
complex consisting of  
3 α- and β-structured 
modules 
phosphoinositides 
Niggli et al. (1995),  
Pearson et al. (2000), 
Moleirinho et al. (2013) 
          
FYVE ~70 Zn2+ finger 
PI(3)P  
(highly stereospecific) 
Kutateladze (2006) 
          
PDZ ~90 
β-sandwich capped 
by 2 α-helices 
PI(4,5)P2, PI(3,4,5)P3 Gallardo et al. (2010) 
          
PH ~120 
β-sandwich capped 
by an α-helix 
phosphoinositides 
Lemmon and Ferguson 
(2000),  
Lemmon (2007) 
          
PX ~110 α- and β-structured 
PI(3)P  
(highly stereospecific) 
Teasdale and Collins 
(2012) 
          
Tubby ~260 
β-sandwich enclosing 
a hydrophobic α-helix 
PI(3,4)P2, PI(4,5)P2, 
PI(3,4,5)P3 
Boggon et al. (1999),  
Santagata et al. (2001) 
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At present, at least 11 distinct classes of globular phospholipid binding domains are known 
(Stahelin, 2009). An overview of these classes is given in Table 2. The interaction of globular binding 
domains with lipid bilayers can be mediated by both the attraction to general physical bilayer 
properties like surface charge, and the stereospecific recognition of particular lipid head groups. 
Interestingly, the contribution of these two modes of interaction to membrane association differs 
even between domains of the same class (Lemmon, 2008). 
One example of a globular phospholipid binding domain is the phox homology (PX) domain, an 
approximately 110 aa long domain containing the consensus sequence R[Y/F]x23-30Kx13-23R 
(R: arginine, Y: tyrosine, F: phenylalanine, x: arbitrary aa, K: lysine). PX domains exhibit a highly 
conserved structure with an electropositive basic binding pocket that directly binds negatively 
charged phosphates of phosphoinositide head groups (Figure 12). Head group binding involves the 
establishment of electrostatic bonds, stacking interactions and the formation of hydrogen bonds, and 
is stereospecific in the majority of PX domains investigated so far. Commonly, phosphatidylinositol 
3-phosphate (PI(3)P), which is primarily found in the cytosolic leaflet of early endosomes, is the 
preferred ligand of PX domains (Seet and Hong, 2006; Teasdale and Collins, 2012). Though, research 
has also revealed the existence of PX domains that do not exhibit a preference for a specific 
phosphoinositide binding partner, as for example the PX domain identified within the myosin-XXI 
converter region (Kanai et al., 2001; Song et al., 2001; Batters et al., 2014). Interestingly, the 
insertion of hydrophobic amino acids into the lipid bilayer has been demonstrated to play an 
important role in the membrane association of certain PX domains (Stahelin et al., 2003, 2007). 
However, structured phospholipid binding domains do not only comprise globular domains. 
Amphipathic helices, which have been identified in many proteins and peptides, are α-helical motifs 
exhibiting two opposite faces, one concentrating hydrophobic amino acids and the other enriched in 
polar residues. Amino acid sequences forming amphipathic helices do not adopt a defined structure 
in solution. Instead, they fold into their helical conformation when inserting into a bilayer. When 
embedded in a bilayer, the hydrophobic face of the helix is buried inside the hydrophobic bilayer 
core while the polar face is located between the membrane lipid heads and at the lipid-water 
interface. Importantly, the folding of amphipathic helices into lipid bilayers depends on the presence 
of lipid packing defects and can thus only proceed in positively curved membranes (see 
subsection 1.5.6; Segrest et al., 1990; Hristova et al., 1999; Madsen et al., 2010; Cui et al., 2011). 
Basic-hydrophobic-basic (BHB) domains are representatives of the group of unstructured 
lipid binding domains. These domains, which are formed by patches of hydrophobic amino acids 
enclosed by basic residues, are proposed to attach to membranes due to a combination of 
electrostatic attraction and insertion of hydrophobic moieties into the lipid bilayer (Figure 12; 
McLaughlin and Murray, 2005; Brzeska et al., 2008). 
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The association of phospholipid binding domains with biomembranes can be regulated and tuned by 
several factors. The stereospecific recognition of phospholipids which are synthesized in a temporally 
or spatially restricted fashion controls the membrane binding reaction in space or time. Furthermore, 
the requirement for soluble second messengers like Ca2+ is an important regulator of bilayer binding. 
In addition, physical properties of biomembranes, e.g. charge or amphiphilicity, are capable of 
modulating attachment of phospholipid binding domains (Lemmon, 2008). In particular, membrane 
curvature has been demonstrated to play a crucial role in protein-bilayer association (e.g. Wetterau 
and Jonas, 1982; Davidson et al., 1998; Bhatia et al., 2009; Gerlach et al., 2010) and will therefore be 
addressed in a separate subsection (see subsection 1.5.6). 
Noteworthily, the attachment of certain peripheral membrane proteins to specific biomembranes is 
guaranteed by the coincidence detection of several membrane characteristics, i.e. of physical 
membrane properties, membrane constituents, or a combination of both. Coincidence detection can 
be implemented by cooperating lipid binding domains, cooperating lipid binding and protein binding 
domains, or even by a single lipid binding domain containing two distinct lipid binding sites 
(Lemmon, 2008). For example, the binding of sorting nexin 1 to endosomal membranes is regulated 
by the combined preference of its BAR domain for positive bilayer curvature and the recognition of 
PI(3)P and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) by its PX domain (Carlton et al., 2004). 
 
 
Figure 12 Membrane binding by PX and BHB domains. (A) Surface structure of the PX domain of the p40
phox
 subdomain of 
NADPH oxidase in complex with PI(3)P. PI(3)P is located within the deep positively charged binding pocket of the PX 
domain. The conserved amino acids of the R[Y/F]x23-30Kx13-23R consensus sequence and their interaction with PI(3)P are 
indicated: the N-terminal arginine (Arg
P3
) electrostatically associates with the 3-phosphate group, the tyrosine (Tyr
inositol
) 
side chain binds the inositol ring via a stacking interaction, lysine (Lys
P1
) electrostatically interacts with the 1-phosphate, 
and the C-terminal arginine (Arg
4,5-hydroxyl
) forms hydrogen bonds with the 4- and 5-hydroxyl groups of the inositol ring. 
Figure taken from Teasdale and Collins (2012). (B) Atomic model of the BHB domain of MARCKS bound to a lipid bilayer. The 
MARCKS BHB region consists of five hydrophobic (green) and 13 basic (blue) amino acid residues. Basic side chains mediate 
electrostatic interaction with the bilayer, while hydrophobic residues penetrate the bilayer core. Both in solution and when 
bound to membranes, the BHB domain adopts an elongated unstructured conformation. Figure taken from McLaughlin and 
Murray (2005). 
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 Biomembrane Curvature 1.5.6
In eukaryotic cells, biomembranes define organelles and compartments highly variable in size ranging 
from vesicles of less than 100 nm in diameter to whole cells of a size of 10 μm and more. In addition, 
various organelles like the ER, the Golgi apparatus, or mitochondria form tubulated, folded, or disk-
like structures. Furthermore, intracellular trafficking processes like endocytosis or vesicular transport 
between distinct organelles involve the generation of highly curved compartments (Karp, 2005; 
McMahon and Boucrot, 2015). Hence, membrane surfaces of diverse degrees of curvature are 
omnipresent within the intracellular environment. 
In general, the term curvature refers to the reciprocal radius of curvature (Goñi, 2014). For vesicular 
lipid bilayers, the radius of curvature is identical to the vesicle radius, i.e. curvature of the bilayer 
surface increases with decreasing vesicle size. The terms negative and positive curvature refer to the 
spatial orientation of curved surfaces: convex surfaces are positively curved, while concave surfaces 
exhibit negative curvature (Antonny, 2011). 
The local curvature of a biomembrane can be regulated by the constituents of the membrane itself 
and by forces exerted on the membrane by the cytoskeleton (McMahon and Boucrot, 2015). 
The fundamental principle of curvature generation and stabilization by membrane 
constituents is the generation of a geometric asymmetry of the opposing membrane leaflets 
(Goñi, 2014). As the molecular geometry of lipids determines the shape of the monolayer they are 
incorporated in, such asymmetry can be imposed by the heterogeneous distribution of lipid species 
between the two leaflets of a biomembrane. Depending on the overall molecule length and the 
cross-sectional areas occupied by the hydrophilic and the hydrophobic moiety, membrane lipids 
favor the assembly into planar, negatively curved, or positively curved monolayers (Figure 13; 
Marsh, 1996; McMahon and Boucrot, 2015). The organization of lipids within monolayers is also 
referred to as lipid packing. 
Apart from lipid constituents, membrane proteins can be involved in curvature generation and 
stabilization as well. Transmembrane proteins possessing a conical structure can simply bend the 
lipid bilayer they are integrated in due to their shape (Fertuck and Salpeter, 1974; Unwin, 2005; 
Fribourg et al., 2014). In addition, the interaction of large integral proteins with membrane lipids can 
enforce a vertical expansion of the bilayer (Holt and Killian, 2010). Crowding and oligomerization of 
membrane proteins can also induce or stabilize membrane curvature, for example due to the 
accumulation of large extramembranous protein domains at one of the two bilayer faces 
(Ĉopiĉ et al., 2012; McMahon and Boucrot, 2015). Further, biomembrane curvature is suggested to 
be regulated by protein scaffolding, i.e. the clustering of peripheral membrane proteins. In this case, 
peripheral proteins are thought to impose their surface shape on the membrane, however the exact 
mechanism underlying this process is still not clear. Another mechanism of curvature regulation by 
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peripheral membrane proteins is the insertion of hydrophobic motifs into the bilayer core 
(Campelo et al., 2008; Stachowiak et al., 2012; Kozlov et al., 2014). 
Biomembrane deformations of larger scale are mediated by the cytoskeleton. Forces required to 
change membrane shape are generated by the polymerization of filaments or by motor-driven 
translocation of membrane-associated filaments (Doherty and McMahon, 2008; Leduc et al., 2010). 
The regulation of membrane shape by cytoskeletal components is crucial for the formation of 
membrane protrusions, as for example filopodia (see subsection 1.5.7). 
 
 
Figure 13 The curvature of biomembranes. (A) Regulation of membrane shape by lipid molecule geometry. Curvature can 
be imposed by an asymmetry of the distribution of lipid species between the two lipid monolayers of a membrane. 
According to their molecular shape, i.e. the overall molecule length and the cross-sectional areas occupied by the 
hydrophilic and the hydrophobic moieties, membrane lipids assemble into (1) positively curved (e.g. PI), (2) negatively 
curved (e.g. PE), or (3) planar monolayers (e.g. PC, PS). Figure taken from Goñi (2014). (B) Regulatory functions of 
membrane curvature. Bilayer shape is capable of controlling the spatial distribution (illustrated above) and the function of 
curvature sensitive lipid binding proteins. The upconcentration of proteins at bilayer surfaces of high positive curvature is 
assumed to be based on the hydrophobic insertion of protein motifs into the bilayer core. This insertion process requires 
the presence of lipid packing defects, the surface density of which increases with increasing membrane curvature. Figure 
taken from Hatzakis et al. (2009). 
 
Importantly, the spatially and temporally controlled emergence of membrane curvature allows for 
the regulation of the localization or function of proteins which exhibit membrane curvature 
sensitivity (MCS). MCS can manifest in two different ways (Madsen et al., 2010): firstly, lipid binding 
proteins can undergo structural adaptations in response to their association with curved bilayers. 
Thereby, bilayer curvature modulates functional properties of these proteins. This mechanism has for 
instance been shown to regulate the catalytic activity of certain membrane-associated enzymes like 
protein kinase C and Thermomyces lanuginosa lipase (Slater et al., 1994; Cajal et al., 2000). The 
second manifestation of MCS, which was considered in the present experimental work with 
myosin-XXI, is characterized by a curvature-dependent membrane association of proteins, which in 
turn can cause a targeted localization or redistribution of proteins within the cellular environment. In 
the following chapters, the term MCS will always refer to a curvature dependency of protein-bilayer 
binding. The N-BAR domain of endophilin A1 (eNBAR), i.e. the functional unit of N-terminal 
amphipathic helix and BAR domain, is one of the motifs identified as a curvature sensor of the 
second type. The investigation of vesicle binding by eNBAR revealed an upconcentration of this 
domain at the surfaces of small vesicles, i.e. at bilayers of high positive curvature (Bhatia et al., 2009). 
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Furthermore, amphipathic helices have been demonstrated to exhibit enhanced binding to positively 
curved membranes (Cornell and Taneva, 2006; Drin et al., 2007; Antonny, 2011). 
Noteworthily, the sensing of positive bilayer curvature is proposed to be mediated by the insertion of 
hydrophobic motifs into the bilayer core (Figure 13). As this insertion is dependent on the presence 
of lipid packing defects, i.e. areas of packing mismatch where the hydrophobic bilayer interior is 
exposed to the aqueous environment, sensitivity for positive membrane curvature too is expected to 
rely on the presence of packing defects (Hatzakis et al., 2009; Madsen et al., 2010; Cui et al., 2011). 
Another interesting aspect of curvature-dependent bilayer binding is that to date several proteins 
have been identified as coincident sensors and inducers of membrane curvature (Wetterau and 
Jonas, 1982; Davidson et al., 1998; Kurten et al., 2001; Carlton et al., 2004; Gerlach et al., 2010; 
Varkey et al., 2010). However, the existence of a functional relation between MCS and bilayer 
deformation is still under debate (e.g. Zimmerberg and Kozlov, 2006; Arkhipov et al., 2009; 
Bhatia et al., 2009; Madsen et al., 2010). 
Importantly, none of the above-mentioned manifestations of MCS has so far been found to exhibit a 
maximum effect within a specific range of bilayer curvature. Instead, increases in bilayer curvature 
always result in an enhanced efficiency of the regulation of protein function or localization 
(Madsen et al., 2010). 
 
 Filopodia 1.5.7
In order to perform specific functions like cell motility, probing of the cell´s environment, secretion, 
or nutrient absorption, eukaryotic cells form plasma membrane protrusions supported by 
cytoskeletal filaments, e.g. actin-based microvilli and filopodia, or microtubule-based cilia and flagella 
(Alberts et al., 2007). 
In the present in vivo studies, fluorophore-labeled myosin-XXI was found to localize within the 
filopodia of transfected mammalian cells. Moreover, myosin-XXI was shown to increase the number 
and length of filopodia formed by transfected cells. As these findings connect myosin-XXI function 
with processes involved in the formation or maintenance of filopodia, a short description of the 
architecture of these membrane protrusions will be given here. 
Filopodia are slender protrusions of the plasma membrane that are supported by tight parallel 
bundles of 10 to 20 actin filaments. They can grow up to several μm, occasionally several tens of μm, 
in length (Mattila and Lappalainen, 2008; Nambiar et al., 2010). The formation of filopodia is a 
complex process promoted by many proteins and is still not understood completely. Simulation 
calculations (Peskin et al., 1993; Mogilner and Oster, 1996) have shown that the force required to 
protrude the plasma membrane in order to form these rod-like structures is provided by the 
polymerization of actin at the membrane-facing barbed ends of actin filaments. As a whole, the 
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length of a filopodium is regulated by the balance between barbed end actin assembly and 
retrograde flow of actin (Mallavarapu and Mitchison, 1999). Retrograde flow is the rearward 
movement of F-actin toward the cell body and is assumed to be driven by myosins (Lin et al., 1996; 
Suter and Forscher, 2000). 
 
 
Figure 14 Model of filopodia formation. In this model, Mattila and Lappalainen (2008) propose a mechanism for the 
initiation and elongation of filopodia. (1) Uncapped actin filaments branching from the ARP2/3-regulated actin network or 
emerging from Dia2-induced nuclei are continuously elongated. Elongation is assisted by Dia2 and/or Ena/VASP family 
proteins. Barbed filament ends face the plasma membrane and are converged by myosin-X thereby creating an initiation 
site of filopodia formation. (2) As the nascent filopodium starts to protrude the plasma membrane, IRSp53 is recruited to 
the initiation site. Once IRSp53 has bound to the membrane, it either assists further membrane deformation or 
alternatively recruits additional components promoting filopodia formation. At this point in time, Ena/VASP proteins might 
also act as initial cross-linkers. (3) Fascin assembles actin filaments into stiff bundles. Myosin-X might now deliver adhesion 
molecules to the filopodia tip and/or link the actin bundle to the plasma membrane. Dia2 stays at the distal end of the 
filopodium. As part of a tip complex, it continues to promote actin polymerization. Figure taken from Mattila and 
Lappalainen (2008). 
 
In addition to actin, several other molecular constituents have been shown to promote the initiation, 
elongation, and stabilization of filopodia taking action at different stages of filopodia assembly and 
growth: the formin Dia2 induces actin nucleation and facilitates addition of G-actin to the growing 
plus ends of filaments, while proteins of the Ena/VASP family prevent capping of the barbed filament 
ends thus preventing a polymerization halt. In addition, Ena/VASP family proteins presumably bundle 
nascent actin filaments (Krause et al., 2003; Schirenbeck et al., 2005, 2006). Other bundling proteins 
then cross-link elongating F-actin to bundles constituting the core of filopodia. One of these proteins 
is fascin, which mediates the generation of actin bundles of increased stiffness (DeRosier and Edds, 
1980). Furthermore, actin-associated motor proteins are proposed to play a role in filopodia 
formation. Myosin-X, which has been demonstrated to localize within filopodia, is assumed to initiate 
filopodia by bundling F-actin at the plasma membrane, to enhance filopodia elongation by 
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transporting components involved in filopodia assembly, and to link integrins to the filopodial actin 
core (Sousa and Cheney, 2005; Tokuo et al., 2007; Watanabe et al., 2010). Also, it is suggested that 
proteins such as IRSp53, which contain lipid binding I-BAR (inverse BAR) domains, promote the 
formation of filopodia by protruding the plasma membrane owing to their membrane deforming 
capability (Scita et al., 2008). In the case of IRSp53, an interaction of membrane-bound protein with 
other components of filopodia formation is considered as well. Adhesion molecules like integrins 
mediate the attachment of filopodia to the surrounding environment (Mattila and Lappalainen, 
2008). A model of filopodia formation as proposed by Mattila and Lappalainen (2008) is depicted in 
Figure 14. 
Importantly, the spatial distribution and the activity of many proteins implicated in filopodia 
assembly are regulated by phospholipid constituents of the plasma membrane. Phosphatidylinositol 
4,5-bisphosphate (PI(4,5)P2) represents one of these constituents as it controls the actin 
polymerization machinery (Hilpelä et al., 2004). 
 
 
Figure 15 Forms of Leishmania throughout the parasitic life cycle. Scanning electron microscopy images of Leishmania 
mexicana. (A) The motile promastigote exhibits an elongated form with a fully developed flagellum. (B) Amastigotes display 
an ovoid form and development of a merely rudimentary flagellum inhibits motility. Scale bars: 2 μm. Images taken from 
The Cell Image Library (2016), Cell Image Library numbers: 10603 (A), 12403 (B). 
 
1.6 Myosin-XXI and Leishmania 
Myosin-XXI is a motor protein specifically expressed by eukaryotes belonging to the class of 
Kinetoplastea (Foth et al., 2006). In the past years, this molecular motor was identified as a critical 
factor for the survival of Leishmania donovani (L. donovani), a parasite of clinical importance as it 
causes the human disease leishmaniasis (Rodrigues et al., 2014). In agreement with its vital role, 
myosin-XXI was found to be involved in the essential biomembrane-associated cellular processes of 
endocytosis, exocytosis, intracellular vesicle trafficking, and flagellum formation (Katta et al., 2010). 
As the present study investigated the molecular bases of L. donovani myosin-XXI function, an 
introduction on the structure and the cellular role of this motor protein will be given in the following 
subsections. Further, cellular architecture and clinical relevance of Leishmania parasites will be 
described. 
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 Leishmania and Their Parasitic Life Cycle 1.6.1
Leishmania are unicellular, uniflagellate parasites belonging to the family of Trypanosomatidae. 
Today, 21 species of the Leishmania genus are known to cause leishmaniasis, a human disease 
belonging to the group of neglected tropical diseases (Rodrigues et al., 2014). 
Leishmania undergo a digenetic life cycle involving two hosts: an insect vector, in which the parasites 
exist in an elongated, flagellate motile form called promastigote, and a mammalian vector, in which 
the parasites differentiate into their immotile amastigote form characterized by an ovoid shape and a 
rudimentary flagellum (Figure 15; Forestier et al., 2011; Rodrigues et al., 2014). 
The Leishmania life cycle is characterized by multiple developmental stages within each host. 
Throughout one cycle, the parasites alternate between their two forms in order to adapt to their 
current habitat (Figure 16; Rodrigues et al., 2014). 
 
 
Figure 16 The life cycle of Leishmania. Leishmania amastigotes are transmitted from a mammalian host to a sandfly during 
its blood meal. In the sandfly midgut or hindgut, amastigotes transform into procyclic promastigotes, which reproduce and 
differentiate into infective metacyclic promastigotes. Upon inoculation into the following mammalian host, metacyclic 
promastigotes are ingested by phagocytes. Within these cells, promastigotes transform back into amastigotes and replicate. 
Rupture of infected cells releases Leishmania into the bloodstream resulting in the infection of further cells. Blood uptake 
by another sandfly initiates the next cycle. Figure taken from Kaye and Scott (2011). 
 
Within the bloodstream of an infected mammalian host, Leishmania exist in their non-motile 
amastigote form. Amastigotes are ingested by a sandfly during its blood meal, and within the sandfly 
gut, they transform into non-infective, flagellated procyclic promastigotes, which quickly reproduce 
and subsequently differentiate into non-dividing, infective metacyclic promastigotes. Metacyclic 
promastigotes migrate to the proboscis from where they are inoculated into another mammalian 
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host during a subsequent blood meal. Within their new mammalian host, promastigotes attach to 
and are ingested by phagocytes. In phagolysosomes, Leishmania transform back into their 
amastigote form and replicate by binary fission. Once a large number of amastigotes has evolved, 
phagocytes rupture and release amastigotes into the bloodstream. Now, amastigotes can reinfect 
further host cells. Once blood of the infected mammalian host is consumed by another sandfly, life 
cycle of Leishmania is repeated (Bates, 1994; Kaye and Scott, 2011; Rodrigues et al., 2014). 
 
 Clinical Relevance 1.6.2
According to the World Health Organization, about 12 million people worldwide currently suffer from 
leishmaniasis with an estimated number of 2 million new cases occurring per year (WHO, 2016). 
Furthermore, 350 million people are at risk of contracting the disease (WHO, 2010). In 2012, 
leishmaniasis was reported to affect patients in a total of 98 countries in five continents (Alvar et al., 
2012). 
Leishmaniasis presents five main clinical manifestations, which are specified in Table 3. 
 
Table 3 Main clinical manifestations of leishmaniasis. Leishmaniasis displays five main clinical manifestations causing 
distinct somatic symptoms, which are summarized below (WHO, 2010; Rodrigues et al., 2014). 
 
  
Clinical Manifestation Symptoms 
    cutaneous leishmaniasis 
 
 
 formation of localized ulcerating skin lesions 
 usually self-healing 
 formation of disfiguring scars 
    diffuse cutaneous 
leishmaniasis 
 formation of non-ulcerative skin lesions 
 thickening of the eyebrows and ear lobes 
    mucocutaneous 
leishmaniasis 
 formation of mucosal lesions of the mouth and the upper respiratory 
tract 
 obstruction and destruction of the nose, the pharynx, and the larynx 
lead to severe mutilation 
    visceral leishmaniasis 
(kala-azar) 
 fever 
 weight loss 
 splenomegaly, hepatomegaly 
 lymphadenopathy 
 possible occurrence of post-kala-azar dermal leishmaniasis 
    post-kala-azar dermal 
leishmaniasis 
 complication of visceral leishmaniasis, which appears up to years 
after apparent successful treatment 
 formation of lesions of skin and mucosa 
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 Cytoskeleton and Molecular Motors of Leishmania 1.6.3
The cytoskeleton of Leishmania is mainly composed of microtubules, which generate a network 
spanning the cytoplasm but also form the subpellicular corset and the axoneme. 
The subpellicular corset, which is essential for maintaining the shape of the parasites, is a cortical 
network of cross-linked microtubules. It is tied to the plasma membrane by thin filaments of 6 nm in 
diameter (Gull, 1999; Rodrigues et al., 2014). 
The axoneme is one of the basic structural elements of the flagellum, a dynamic whip-like membrane 
protrusion essential for motility, cellular organization, parasite attachment to the sandfly gut, and 
sensory perception. The flagellum originates from a structure called basal body and extends through 
the flagellar pocket, a large membrane invagination which is also the site of endocytosis and 
exocytosis. In their non-motile amastigote stage, Leishmania only carry a rudimentary flagellum, 
which contains an axoneme composed of a ring of nine canonical microtubule doublets. In the 
promastigote stage, the flagellum is fully developed and in addition to the nine canonical pairs of 
microtubules, harbors a microtubule doublet within its center (Field and Carrington, 2009; 
Gluenz et al., 2010). Apart from the axoneme, the promastigote flagellum is composed of a second 
basic structure, the paraflagellar rod. The paraflagellar rod, a lattice-like array of filaments, is located 
alongside the axoneme with filaments of varying thickness interlinking both structures. It is 
composed of a large number of proteins many of which have not been identified yet, and has been 
shown to be crucial for parasite motility (Santrich et al., 1997; Gull, 1999; Rodrigues et al., 2014). 
In agreement with microtubules representing the major cytoskeletal constituent, several 
microtubule-associated motor proteins have been identified in Leishmania, as for example a class XIII 
kinesin or two distinct dynein-2 heavy chains. Furthermore, processes like intraflagellar transport and 
flagellum assembly and disassembly are proposed to involve the activity of microtubule-associated 
molecular motors (Adhiambo et al., 2005; Blaineau et al., 2007; Cole and Snell, 2009). 
In recent years, studies of Leishmania have also demonstrated the presence of actin within the 
parasites. In L. donovani promastigotes, actin was found to be distributed along the flagellum and to 
form granules, patches, and short filaments and bundles within the cytoplasm (Sahasrabuddhe et al., 
2004). Despite the fact that no evidence for the existence of a complex actin network within 
Leishmania has so far been reported, the presence of dynamic i.e. polymerizing and depolymerizing 
actin was shown to be essential for the formation of a functional flagellum, endocytosis, exocytosis, 
and intracellular vesicle transport (Tammana et al., 2008; Katta et al., 2010; Kumar et al., 2012; 
Rodrigues et al., 2014). Additionally, genetic analysis revealed that two myosin genes exist within the 
Leishmania genome with one gene encoding a class IB myosin and the other encoding myosin-XXI 
(El-Sayed et al., 2005; Odronitz and Kollmar, 2007). While verification of myosin-Ib expression in 
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Leishmania has not been successful, myosin-XXI was demonstrated to be expressed in Leishmania 
and was shown to fulfil tasks critical for parasite survival (Katta et al., 2009, 2010). 
 
 Myosin-XXI 1.6.4
Myosin-XXI is a kinetoplastid-specific motor protein, which had originally been classified as class XXI 
myosin but was assigned to class XIII in a later phylogenetic analysis (Foth et al., 2006; Odronitz and 
Kollmar, 2007). As this motor protein is referred to as myosin-XXI in the literature cited in the present 
work, this nomenclature is retained. 
Within the scope of this thesis, experimental studies of L. donovani myosin-XXI were performed. 
Accordingly, functional and structural properties of this specific motor protein will be described here.  
The structure of 1050 aa long L. donovani myosin-XXI (Figure 17, Table C.1) comprises the 
typical domain sequence of myosins consisting of motor domain, neck region, and tail domain. The 
catalytic domain of myosin-XXI is preceded by an N-terminal SH3-like domain, the function of which 
still needs to be investigated (Odronitz and Kollmar, 2007; Batters et al., 2014). The converter region 
(aa 662-747) in the C-terminal portion of the head is directly followed by an IQ motif (aa 754-769) 
within the neck of the motor protein. Noteworthily, several aa stretches resembling an IQ motif were 
identified within the myosin-XXI sequence but binding of calmodulin or calmodulin-like proteins was 
exclusively attributed to the region of aa 754 to 769. The neck domain was predicted to contain a 
coiled coil region, which is proposed to mediate dimerization. 
 
 
Figure 17 Structure of L. donovani myosin-XXI. L. donovani myosin-XXI consists of 1050 aa and exhibits the typical myosin 
structure comprising a motor, a neck, and a tail domain. At its N-terminus, the motor is preceded by an SH3-like domain. In 
a previous study of our lab (Batters et al., 2014), the conserved structural motifs of the ATP/ADP binding pocket, switch I 
(Sw. I), switch II (Sw. II), and the relay loop were localized. Furthermore, the converter domain in the C-terminal part of the 
head was located. Within the neck domain of myosin-XXI, presence of a light chain binding IQ motif was demonstrated and 
existence of a coiled coil region was predicted. The latter is assumed to mediate dimer formation. Additional potential 
coiled coil regions were found within the tail domain. The indicated score, which can adopt values between 0 and 10, 
quantifies propensity of oligomerization. Positive values indicate dimerization, negative values imply trimer formation. 
Within the myosin-XXI converter, neck and tail, several lipid binding sites were identified. These sites comprise a PX domain 
and potential lipid binding motifs exhibiting a BHB sequence. BHB regions in the top row were determined by basic and 
hydrophobic score calculation, BHB regions in the bottom row were determined by sequence analysis. The indicated scale 
specifies intramolecular position in units of 100 aa. 
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Additional potential coiled coil regions were located within the myosin tail but have not been 
experimentally characterized (Batters et al., 2012, 2014). In contrast to other myosins known to date, 
the C-terminus of the myosin-XXI tail contains two ubiquitin-associated (UBA) domains (Odronitz and 
Kollmar, 2007). UBA domains are typically found in proteins involved in the proteasomal degradation 
pathway, DNA excision repair, or protein kinase-dependent cell signaling (Hofmann and Bucher, 
1996). However, the specific function of the myosin-XXI UBA domains is still to be investigated 
(Katta et al., 2009). 
As described in a previous publication of our lab (Batters et al., 2014), myosin-XXI also contains 
binding sites for phospholipids. Basic and hydrophobic score calculations and sequence analyses 
revealed the existence of lipid binding domains within the tail, neck, and converter domain. These 
lipid binding sites comprise a converter-located PX domain and several potential lipid binding motifs 
displaying basic-hydrophobic-basic sequences. In vitro binding studies based on membrane lipid 
strips and co-sedimentation assays demonstrated that myosin-XXI is capable of associating with 
phospholipids via its PX domain and via several binding sites C-terminal of aa 730. 
 
 
Figure 18 Model of the regulation of myosin-XXI dimerization, motility, and lipid binding. In this model, our research 
group proposes that the binding of calmodulin or calmodulin-like proteins to the myosin-XXI neck prevents dimerization 
thus keeping myosin-XXI in a monomeric, lipid binding state. Mechanical stabilization of the neck due to the association 
with calmodulin or calmodulin-like proteins generates a functional lever arm thus enabling myosin-XXI motility. 
Additionally, lipid binding sites of myosin-XXI are accessible in the motor protein´s monomeric conformation. For the 
calmodulin and calmodulin-like protein species investigated thus far binding to myosin-XXI requires presence of Ca
2+
. 
However, association with myosin-XXI can be reversible or irreversible depending on the respective calmodulin or 
calmodulin-like protein. As illustrated above, L. donovani calmodulin-like protein 1 dissociates from the neck at low Ca
2+
 
levels while in contrast, L. donovani calmodulin-like protein 2 stays irreversibly bound to myosin-XXI. Figure taken from 
Batters et al. (2014). 
 
The investigation of myosin-XXI oligomerization states by our research group, which was 
implemented using size exclusion chromatography and Förster resonance energy transfer, led to the 
proposal of a model describing the regulation of myosin-XXI dimerization, motility, and lipid binding 
(Figure 18). According to this model, binding of calmodulin or calmodulin-like proteins to the IQ motif 
within the neck of myosin-XXI prohibits dimerization of the motor protein due to the impairment of 
coiled coil formation. In turn, the monomeric conformation of myosin-XXI ensures the accessibility of 
its lipid binding sites. Additionally, association of calmodulin or calmodulin-like proteins generates a 
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functional lever arm enabling myosin-XXI motility. Depending on the specific calmodulin or 
calmodulin-like protein, the interaction with the myosin-XXI IQ motif can be reversible or not. In 
agreement with this model, monomeric myosin-XXI was shown to induce gliding of actin filaments in 
vitro and to bind various phospholipids. Interestingly, myosin-XXI monomers were also capable to 
drive filament movement when bound to lipid vesicles (Batters et al., 2012, 2014). 
In in vivo studies, myosin-XXI was shown to be expressed throughout both stages of the L. donovani 
life cycle. Though, the expression level in promastigotes is approximately 20 times higher than in 
amastigotes. Immunofluorescence and immune-gold staining revealed that the distribution of 
myosin-XXI within the parasite differs for both stages: while in the amastigote, myosin-XXI is 
concentrated at the apical end of the cell, promastigotes exhibit a sparse myosin-XXI distribution 
throughout the cytoplasm and a pronounced concentration of the motor protein within the proximal 
part of the flagellum and along the proximal length of the paraflagellar rod (Figure 19; Katta et al., 
2009). 
Gene knockout studies further demonstrated that in L. donovani, myosin-XXI and actin-based 
transport processes mediated by myosin-XXI play a critical role in endocytosis, exocytosis, 
intracellular vesicle trafficking, and development of a functional flagellum including paraflagellar rod 
formation. Importantly, a double knockout of both myosin-XXI gene copies could not be 
implemented thus demonstrating myosin-XXI to be essential for parasite survival (Katta et al., 2010). 
 
 
Figure 19 Cellular localization of myosin-XXI throughout the life cycle of L. donovani . While expression of myosin-XXI was 
verified in both the amastigote and the promastigote form of L. donovani, the observed cellular localization patterns 
differed between the two forms. (A) Images of L. donovani amastigotes immunostained for actin (red) and myosin-XXI 
(green). Myosin-XXI accumulates at the apical ends of the cells. (B) Images of an L. donovani promastigote immunostained 
for the paraflagellar rod (red) and myosin-XXI (green). Myosin-XXI is sparsely distributed throughout the cytoplasm and 
concentrates within the proximal part of the flagellum and along the proximal length of the paraflagellar rod. Scale bars: 
5 μm. Images taken from Katta et al. (2009). 
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2 Research Objectives 
Myosin-XXI, which had been identified in the genome of several trypanosomatids in 2005 (El-Sayed 
et al., 2005), was initially characterized regarding its cellular localization and functions in L. donovani 
by in vivo studies of the Gupta research group (Katta et al., 2009, 2010). These investigations 
revealed that myosin-XXI is absolutely essential for parasite survival and that endocytosis, exocytosis, 
vesicular trafficking, and flagellum formation in L. donovani depend on actin-based transport 
processes mediated by myosin-XXI. 
The demonstrated vital necessity of myosin-XXI expression and the involvement of this cytoskeletal 
motor in such manifold cellular processes motivated the present study, which aimed to further 
elucidate the molecular bases of myosin-XXI´s physiological functionality. For this purpose, 
experimental work comprised both in vivo and in vitro approaches. 
 
2.1 In Vivo Experimental Approaches 
According to Katta et al. (2009), the distribution of myosin-XXI within L. donovani promastigotes is 
regulated by the motor protein´s tail domain. In the present study, myosin-XXI localization and 
functionality were aimed to be further elucidated by analyzing the cellular distribution of 
fluorescently labeled full-length myosin-XXI and myosin-XXI fragments, and by investigating the 
potential colocalization of these proteins with eukaryotic cellular structures and compartments. In 
order to inspect myosin-XXI constructs in a physiological environment devoid of endogenously 
expressed myosin-XXI, i.e. to avoid an influence of endogenous myosin-XXI on the experimental 
results, transfection studies in mammalian cells were carried out. 
 
2.2 In Vitro Experimental Approaches 
To more precisely characterize myosin-XXI in a controlled environment harboring only a limited 
number of interaction partners, the present study also comprised in vitro investigations. In order to 
determine the directionality of myosin-XXI translocation along filamentous actin, gliding filament 
assays with dual-labeled F-actin were performed. Further, as previous studies of our lab had revealed 
the existence of myosin-XXI lipid binding domains and had demonstrated the capability of vesicle-
associated myosin-XXI to drive movement of actin filaments, the present work aimed to gain deeper 
insight into the dynamic behavior of the bilayer-bound complex of myosin-XXI and actin. Targeting at 
the elimination of spatial constraints by the limited size of vesicles, experimental set-ups were based 
on planar lipid bilayer systems. Since bilayer-related experiments yielded hints on an impact of 
bilayer shape on the binding of myosin-XXI, research objectives were complemented by the 
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clarification of a potential membrane curvature sensitivity of myosin-XXI. The latter aspect was 
tested with the help of Single Liposome Curvature assays. 
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3 Materials and Methods 
3.1 Solutions, Gels, and Lipid Stocks 
This section gives an overview about the preparation or treatment of buffers, medium, gels, and 
lipids utilized in the procedures and experiments described later. 
Water (H2O) used for the preparation of solutions or in experimental procedures was always double-
distilled deionized water. 
 
 Buffers 3.1.1
Buffer solutions were prepared according to the following recipes: 
2x SDS Gel Loading Buffer: 
100 mM Tris-HCl (pH 6.8), 20 % (v/v) glycerol, 138.7 mM SDS, 0.2 % (w/v) bromphenol 
blue-xylene cyanol powder (Sigma-Aldrich), 200 mM β-mercaptoethanol 
6x SDS Gel Loading Buffer: 
375 mM Tris-HCl (pH 6.8), 50 % (v/v) glycerol, 346.8 mM SDS, 0.2 % (w/v) bromphenol 
blue-xylene cyanol powder (Sigma-Aldrich), 1.4 M β-mercaptoethanol 
6x Gel Loading Buffer: 
30 % (v/v) glycerol, 0.25 % (w/v) bromphenol blue-xylene cyanole powder (Sigma-
Aldrich), 0.25 % (w/v) xylene cyanol 
AB-/2x BSA: 
AB-, 14.9 μM BSA 
AB-/BSA: 
AB-, 7.5 μM BSA 
Actin Extraction Buffer (ACEX Buffer): 
2 mM Tris-HCl (pH 8.0), 0.2 mM CaCl2, 1 mM DTT, 0.2 mM ATP 
ATP-Free Assay Buffer (AB-): 
25 mM imidazole, 25 mM KCl, 4 mM MgCl2, 1 mM EGTA, pH 7.4 
ATP-Supplemented Assay Buffer (AB+): 
25 mM imidazole, 25 mM KCl, 4 mM MgCl2, 1 mM EGTA, 2 mM ATP, pH 8.0 
Blocking Buffer: 
TBS, 0.05 % (v/v) Tween 20, 5 % (w/v) skim milk powder 
Blotting Buffer: 
80 % (v/v) TG Buffer, 20 % (v/v) methanol 
 
Materials and Methods 
40 
Carbonate Buffer: 
480 mM NaHCO3, pH 8.5 
G-Actin Buffer: 
2 mM Tris-HCl (pH 7.5), 0.2 mM CaCl2, 0.2 mM ATP 
GF 150 Buffer (Gel Filtration 150 Buffer): 
50 mM Tris-HCl (pH 7.5), 150 mM NaCl 
Guba-Straub Solution: 
0.3 M KCl, 0.1 M KH2PO4, 50 mM K2HPO4, 1 mM ATP, 5 mM MgCl2, 1 mM DTT, pH 6.5 
High Salt Buffer: 
40 mM Potassium Phosphate Buffer (pH 6.5), 1 M KCl, 4 mM MgCl2, 2 mM DTT 
His Low 500: 
50 mM Tris-HCl (pH 7.5), 40 mM imidazole, 500 mM NaCl 
His High 500: 
50 mM Tris-HCl (pH 7.5), 400 mM imidazole, 500 mM NaCl 
HNa 100: 
10 mM HEPES (pH 7.0), 100 mM NaCl, 1 mM DTT, 1 mM EGTA 
KMg 25: 
10 mM MOPS (pH 7.0), 25 mM KCl, 1 mM DTT, 1 mM EGTA, 1 mM MgCl2 
KMg Activation Buffer: 
KMg 25, 0.4 μM glucose oxidase, 1 mM ATP, 10 μM calmodulin, 5.6 mM glucose, 1.8 nM 
catalase 
Lipid Buffer 150: 
20 mM HEPES, 150 mM NaCl, 1 mM DTT, pH 7.4 
Lipid Buffer 500: 
20 mM HEPES, 500 mM NaCl, 1 mM DTT, pH 7.4 
Lipid TBS: 
10 mM Tris, 150 mM NaCl, pH 7.4 
Low Salt Buffer: 
20 mM Potassium Phosphate Buffer (pH 6.5), 40 mM KCl, 2 mM MgCl2, 2 mM DTT  
Lysis Buffer: 
PBS, 50 % (v/v) 2x SDS Gel Loading Buffer 
Motility Buffer: 
AB+, 7.2 μM BSA, 0.3 μM glucose oxidase, 38.1 nM catalase, 7.9 mM glucose, 9.5 mM 
DTT 
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Myosin-VI Buffer: 
20 mM Tris-HCl (pH 7.5), 20 mM imidazole, 25 mM NaCl, 5mM MgCl2, 1 mM EGTA, 
10 mM DTT 
Myosin Extraction Buffer: 
90 mM KH2PO4, 60 mM K2HPO4, 300 mM KCl, pH 6.8 
Myosin Preparation Solution: 
50 mM Potassium Phosphate Buffer (pH 7.0), 5 mM DTT, 5 mM EDTA, 3 M KCl, pH 7.0 
PBS/BSA: 
PBS, 0.3 mM BSA 
Phosphate-Buffered Saline (PBS): 
2.7 mM KCl, 1.5 mM KH2PO4, 137.9 mM NaCl, 8.1 mM Na2HPO4 
Potassium Phosphate Buffer: 
mixture of 1 M KH2PO4 and 1 M K2HPO4 in a volume ratio depending on the desired pH 
Rigor Buffer: 
AB-, 7.2 μM BSA, 0.3 μM glucose oxidase, 38.1 nM catalase, 7.9 mM glucose, 9.5 mM 
DTT 
STORM Buffer: 
Lipid TBS, 1.2 μM glucose oxidase, 160 nM catalase, 33.3 mM glucose, 80 mM DTT 
Tris-Buffered Saline (TBS): 
50 mM Tris, 150 mM NaCl, pH 7.6 
Tris/Borate/EDTA Buffer (TBE Buffer): 
1 mM EDTA (pH 8.0), 44.6 mM Tris, 44.5 mM boric acid, pH 8.3 
Tris Glycine Buffer (TG Buffer): 
1.3 M glycine, 125 mM Tris, 17.3 mM SDS, pH 8.3 
Tris-HCl: 
1 M Tris, HCl; amount of HCl depends on the desired pH 
Wash Buffer: 
TBS, 0.05 vol% Tween 20, 1 % (w/v) skim milk powder 
 
 Gels and Staining Solutions for Gel Electrophoresis 3.1.2
In order to separate DNA or proteins according to their molecular weight in gel electrophoresis, 
polyacrylamide gels for protein separation and agarose gels for DNA separation were prepared. 
Additionally, staining solutions for the visualization of protein or DNA bands were produced: 
agarose gel: 
TBE Buffer, 0.8 % to 1.2 % (w/v) agarose, 4·10-3 % (v/v) Gel Red™ dye (Biotium) 
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Blue Stain Solution: 
Destain Solution, 1.2 mM Coomassie Brilliant Blue G-250 
Destain Solution: 
45 % (v/v) methanol, 10 % (v/v) acetic acid 
resolving gel: 
375.9 mM Tris-HCl (pH 8.8), 1.0/1.3/2.0 M acrylamide, 24.4/32.5/48.8 mM bis-
acrylamide, 3.5 mM SDS, 1.4 mM APS, 0.04 % (v/v) TEMED; acrylamide:bis-acrylamide 
molar ratio remains constant 
stacking gel: 
125.5 mM Tris-HCl (pH 6.8), 0.7 M acrylamide, 16.6 mM bis-acrylamide, 3.5 mM SDS, 
4.4 mM APS, 0.1 % (v/v) TEMED 
SYBR Green Staining Solution: 
TBE, 1 % (v/v) 10,000X SYBR® Green I Nucleic Acid Gel Stain (Thermo Fisher Scientific) 
 
 Medium and Agar Plates 3.1.3
For Escherichia coli (E. coli) cell culture, medium and agar plates were prepared the following way: 
2x YT Medium: 
1.6 % (w/v) tryptone, 1.0 % (w/v) yeast extract, 85.6 mM NaCl, pH 7.5 
Agar:  
2x YT Medium, 1.5 % (w/v) bacterial agar 
 
 Other Solutions 3.1.4
In addition to the above-mentioned mixtures, the following solutions were utilized in sample 
preparation:  
Mowiol Embedding Solution: 
89.7 mM Tris-HCl (pH 8.5), 17.8 % (v/v) glycerol, 2.9 mM Mowiol® 4-88 (Sigma-Aldrich) 
Oxidizing Solution:  
0.5 mM KMnO4, 16.6 mM NaIO4, 1.8 mM K2CO3 
 
 Stock Solutions of Lipids and Lipophilic Fluorescent Dye 3.1.5
In experiments with lipid vesicles and planar lipid bilayers, the following lipids and carbocyanine dye 
were used: 
phosphocholines (Sigma-Aldrich): 
 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 
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 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) 
phosphoinositides (Avanti Polar Lipids): 
 L-α-phosphatidylinositol-4-phosphate (from porcine brain) (PI(4)P) 
 1,2-dihexanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) (denoted as 
PI(3,5)P2) 
 L-α-phosphatidylinositol-4,5-bisphosphate (denoted as PI(4,5)P2) 
conjugated phospholipids (Thermo Fisher Scientific): 
 N-(biotinoyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (Biotin DHPE) 
 Lissamine™ Rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine 
(Rhodamine DHPE) 
other lipids: 
 bovine brain extract (type I, Folch fraction I; Sigma-Aldrich) 
 cholesterol (Sigma-Aldrich) 
carbocyanine dye (Thermo Fisher Scientific): 
 3,3'-dihexadecyloxacarbocyanine perchlorate (DiO) 
All lipids were obtained as dried powders, and stock solutions were prepared by dissolving these 
powders in chloroform in a concentration range between 40 μg/ml and 10 mg/ml. Stock solutions 
were stored at -20°C until use. 
DiO dried powder was dissolved in dimethylformamide following manufacturer´s guidelines. 
Carbocyanine dye stock solution contained 40 μg/ml DiO and was stored at 4°C protected from light. 
 
3.2 Cloning 
To produce recombinant DNA constructs used in protein expression and mammalian cell 
transfections, respective DNA templates were amplified and cloned into vectors suitable for the 
intended use. Subsequently, the resulting recombinant constructs were further amplified and 
purified.  
 
 Amplification of DNA  3.2.1
Polymerase Chain Reaction (PCR) 
Prior to cloning, DNA templates were amplified by polymerase chain reaction. PCR was executed as 
follows: DNA was mixed with primers (Sigma-Aldrich; Table A.3), deoxynucleotides (Thermo Fisher 
Scientific) and Phusion Hot Start II DNA Polymerase (Thermo Fisher Scientific) as recommended by 
suppliers, and the mixture was immediately subjected to heating and cooling according to the 
following touchdown PCR protocol: 
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1. T=98°C, Δt=45 s 
2. 9 cycles (with a temperature decline of 1°C in step 2.2 after each cycle) of:  
2.1 T=98°C, Δt=15 s 
2.2 T=68°C, Δt=30s 
2.3 T=72°C, Δt=150 s 
3. 29 cycles of: 
3.1 T=98°C, Δt=15 s 
3.2 T=60°C, Δt=30 s 
3.3 T=72°C, Δt=150 s 
4. T=72°C, Δt=120 s 
T denotes the temperature of each incubation step, Δt its duration. Once PCR was finished, agarose 
gel electrophoresis was performed as described in the next subsection. Subsequently, amplified DNA 
was purified and stored at -20°C until further processing. Purification was executed using the 
PureLink® Quick Gel Extraction and PCR Purification Combo Kit (Thermo Fisher Scientific) according 
to manufacturer´s protocol.  
 
Agarose Gel Electrophoresis 
To verify the presence of DNA molecules of the correct number of base pairs, samples were 
subjected to agarose gel electrophoresis. DNA samples were mixed with 6x Gel Loading Buffer in a 
5:1 volume ratio, and samples and a molecular weight size marker were injected into the gel. 
Electrophoresis was executed in TBE Buffer at an electric current of 80 mA, and agarose gels were 
imaged in a ChemiDocTM XRS+ gel imaging system (Bio-Rad). 
 
 Cloning and Isolation of Recombinant DNA 3.2.2
After a DNA template was amplified in polymerase chain reaction, it was inserted into a vector 
suitable for the intended use of the resulting recombinant plasmid. Following this, the plasmid was 
amplified in competent E. coli, and amplified plasmids were isolated by minipreparation or by 
maxipreparation. DNA constructs utilized in the transfection of mammalian cells or in the bacterial 
expression of proteins were readily processed at this point (Figure 20). In the case of DNA intended 
to be used for protein expression by insect cells, further treatment was necessary: The DNA template 
encoding the protein was transposed from the plasmid into a baculovirus shuttle vector (bacmid), 
which was in turn used to create a baculovirus required for the infection of insect cells (Figure 20).  
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Figure 20 Cloning and isolation of recombinant plasmids for use in protein expression and mammalian cell transfections. 
In the above scheme, the principle steps performed during the creation, amplification, and isolation of recombinant DNA 
constructs are illustrated: once, the DNA template encoding the respective protein had been amplified by PCR, restriction 
enzyme digestion prepared both the template and the selected plasmid vector for subsequent ligation. In order to amplify 
the resulting recombinant plasmid, the latter was transformed into competent DH5α E. coli cells. Following multiplication of 
competent cells, the amplified plasmid was purified. At this point, cloning of recombinant constructs intended to be utilized 
in transfections of mammalian cells was completed. Further, proteins of a molecular weight below 100 kDa could now be 
expressed upon transformation of the purified plasmid into competent BL21 E. coli. Plasmids encoding proteins with a 
molecular weight exceeding 100 kDa had to be further processed. Respective recombinant constructs were transformed 
into DH10Bac™ Competent E. coli. Within these cells, the DNA template was transposed into a baculovirus shuttle vector, 
the so-called bacmid. After multiplication of E. coli, the bacmid was isolated and transfected into Sf21 cells, in which the 
bacmid was amplified and packaged in a baculovirus. Perishing Sf21 cells released the baculovirus into the surrounding 
medium, from where the virus was purified. Subsequent to two baculovirus amplification steps in Sf21, the baculovirus was 
ready to be used to induce protein expression in Sf21 cells. 
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Cloning and Isolation of Recombinant Plasmids 
To prepare the insertion of a DNA template into a vector, both DNA constructs were subjected to 
restriction enzyme digestion applying identical enzymes. Restriction enzymes and associated reaction 
buffers were purchased from New England Biolabs and applied according to manufacturer´s 
guidelines. A summary of all restriction enzymes, DNA templates and vectors can be found in 
Table A.1 and Table A.2. 
Following restriction enzyme digestion, digested DNA was isolated from remaining undigested DNA. 
For this purpose, DNA samples were mixed with SYBR Green Staining Solution and 6x Gel Loading 
Buffer in a volume ratio of 10:1:2 and subjected to agarose gel electrophoresis. DNA bands were 
visualized in a gel imaging system, and digested DNA was excised from the gel to be purified using 
the PureLink® Quick Gel Extraction and PCR Purification Combo Kit (Thermo Fisher Scientific). 
In the next step, digested vectors and DNA templates were ligated by application of the 
Rapid DNA Ligation Kit (Thermo Fisher Scientific). Implementing manufacturer´s instructions, ligated 
DNA, i.e. recombinant plasmids, was then transformed into competent DH5α E. coli cells (Library 
Efficiency® DH5α™ Competent Cells; Thermo Fisher Scientific). After transformation, cells were 
plated on agar plates supplemented with 50 μg/ml antibiotic (kanamycin or ampicillin), and 
incubated at 37°C for at least 15 h. To amplify recombinant plasmids transformed into DH5α, 
colonies were picked from the incubated agar plates and each colony was transferred into 5 ml 
2x YT Medium supplemented with 50 μg/ml antibiotic. Cultures were incubated in a dry block 
incubator at 200 rpm and 37°C overnight.  
Recombinant DNA was purified from cell cultures using the PureLink® Quick Plasmid Miniprep Kit 
(Thermo Fisher Scientific). To verify the correct composition of the recombinant plasmid, purified 
plasmids were tested by another restriction enzyme digestion. Molecular sizes of the digestion 
products were determined in agarose gel electrophoresis. In addition, plasmids were sent to GATC 
Biotech for sequencing.  
Depending on the amounts of recombinant DNA required in later procedures, plasmids could be 
further amplified. For this purpose, transformation into DH5α and subsequent amplification were 
repeated setting up bacterial cultures of larger volume. Recombinant DNA was isolated with the help 
of a PureLink® HiPure Plasmid Filter Maxiprep Kit and a PureLink™ HiPure Precipitator Module 
(Thermo Fisher Scientific) according to manufacturer´s guidelines.  
DNA content of purified samples was determined by absorbance measurements at a wavelength of 
260 nm in a Biophotometer® plus (Eppendorf). 
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Cloning and Isolation of Recombinant Baculoviruses 
As expression in E. coli is not suitable for proteins of a molecular weight exceeding 100 kDa 
(Bell, 2001), expression in insect cells was chosen for large proteins. Accordingly, L. donovani full-
length myosin-XXI (aa 1-1050, called FL-XXI here), the myosin-XXI motor truncation of aa 1-800 
(Trunc-XXI), and chicken (Gallus gallus) myosin-VI were expressed with this method. As all myosin 
constructs were coexpressed with Xenopus laevis calmodulin, procedures described in the following 
subsections were also applied to calmodulin DNA.  
To prepare DNA for the infection of insect cells, the Bac-to-Bac® Expression System (Thermo Fisher 
Scientific) was utilized. At first, the DNA template was cloned into the pFastBac™HT B plasmid 
following the procedures described earlier. 
In the following step, the DNA template was transposed from the pFastBac™HT B plasmid into a 
baculovirus shuttle vector (bacmid). For this purpose, the recombinant plasmid was transformed into 
DH10Bac™ Competent E. coli (Thermo Fisher Scientific). This E. coli strain harbors the bMON14271 
bacmid and expresses a transposase which transfers DNA from pFastBac™HT B into this bacmid. 
Transformation of the plasmid into DH10 Bac™ cells and subsequent bacmid purification were 
implemented following the protocol provided by the manufacturer. Purified bacmid was stored 
at -20°C. 
Subsequently, recombinant bacmid was transfected into Sf21 cells (Spodoptera frugiperda ovary 
cells) using Cellfectin® II Reagent (Thermo Fisher Scientific) according to manufacturer´s instructions. 
Regulated by the polyhedrin promoter and the simian virus 40 polyadenylation signal 
contained in the bacmid, Sf21 cells replicated bacmid DNA and expressed proteins required for the 
self-assembly of baculoviruses. Once characteristics of a late baculoviral infection phase could be 
observed, i.e. once sufficient amounts of baculovirus had been released into the medium, cells were 
sedimented by 15 min of centrifugation at 1,000 x g and 4°C. The supernatant, which contained the 
so-called passage 1 baculovirus, was transferred into a clean tube and stored at 4°C protected from 
light. 
To increase the amount and titer of baculovirus, infection of Sf21 cells with passage 1 baculovirus 
was performed, again implementing manufacturer´s instructions. Sf21 cells in suspension culture 
were infected by simply adding baculovirus and incubated in a shaking incubator at 27°C and 
140 rpm. Viability of Sf21 cells was examined with the help of a TC10™ Automated Cell Counter 
(Bio-Rad), and as soon as viability decreased to a value between 50 % and 60 %, cells were 
centrifuged at 1,000 x g and 4°C for 15 min. The supernatant, which contained the passage 2 
baculovirus, was transferred into a clean tube and stored at 4 °C protected from light. Using 
passage 2 baculovirus, the amplification procedure described above was repeated resulting in a 
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passage 3 baculovirus stock, which was used for the infection of Sf21 cells for the purpose of protein 
expression. 
 
3.3 Protein Expression and Purification 
Depending on the molecular weight, different expression systems were applied to produce the 
proteins utilized in later experiments. In accordance with the literature (Bell, 2001), expression in 
E. coli was only applied for proteins with a molecular weight below 100 kDa, i.e. for the rat 
endophilin A1 N-BAR domain (aa 1-247) and all myosin-XXI fragments except for Trunc-XXI. FL-XXI 
(unlabeled or fused to eGFP (enhanced green fluorescent protein)), Trunc-XXI (unlabeled or fused to 
eGFP), and myosin-VI were coexpressed with calmodulin in Sf21 cells.  
Independent from the expression system, all proteins except for calmodulin were expressed with a 
polyhistidine tag encoded by the vectors utilized. Accordingly, all proteins were purified by 
immobilized metal affinity chromatography. Expressed calmodulin was bound to myosin and thus did 
not need to be purified. 
Actin and heavy meromyosin were not expressed in cell culture but purified from rabbit skeletal 
muscle tissue.  
 
 Protein Expression 3.3.1
E. coli Expression System 
For bacterial expression of proteins, competent BL21 E. coli cells (One Shot® BL21 Star™ (DE3) 
Chemically Competent E. coli, Thermo Fisher Scientific) were used. According to manufacturer´s 
recommendations, DNA was transformed into BL21 cells and shake cultures in 2x YT Medium 
supplemented with 50 μg/ml antibiotic were prepared. After protein expression was induced by the 
addition of 1 mM IPTG, cultures were further incubated in a shaking incubator at 180 rpm and a 
temperature of 27°C for at least 4 more h. Finally, cells were sedimented at 2,000 x g and 4°C for 
20 min. Resulting pellets were resuspended in 10 ml Buffer B per 500 ml culture. Buffer B was 
supplemented with one cOmplete™ EDTA-free protease inhibitor cocktail tablet (Roche) per 40 ml 
buffer. Resuspended pellets were stored at -80°C until protein purification. 
 
Insect Cell Expression System 
To express FL-XXI, Trunc-XXI, or myosin-VI in Sf21 cells, a 500 ml suspension culture of 0.8·106 ml-1 
Sf21 cells was prepared. Cells were kept in Supplemented Grace´s Insect Medium (Thermo Fisher 
Scientific) enriched with 10 % (v/v) heat inactivated fetal bovine serum, 0.1 % (v/v) Pluronic® F-68, 
and 0.01 % (w/v) Normocin™. Since calmodulin is an important regulator of myosin motor function 
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(Cheung, 1980), the above-mentioned constructs were always coexpressed with calmodulin. For this 
purpose, 40 ml of myosin passage 3 baculovirus stock and 20 ml of calmodulin passage 3 baculovirus 
stock were added to the suspension culture and cells were incubated in a shaking incubator at 27°C 
and 140 rpm. After the first 72 h of incubation, cell viability was determined every 24 h using an 
automated cell counter. When cell viability was 50 % to 60 %, cells were centrifuged at 8,000 x g and 
4°C for 20 min. After disposal of the supernatant, the pellet was resuspended in 40 ml Myosin 
Extraction Buffer. One cOmplete™ EDTA-free protease inhibitor cocktail tablet (Roche) was dissolved 
in the resuspension, and the solution was stored at -80°C until purification of the expressed protein. 
 
 Protein Purification 3.3.2
Purification of Proteins Expressed in Cell Culture 
As all proteins expressed in BL21 or Sf21 cell culture contained a polyhistidine tag, these proteins 
were purified by immobilized metal affinity chromatography using a 5 ml Sepharose column 
functionalized with bivalent nickel ions (HisTrap FF, GE Healthcare).  
Prior to purification, frozen pellets resultant from protein expression were thawed in a water bath at 
room temperature (RT). In the case of myosin-VI, thawed solution was additionally supplemented 
with 1 mM DTT, 1 mM ATP, 5 mM MgCl2, and 1 mM calmodulin. Subsequently, samples were tip-
sonicated (duration: 195 s, cycle: 50 %, power: 45 %; Bandelin Sonopuls HD 2070 ultrasonic 
homogenizer) while kept on ice. Myosin-VI samples were then left to incubate at 4°C for 30 min to 
60 min, all other samples were further processed immediately. In the next step, samples were 
centrifuged at 33,000 x g and 4°C for 20 min, and resulting supernatants were filtered through a 
syringe filter of 450 nm pore diameter (Sarstedt).  
Now, immobilized metal affinity chromatography was carried out a temperature of 4°C (Figure 21). 
All buffers utilized were supplemented with 1 mM DTT directly before use. After the Sepharose 
column was equilibrated in His Low 500 or PBS, the sample was loaded onto the column. Unbound 
constituents were removed by washing the column with His Low 500 or PBS respectively. Afterwards, 
the column was subjected to several washing steps with increasing volume fractions of His High 500 
to elute bound protein by applying an increased imidazole concentration. During the elution process, 
fractions were collected which were then analyzed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE). Fractions exhibiting high content of desired protein and low 
contamination by other proteins were pooled and concentrated at 4°C and 7,000 x g using centrifugal 
filters of 30 kDa molecular weight cut-off (Amicon® Ultra Centrifugal Filters, Merck Millipore). ENBAR 
samples were not treated further at this point.  
FL-XXI and its fragments were further purified by size exclusion chromatography with an 
agarose/dextran column (Superdex 200 10/300 GL, GE Healthcare). Size exclusion chromatography 
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was executed at 4°C and again the applied buffer was supplemented with 1mM DTT immediately 
before use. After the column was equilibrated in GF 150 Buffer, the sample was loaded onto the 
column and run through the matrix in a constant flow of GF 150 Buffer. Fractions were collected and 
subjected to SDS-PAGE. Fractions containing the least concentration of contaminant protein were 
pooled and concentrated as described above.  
Following purification, proteins were flash-frozen in liquid nitrogen and stored at -80°C. 
 
 
Figure 21 Protein purification by immobilized metal affinity chromatography. In the above figure, data obtained during 
the purification of a polyhistidine-tagged fusion protein of eGFP and full-length myosin-XXI (molecular weight: ~140 kDa) 
are depicted. The diagram displays UV absorbance of fractions collected during the purification process. Along the 
horizontal axis, buffer volume is quantified. Fractions collected are indicated as “F”. The extent of UV absorption is a direct 
measure for the protein content of these fractions, however not for their purity. Before absorbance measurements were 
carried out, the sample intended for purification was loaded onto the Sepharose column. Subsequently, unbound 
constituents were removed from the column by washing with PBS. During the latter step (labeled as 0 %), UV detection was 
started. Following removal of unbound components, polyhistidine-tagged column-associated protein was eluted in several 
washing steps with increasing volume fractions of His High 500 (5 %, 25 %, and 100 %), i.e. with increasing imidazole 
concentrations. Collected fractions were then subjected to SDS-PAGE. In the lower panel, images of respective 
polyacrylamide gels are shown. Arrows assign fractions to corresponding lanes. Here, fractions 11 to 14 were pooled and 
further processed. 
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Purification of Proteins from Rabbit Skeletal Muscle 
As purification techniques for the extraction of G-actin and HMM from rabbit skeletal muscle are 
well-established, these proteins were not expressed in cell culture. Instead, myosin-II glycerol stocks 
and acetone powder were prepared from muscle tissue and could be stored at -20°C for several 
months (Margossian and Lowey, 1982; Pardee and Spudich, 1982). Later, HMM could be prepared 
from myosin-II glycerol stock, and G-actin could be purified from acetone powder (Figure 22). 
 
1. Purification of Myosin-II and Preparation of HMM: 
Myosin-II was extracted from rabbit skeletal muscle as described by Margossian and Lowey (1982) 
with modifications. Prior to purification, all required buffers were freshly prepared and prechilled at 
4°C. DTT and ATP contained in the buffers were added immediately before use. In short, dorsal 
lateral and hind leg muscles were excised from a rabbit, minced and stirred in Guba-Straub Solution 
to dissolve myosin-II. The mixture was centrifuged at 4,000 x g for 30 min, resulting in the separation 
of myosin-II, which was contained in the supernatant, and actin, which remained in the precipitate. 
Actin extraction from the precipitate will be described in the next subsection.  
Myosin-II contained in the supernatant was further purified by filtration through minced moistened 
filter paper and extraction in prechilled H2O. The resulting precipitate was dissolved in 20 ml of 3 M 
KCl per 100 ml of precipitate. After a 10 min centrifugation at 4,000 x g, the resulting supernatant 
was again subjected to an extraction in prechilled H2O. Sedimented myosin-II was dissolved in 
Myosin Preparation Solution. A myosin-II glycerol stock was prepared by the addition of 50 % (v/v) of 
prechilled glycerol.  
To prepare HMM from the myosin-II glycerol stock, chymotryptic digestion was applied. At first, 
myosin-II was extracted in ice-cold H2O and the resulting precipitate was resuspended in High Salt 
Buffer. Subsequently, digestion was carried out applying 2 μM α–chymotrypsin. Digestion was 
stopped with the help of 1.3 mM trypsin-chymotrypsin inhibitor. To isolate HMM from undigested 
myosin-II and light meromyosin, the solution was dialyzed in Low Salt Buffer at 4°C overnight using a 
membrane with a 3.5 kDa molecular weight cut-off. The dialyzed sample was then subjected to a 
45 min centrifugation at 21,000 x g and 4°C. The supernatant was supplemented with 30 % 
(w/v) sucrose, flash-frozen in liquid nitrogen, and stored at -80°C. 
 
2. Purification of G-Actin: 
G-actin was isolated from pretreated minced rabbit skeletal muscle obtained during the purification 
of myosin-II. The protocol for G-actin purification was adapted from Pardee and Spudich (1982). 
Buffers and solutions were freshly prepared and prechilled at 4°C prior to use. Precipitated muscle 
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mince was subjected to several extraction steps in 47.6 mM NaHCO3, 1 mM EDTA (pH 7.0), H2O, and 
acetone. By overnight drying in vacuo, the resulting residue was transformed into acetone powder. 
Before actin was extracted from acetone powder, ACEX Buffer was freshly prepared and 
prechilled on ice. Thereafter, 6 g of powder were dissolved in 120 ml ACEX Buffer and stirred for 
30 min. The solution was two times filtered through 4 layers of sterile cheesecloth and the flow-
through was centrifuged at 33,000 x g for 15 min. The resulting supernatant was transferred into a 
beaker, and actin polymerization was induced by adjusting compound concentrations to 5 mM Tris, 
50 mM KCl, 2 mM MgCl2, and 1mM ATP. After the solution was stirred for 2 h, filamentous actin was 
separated from tropomyosin by salt-precipitation: KCl concentration was increased to 0.8 M, and pH 
was adapted to a value between 8.3 and 8.5 using 1 M KOH. Then, F-actin was precipitated by 40 min 
of centrifugation at 361,000 x g. The resulting pellet was incubated on ice in ACEX Buffer for several 
minutes. Afterwards, the softened pellet was gently homogenized in ACEX Buffer for 30 min. During 
homogenization, the sample was constantly kept on ice. In the next step, the resulting solution was 
dialyzed in ACEX Buffer overnight to depolymerize F-actin into its globular monomeric form. For this 
purpose, a membrane with a molecular weight cut-off of 3.5 kDa was utilized. Thereupon, the sample 
was centrifuged at 14,000 x g for 15 min and the pellet was discarded. The obtained G-actin solution 
was stored in liquid nitrogen until use. 
 
 
Figure 22 Purification of proteins from rabbit skeletal muscle. (A) Polyacrylamide gel of purified HMM (molecular weight: 
~180 kDa). (B) Polyacrylamide gel of samples from different stages of the G-actin purification process: (1) before salt-
precipitation, (2) after salt-precipitation, (3) after overnight dialysis (molecular weight of G-actin: 42 kDa). 
 
Protein Detection and Determination of Concentration 
Throughout and at the end of each purification process, presence and purity of the purified protein 
had to be verified. For this purpose, samples were subjected to SDS-PAGE. Following this, protein 
concentration was determined in light absorbance assays. 
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1. SDS-PAGE: 
Discontinuous SDS-PAGE was performed according to Laemmli (1970) with modifications. Prior to 
SDS-PAGE, samples were mixed with 2x SDS Gel Loading Buffer or 6x SDS Gel Loading Buffer in a 1:1 
or 5:1 volume ratio respectively. Proteins were linearized by a 5 min incubation in a heat block at 
95°C.  
Following this, samples were injected into a polyacrylamide gel composed of a stacking gel and a 
resolving gel. During gel electrophoresis, protein samples were concentrated into small bands in the 
stacking gel, and separated according to their molecular weight in the resolving gel. Concentration 
and separation process resulted from different pore sizes of stacking and resolving gel. Pore sizes 
were adjusted via acrylamide/bis-acrylamide content of the gels. To quantify the molecular weight of 
the proteins analyzed, a prestained molecular weight marker was always added to the gels. 
SDS-PAGE was carried out in TG Buffer at a voltage of 200 mV. Once gel electrophoresis was 
terminated, polyacrylamide gels were stained in Blue Stain Solution. Destain Solution was applied to 
remove dye from the polyacrylamide gel, leaving detectable protein bands for subsequent analysis. 
Gel imaging was performed in a gel imaging system. 
 
2. Determination of Protein Concentration: 
Protein concentration of purified samples was determined by light absorbance assays. In all of these 
assays, absorbance of the sample buffer was measured first to correct later detected absorbance 
values of the protein solution.  
For concentration determination of HMM samples, absorbance A(λ) at a wavelength of λ=280 nm was 
measured with a UV-Vis spectrophotometer. Protein concentration c was then calculated from 
(Stoscheck, 1990): 
 𝑐 [
𝑚𝑔
𝑚𝑙
] = 𝐴(280 𝑛𝑚) ∙ 𝑙[𝑐𝑚] 
   (3) 
In the above equation, l denotes the optical path length.  
Determination of G-actin concentration was implemented by UV-Vis spectrophotometric 
measurement of the absorbance at wavelengths of 290 nm and at 310 nm, and the following 
calculation:  
 
𝑐 [
𝑚𝑔
𝑚𝑙
] =
𝐴(290 𝑛𝑚) − 𝐴(310 𝑛𝑚)
0.62
 
  
 (4) 
For all other proteins, light absorbance measurements at 280 nm and 310 nm or Bradford Assays 
were performed. In the first case, light absorbance at the two wavelengths was measured and 
protein concentration was computed from Beer-Lambert law: 
 
𝑐 =
𝐴(280 𝑛𝑚) − 𝐴(310 𝑛𝑚)
𝜀 ∙ 𝑙
 
  
 (5) 
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Here, ε represents the molar extinction coefficient and l again denotes the optical path length. Molar 
extinction coefficients were determined with the help of MacVector 13 software (MacVector). 
Implementation of Bradford assays was adapted from Bradford (1976). Samples were mixed with a 
Coomassie Brilliant Blue G-250-containing solution (Protein Assay Dye Reagent Concentrate, Bio-Rad) 
and photometric absorption measurements at a wavelength of 595 nm were performed. Protein 
concentration determination was based on the shift of the dye´s absorption maximum upon protein 
binding. Before the assay was performed with a sample of unknown protein concentration, 
measurements with BSA standards of concentrations c ranging from 0.2 mg/ml to 0.9 mg/ml were 
performed. Applying Microsoft Excel, the following linear fit with fit parameters m and n was 
adjusted to the data obtained from BSA standards: 
 𝐴(595 𝑛𝑚) = 𝑐 [
𝑚𝑔
𝑚𝑙
] ∙ 𝑚 + 𝑛    (6) 
In the next step, absorbance measurements of the samples with unknown protein content were 
performed. Concentrations were then calculated from equation (6) using the values of m and n 
obtained from fitting. 
 
3.4 In Vivo Functional Protein Analysis 
To gain insight into myosin-XXI´s potential functions in a cellular environment, transfections with 
various myosin-XXI DNA constructs were carried out. To avoid interference of endogenously 
expressed myosin-XXI, mammalian cell lines COS-7 (Cercopithecus aethiops kidney fibroblasts) and 
HeLa (human cervix epithelial carcinoma cells) were utilized in transfection experiments. In addition 
to the investigation of the cellular localization of myosin-XXI in fixed cell samples, the dynamic 
behavior of myosin-XXI was investigated with the help of live records of transfected cells. Further, 
the influence of myosin-XXI on the formation of membrane protrusions was studied by the analysis 
of filopodia length and density of fixed cells. Myosin-XXI expression of transfected HeLa and COS-7 
cells was confirmed by western blotting. 
 
 Cell Culture and Transfections 3.4.1
Cells were grown at a temperature of 37°C in an atmosphere of 10 % CO2 (COS-7) or 5 % CO2 (HeLa) 
content. COS-7 cells were maintained in Minimum Essential Medium (Thermo Fisher Scientific), and 
HeLa cells were kept in Dulbecco´s Modified Eagle Medium (Thermo Fisher Scientific), each 
supplemented with 10 % (v/v) fetal bovine serum. Cells were not transfected before a minimum 
passage number of 6 and after a maximum passage number of 27. Prior to transfection, cells were 
seeded in 6-well plates and left to grow for 24 h. If cells were later to be fixed to prepare durable 
samples for confocal microscopy, wells were equipped with flamed clean circular coverslips 
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(diameter: 25 mm) before seeding (see subsection 3.5.1 for cleaning protocol). If live imaging was 
intended, cells were grown in glass bottom cell culture dishes. Transfection of plasmid DNA was 
implemented using Lipofectamine® 2000 Transfection Reagent (Thermo Fisher Scientific) following 
manufacturer´s instructions. Cells were incubated with Lipofectamine® 2000-DNA mixture for 4 h to 
6 h. Afterwards, cells were left to grow for 24 h, 48 h, or 72 h before further treatment. Plasmids 
introduced into the cells contained a fluorophore sequence and DNA encoding a myosin-XXI 
construct. Furthermore, plasmids only encoding a fluorophore were used for control experiments. A 
detailed list of all plasmids used in transfections can be found in Table A.2. In addition to 
transfections with only one plasmid, mammalian cells were also co-transfected with either two 
plasmids or a plasmid and a baculovirus at a time. In co-transfection experiments, a plasmid 
containing myosin-XXI DNA and a construct for the staining of a certain cell structure were applied in 
order to acquire information about myosin-XXI cellular localization. The additional plasmid applied in 
co-transfections with two plasmids encoded a fusion protein of RFP (red fluorescent protein) and 
lifeact, a peptide used for staining of the actin cytoskeleton (Riedl et al., 2008). Baculoviruses (Cell 
Light® Reagents BacMam 2.0, Thermo Fisher Scientific) used in co-transfections encoded markers for 
early endosomes, Golgi apparatus, and endoplasmic reticulum. They were added to transfected cells 
immediately after cells had been incubated with Lipofectamine® 2000-DNA mixture. Baculovirus 
concentrations used varied between 1.2·106 and 1.6·106 particles per 105 cells. In all transfections 
and co-transfections performed, plasmid DNA was applied at a concentration of 0.2 µg to 2.2 µg per 
105 cells and DNA to Lipofectamine® 2000 ratios ranged between 1:1.3 μg/μl and 1:4.6 μg/μl.  
Once transfection was completed, cells were either subjected to live imaging, lysed for 
western blotting, or fixed for later confocal microscopy. For fixation, cells were washed with PBS and 
incubated in 4 % (w/v) paraformaldehyde in PBS for 10 min to 15 min. Subsequently, samples were 
again washed with PBS and treated with 50 mM NH4Cl in PBS for 15 min to 30 min. Following 
washing with PBS, samples were either further treated in a staining procedure (see subsection 3.4.2) 
or already mounted on microscope slides for microscopic inspection. 
 
 Staining of the Actin Cytoskeleton and Clathrin-Coated Vesicles 3.4.2
In order to gain information about the cellular localization of transfected myosin-XXI constructs, actin 
filaments and clathrin-coated vesicles within the cells were stained after transfection.  
All incubation steps described below were carried out at RT in a humid atmosphere. All required 
solutions were prechilled on ice prior to use. To prepare cells for the uptake of staining reagents, 
cells were simultaneously permeabilized and blocked in PBS/BSA supplemented with 0.1 % (v/v) 
Triton X-100 for 15 min. Staining of actin filaments was implemented by treating permeabilized cells 
with 264 nM phalloidin-TRITC in PBS/BSA for 30 min. Immunostaining of clathrin-coated vesicles was 
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implemented with the help of anti-clathrin heavy chain rabbit polyclonal antibody (abcam) and 
cyanine 3-conjugated polyclonal goat anti-rabbit antibody (Jackson ImmunoResearch): initially, 
permeabilized cells were incubated with 1 μg/ml anti-clathrin antibody in PBS/BSA for 1 h. Following 
washing with PBS, samples were treated with 3 μg/ml secondary antibody in PBS/BSA for another 
hour. Subsequent to staining, samples were washed with PBS and were then mounted onto 
microscope slides. 
 
 Preparation of Durable Samples, Confocal Microscopy, and Analysis of Confocal 3.4.3
Images 
Coverslips with fixed transfected cells were attached to 26x76 mm2 microscope slides (Menzel) using 
Mowiol Embedding Solution. Immediately before the solution was applied, approximately 3 % (m/v) 
1,4-diazabicyclo[2.2.2]octane were added in order to improve lifetime of the dyes contained in the 
cell samples. 
Confocal images of durable samples were recorded using a 60x or a 100x oil immersion objective. 
DsRed2 (Discosoma species red fluorescent protein 2) and RFP were excited with a 544 nm laser, 
ZsGreen1 (Zoanthus species green fluorescent protein 1) and eGFP excitation was implemented with 
a 488 nm laser. 
To elucidate a possible impact of myosin-XXI on the formation and dynamics of membrane 
protrusions, filopodia density and length was analyzed for HeLa and COS-7 cells transfected with 
equal concentrations of vector encoding FL-XXI-ZsGreen1 fusion protein, Trunc-XXI-ZsGreen1 fusion 
protein, or solely ZsGreen1. Based on the literature (Berg and Cheney, 2002), filopodia were defined 
as membrane protrusions of a width smaller than 1 μm and a length greater than 0.75 μm. Density of 
filopodia was calculated as the ratio of filopodia number to membrane circumference in the 
xy-plane. Membrane circumference was measured with the help of NIS-Elements Advanced Research 
4.00 software. Number of filopodia was deduced in the course of length determination. Two 
different approaches were deployed to measure filopodia length: In the analysis of HeLa cells, length 
of a filopodium was defined as the length of a straight line connecting the origin and the tip of a 
filopodium, and origin and tip of each filopodium were identified in z-series records. For COS-7 cells, 
filopodia lengths were automatically derived from average images of z-stack records. Average images 
were processed in ImageJ 1.46r by sharpening, manual removal of the image parts depicting the cell 
body, and converting remaining structures (i.e. filopodia) into single-pixel format. Lengths were then 
computed applying automated particle analysis. For better evaluation of the analysis results, 
fluorescence intensity signals of the cell bodies of analyzed cells were compared as a measure for 
different expression levels. Intensities were quantified with the NIS-Elements Advanced Research 
4.00 software. 
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 Live Imaging and Analysis of Records 3.4.4
Live images of transfected HeLa cells were recorded with the confocal microscopy system applying 
the same settings as stated in the previous subsection. During the imaging process, cells were 
maintained in phenol red free Minimum Essential Medium (Thermo Fisher Scientific) in a stage top 
incubation chamber which sustained a humid atmosphere of 37°C temperature and 5 % CO2 content.  
Records were analyzed regarding myosin-XXI movement and length changes of filopodia. 
Furthermore, the time course of the fluorescence intensity of myosin-XXI accumulations inside 
filopodia tips was measured. Myosin-XXI movement within filopodia shafts was analyzed with the 
SpotTracker plugin in ImageJ. Tracking was only applied during phases of constant filopodia length 
and position. The rates of length changes of filopodia were determined by tracking stable myosin-XXI 
accumulations inside the tips of filopodia, again utilizing the ImageJ SpotTracker plugin. Fluorescence 
intensities of myosin-XXI accumulations inside filopodia tips were quantified using the NIS-Elements 
Advanced Research 4.00 software. Intensity measurements were only carried out during phases of 
stable filopodia length and fixed tip position. 
 
 Cell Lysis and Western Blotting 3.4.5
Western blotting was utilized to verify the expression of FL-XXI-ZsGreen1 fusion protein, Trunc-XXI-
ZsGreen1 fusion protein, and ZsGreen1 by HeLa and COS-7 cells transfected with the corresponding 
plasmid.  
Once transfection procedure was finished, cells were washed in ice-cold PBS and scraped into ice-
cold Lysis Buffer. Lysates were boiled at 95°C for 5 min and briefly tip-sonicated. Linearized samples 
were then subjected to SDS-PAGE. Proteins were subsequently transferred onto a nitrocellulose 
membrane by electroblotting in Blotting Buffer at a voltage of 100 V. Afterwards, the nitrocellulose 
membrane was blocked in Blocking Buffer at RT for 15 min. Then, the membrane was incubated with 
anti-RCFP rabbit polyclonal pan antibody (Clontech) at 4°C overnight. This primary antibody was 
supplied as serum and diluted 1:1,000 in Blocking Buffer. After washing with Wash Buffer, incubation 
with 0.1 μg/ml horseradish peroxidase-conjugated polyclonal goat anti-rabbit antibody (abcam) in 
Blocking Buffer was carried out for 1 h. Subsequent to washing with Wash Buffer, Clarity™ Western 
ECL Blotting Substrate (Bio-Rad) was applied to the membrane according to manufacturer´s 
instructions. Chemiluminescence signal was detected with the help of a gel imaging system. 
 
3.5 In Vitro Functional Protein Analysis 
In in vitro experiments, myosin-XXI motility on different surfaces, and its binding behavior to 
phospholipids were investigated. Gliding filament assays on nitrocellulose and on lipid vesicle-
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covered surfaces were performed to gain information about the directionality of myosin-XXI 
movement along F-actin, and to verify that myosin-XXI is capable of inducing filament movement 
when bound to lipids. The dynamic behavior of the bilayer-bound actin-myosin-XXI complex and the 
capability of myosin-XXI to bind to planar lipid bilayers were investigated with the help of supported 
and tethered lipid bilayers. Furthermore, potential curvature sensitivity of myosin-XXI was elucidated 
in co-sedimentation assays and Single Liposome Curvature (SLiC) assays. 
 
 General Preparation Techniques 3.5.1
In order to execute the in vitro experiments described in later subsections, certain preparation 
techniques had to be performed repeatedly. These commonly used techniques are described in the 
following subsections.  
 
Preparation of Coverslips and Flow Cells 
Before coverslips were utilized in any experimental procedure, they were cleaned to avoid sample 
contamination. If not used in cell culture, coverslips were attached to microscope slides to form 
experimental chambers. 
Coverslips were cleaned by applying an etch solution made of H2O, 50 % (w/v) H2O2, and 30 % (w/v) 
NH3 in a volume ratio of 5:1:1. Coverslips were incubated in this solution at a temperature of 70°C for 
2 to 3 hours. Following this, coverslips were intensely washed with H2O and with methanol. 
Coverslips were left to dry and stored at RT. Coverslips used in cell culture, were additionally 
sterilized by flaming, and were immediately transferred into sterile 6-well plates. 
 
 
Figure 23 Construction of flow cells. Each flow cell was assembled from a cleaned coverslip mounted on a microscope slide. 
Flow cell walls enclosed two experimental channels, and consisted of glass or of a combination of double-sided tape and 
gaffer tape. 
 
Flow cells (Figure 23) constructed from cleaned coverslips were mounted on 26x76 mm2 microscope 
slides (Menzel). Flow cells used in gliding filament assays on nitrocellulose or lipid vesicles further 
were constructed using cleaned 24x40 mm2 coverslips (Menzel) attached to the microscope slides 
with double-sided tape and gaffer tape. Prior to attachment to a microscope slide, coverslips were 
coated with 0.6 mg/ml nitrocellulose in pentyl acetate. Flow cells used for the preparation of 
supported lipid bilayers (SLB) or for SLiC assays were completely made from glass to assure integrity 
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of the flow cell throughout long incubation times: Flow cell walls consisted of 3x40 mm2 coverslips 
(Menzel), and flow cells were closed with 26x40 mm2 cleaned coverslips. UV glue (Loctite AA 350, 
Henkel) was utilized for the attachment of all components. In the case of SLiC assays, cleaned 
coverslips were additionally coated with polyethylene glycol (PEG) before attachment (see 
subsection 3.5.5). 
 
Polymerization and Fluorescent Labeling of Actin 
To investigate myosin-XXI in gliding filament assays, purified G-actin was polymerized to form 
filaments. To ensure visibility in total internal reflection fluorescence (TIRF) microscopy, actin was 
polymerized in the presence of fluorescently labeled phalloidin. Phalloidin was conjugated to 
tetramethylrhodamine B isothiocyanate (TRITC) or fluorescein isothiocyanate (FITC), and further 
served as stabilizing agent preventing depolymerization of filaments (Lengsfeld et al., 1974). For 
studies of myosin directionality, polar labeling of actin with two dyes was implemented. For any 
other investigation, solely phalloidin-FITC was utilized for labeling. 
 
1. Preparation of FITC-Labeled F-Actin: 
Polymerization of actin was induced by the application of K+, Mg2+, and ATP as these constituents had 
been shown to promote formation of actin filaments (Straub, 1943; Price, 1946; Feuer et al., 1948). 
For this purpose, purified G-actin was mixed with 10 times concentrated AB+ in a 9:1 volume ratio 
and incubated on ice for 1 h. Subsequently, the resulting F-actin solution was diluted by a factor of 60 
in AB-. Diluted F-actin and phalloidin-FITC were mixed in equimolar concentrations of actin 
monomers and phalloidin. The mixture was incubated on ice for 2 more hours. F-actin was stored at 
4°C until use. 
 
2. Preparation of Dual-Labeled F-Actin: 
To attain a polar labeling of actin filaments with two distinct fluorescent dyes, actin was 
consecutively incubated with phalloidin-TRITC and phalloidin-FITC. The development of the applied 
method was based on a protocol published by Herm-Götz et al. (2002). At first, purified monomeric 
actin was diluted in G-Actin Buffer to a final G-actin concentration of 1.9 µM. Following a 15 min 
incubation on ice, polymerization was induced by the addition of 100 mM solid KCl, and the sample 
was incubated at RT for 10 min. Phalloidin-TRITC was added to the actin solution so that molar ratio 
of phalloidin to G-actin was 1:1. The mixture was left to incubate on ice overnight. The next morning, 
the solution was supplemented with human plasma gelsolin and incubated on ice for 30 min. Gelsolin 
is a capping protein preventing polymerization at the barbed end (also called plus end) of F-actin 
(Harris and Weeds, 1984). Molar ratio of gelsolin to G-actin was adjusted to a value between 1:10 
Materials and Methods 
60 
and 1:100. In the next step, a 10- to 15-fold excess of purified G-actin was added to the capped actin 
seeds. After a 5 min incubation on ice, actin polymerization was again induced by the application of 
100 mM solid KCl. Then, phalloidin-FITC was added in an equimolar amount to unlabeled G-actin. The 
mixture was left to incubate on ice for 1 h to 3 h. This procedure resulted in actin filaments exhibiting 
TRITC-labeled barbed ends and FITC-labeled pointed ends (also called minus-ends). Filaments were 
stored at 4 °C. Samples had to be used within 48 h as gelsolin also exhibits an actin severing activity 
causing disassembly of filaments even in the presence of phalloidin (Norberg et al., 1979; Allen and 
Janmey, 1994). 
 
Preparation of Unilamellar Vesicles 
In order to prepare unilamellar vesicles, lipid composition had to be determined. Molar ratios of the 
different lipids and carbocyanine dyes were specified and required volumes of stock solutions were 
calculated using the molecular weight values stated by the suppliers. For bovine brain extract, only 
lipid composition was declared by the manufacturer: Extract consists of phosphatidylserine (PS), 
cerebrosides and phosphatidylinositol (PI) in a molar ratio of 5:4:1. For this reason, molecular weight 
M of bovine brain extract was estimated as: 
 𝑀 = 0.5 ∙ 𝑀𝑃𝑆 + 0.4 ∙ 𝑀𝐶 + 0.1 ∙ 𝑀𝑃𝐼 = 815.48 
𝑔
𝑚𝑜𝑙
    (7) 
Molecular weights MPS of PS (824.97 g/mol), MC of cerebrosides (781.95 g/mol), and MPI of PI 
(902.13 g/mol) were adopted from porcine brain PS, porcine brain cerebrosides, and bovine liver PI 
as stated by Avanti Polar Lipids. 
To prepare unilamellar vesicles, stock solutions were mixed in the desired molar ratios, and 
evaporated in a vacuum concentrator at 30 °C until complete removal of all solvents. Thereafter, the 
resulting lipid cake was resuspended in aqueous buffer (Lipid TBS, Lipid Buffer 500, Lipid Buffer 150, 
or HNa 100). The resulting solution was subjected to multiple freeze-thaw cycles using liquid nitrogen 
and a water bath. Temperature of the water bath ranged between 50°C and 65°C depending on the 
phase transition temperatures of the lipids contained in the solution. 
 
 Gliding Filament Assays 3.5.2
In gliding filament assays, functionality of myosin-XXI was investigated by immobilizing myosin on a 
surface, adding actin filaments and monitoring filament movement in the presence of ATP. Assays 
were performed in flow cells made from nitrocellulose-coated coverslips. All buffers used were 
degassed before the experiments and sample preparation was carried out at RT. Filament movement 
was recorded by a Nikon 1AR TIRF microscopy system using a 100x Nikon Apochromat oil immersion 
objective (NA 1.49). Fluorophore excitation was achieved by 488 nm and 544 nm laser irradiation.  
 
Materials and Methods 
61 
Gliding Filament Assays on Nitrocellulose-Coated Glass Surfaces 
Gliding filament assays on nitrocellulose-coated glass surfaces (Figure 24) were carried out to 
determine myosin directionality, and to verify functionality of myosin-XXI samples prior to use in 
further experiments. 
Assays were carried out according to Kron and Spudich (1986) with modifications. In short, a 240 nM 
dilution of myosin-XXI in AB- and a 26 nM (monomer concentration) dilution of F-actin in AB-/BSA 
were prepared. Myosin-XXI was then injected into the flow chamber and incubated for 3 min. 
Afterwards, the nitrocellulose surface was blocked with AB-/BSA for 3 min. F-actin solution was 
added and left to incubate for another 3 min. The chamber was then rinsed with Rigor Buffer and 
transferred to the TIRF microscope to verify binding of actin filaments. Filament movement was 
initiated by the addition of 1 mM ATP in Rigor Buffer. 
Gliding filament assays with HMM and myosin-VI followed the same procedure with the following 
modifications: For HMM assays, protein solutions were diluted to concentrations of 140 nM HMM 
and 8 nM G-actin. Furthermore, 10 μM ATP was applied to induce motor motility. Experiments with 
myosin-VI were implemented using 2.3 μM myosin-VI and 7 nM G-actin. Assay Buffer was replaced 
by Myosin-VI Buffer, and ATP concentration was increased to 10 mM. ATP concentration was 
adapted for each myosin to reduce the frequency of filament rupture.  
 
 
Figure 24 Gliding filament assay on a nitrocellulose-coated glass surface. In this assay, myosin was unspecifically bound to 
a coverslip treated with nitrocellulose. Subsequently, BSA was applied to block the sample surface. In the next step, 
fluorescently labeled F-actin was added, which attached to immobilized myosin molecules. Upon addition of ATP, filament 
gliding could be observed with the help of fluorescence microscopy. 
 
Gliding Filament Assays on Lipid Vesicles 
To confirm myosin-XXI´s vesicle binding capability and motor motility in a lipid-bound state, gliding 
filament assays on lipid vesicle-coated surfaces were carried out.  
Prior to the experiments, vesicles were treated in an ultrasonic bath (Sonorex RK 100 H, Bandelin) at 
RT for 10 min and extruded through a polycarbonate membrane at least 21 times (membrane pore 
diameter: 30, 100, 200, 400, 800, or 1000 nm). Vesicle solutions were diluted in Lipid Buffer 500 to 
attain lipid concentrations of 10 μg/ml or 40 μg/ml. Lipids were then injected into a flow chamber 
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and incubated at RT for 10 min. The flow cell was then rinsed with AB-/2x BSA and incubated for 5 to 
10 min. BSA was applied to prevent nonspecific protein binding to the nitrocellulose surface. FL-XXI 
was diluted in AB- to a final concentration of 0.4 μM, rinsed into the chamber, and incubated for 3 
min. An 8.6 nM (monomer concentration) dilution of FITC-labeled F-actin in AB-/2x BSA was prepared 
and added to the sample. After another 3 min of incubation, the flow cell was rinsed with Rigor 
Buffer and filament binding to the surface was confirmed by TIRF microscopy. Subsequently, Motility 
Buffer was flushed into the chamber and filament movement was recorded. 
Lipid vesicles utilized in gliding filament assays contained POPC, 1.2 mol% Rhodamine DHPE, and 
4.8 mol% to 9.7 mol% of a phosphoinositide (PI(4)P, or PI(3,5)P2). Rhodamine DHPE allowed visual 
verification of vesicle binding to the nitrocellulose surface. PI(4)P and PI(3,5)P2 were added as 
myosin-XXI binding to those phospholipids had been demonstrated (Batters et al., 2014). As a 
negative control, vesicles merely composed of POPC and 1.1 mol% Rhodamine DHPE were used. 
 
Analysis of Filament Movement 
Myosin directionality was determined using NIS-Elements Advanced Research 4.00 software (Nikon) 
for analysis. Filament movement was manually tracked and color of the leading filament end was 
registered. For a filament to be taken into account for analysis, movement of the filament had to be 
detectable in at least 3 consecutive frames, and the filament´s entire length had to be visible for at 
least 3 consecutive frames of filament movement. Furthermore, each filament had to exhibit exactly 
two distinct parts of different labeling, and each of these parts had to be of at least 2 pixels of length 
along the filament axis.  
To determine the speed of gliding filaments, ND2 files generated by the Nikon software were 
converted into GMV files in ImageJ 1.46r with the help of a self-written macro. Filaments could then 
be manually tracked using GMimPro image sequence processor (Mashanov and Molloy, 2007). Tracks 
of filament movement persisting for less than 5 consecutive frames were excluded from the analysis. 
Average filament gliding speed was calculated as the mean of the speed values of all single steps of 
all tracked filaments. 
 
 Binding of Myosin-XXI to Planar Lipid Bilayers 3.5.3
To elucidate the dynamic behavior of the actin-myosin-XXI complex and to investigate the capability 
of myosin-XXI to bind to planar lipid bilayers systems, two types of bilayers were prepared 
(Figure 25): supported lipid bilayers consist of a lipid double layer directly applied to the surface of 
the substrate. Tethered lipid bilayers are lifted from the substrate and attached to the substrate 
surface by singular molecular anchors. Before these bilayers were utilized in experiments with 
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myosin-XXI, presence of a fluid membrane was verified by Fluorescence Recovery after 
Photobleaching (FRAP) tests. 
 
 
Figure 25 Types of planar lipid bilayers. In order to perform bilayer binding experiments, two types of planar lipid bilayers 
were prepared: supported bilayers (left) consist of a lipid double layer directly located on the surface of a coverslip, while 
tethered bilayers (right) are attached to a PEG-coated glass surface via Lipo-PEG anchors. PEG/Lipo-PEG coating required 
preceding chemical treatment of coverslips resulting in the self-assembly of an OCT film. Presence of the PEG cushion 
beneath tethered lipid bilayers passivated the glass surface thus reducing unspecific attachment of proteins. 
 
Preparation of Planar Lipid Bilayers 
1. Preparation of Supported Lipid Bilayers: 
In order to prepare supported lipid bilayers, unilamellar vesicles containing Rhodamine DHPE were 
produced. Rhodamine DHPE was added to permit later FRAP measurements of the readily formed 
bilayers. In advance to some experiments, vesicles were additionally treated in an ultrasonic bath at 
RT for 10 min. Furthermore, some of the lipid solutions were then centrifuged at 4°C and at least 
13,000 x g for 15 min or longer to remove lipid aggregates. Immediately before bilayer preparation, 
vesicles were diluted in aqueous buffer to a concentration between 0.02 mg/ml and 2.0 mg/ml. 
Buffers used were HNa100 and Lipid Buffer 500. SLB were prepared in glass flow cells made with 
uncoated cleaned coverslips. 
First, a flow cell was filled with buffer and thereafter, diluted lipid solution was flushed in. Vesicles 
were left to attach to the glass surface during an incubation period of at least 30 min at RT in a humid 
environment. Once attachment had occurred, bilayer formation resulted from rupture of the 
vesicles. Rupture was achieved by simply incubating flow cells until bilayer formation could be 
observed, or by rinsing flow chambers with H2O thus exposing vesicles to an osmotic shock. Prior to 
experimental use, bilayers were again rinsed with buffer. 
 
2. Preparation of Tethered Lipid Bilayers: 
Tethered lipid bilayers were prepared in a two-step procedure: At first, coverslips (20x15 mm2; Carl 
Roth) were passivated and functionalized with tethers. In the second step, phospholipids were 
applied. 
For the purpose of substrate passivation and creation of tethers, coverslips were prepared according 
to Daniel et al. (2007) and Wasserman et al. (1989) with modifications. All equipment used in this 
procedure was incubated at 120°C for several hours prior to use to remove all water. Coverslips were 
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prepared for coating by several cleaning procedures. After they were cleaned with acetone, 
isopropanol, and H2O, coverslips were subjected to RCA cleaning (RCA: Radio Corporation of 
America): coverslips were consecutively incubated in a solution of H2O, 30 % H2O2, 25 % NH3 
(5:1:1 volume ratio) at 80°C, a solution of H2O, 30 % H2O2, 37 % HCl (5:1:1 volume ratio) at 120°C, and 
again in a solution of H2O, 30 % H2O2, 25 % NH3 at 80°C, each for 30 min. Afterwards, coverslips were 
dried under a stream of nitrogen and incubated at 120 °C and at a pressure of 40 mbar for 5 min in a 
vacuum drying oven to remove remaining water.  
Dried clean coverslips were then coated with a self-assembled octenyltrichlorosilane (OCT) film by 
incubating them in 0.2 % (v/v) OCT in anhydrous hexadecane while kept in a nitrogen atmosphere 
overnight. After a 3 min ultrasound treatment in chloroform, coverslips were dried under a stream of 
nitrogen and incubated at RT and 40 mbar for 1 h. To oxidize OCT films, coverslips were incubated in 
Oxidizing Solution overnight. Subsequently, coverslips were successively cleaned in the following 
solutions for several seconds: 0.4 M NaHSO3, H2O, 1 M HCl, H2O, and ethanol.  
After drying with nitrogen and in the vacuum drying oven at 40 mbar at RT, OCT surfaces were 
functionalized with amino-terminated polyethylene glycol conjugated to phosphoethanolamine (1,2-
distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000], Avanti Polar 
Lipids; called Lipo-PEG here). For this purpose, coverslips were incubated in a solution containing 
15.2 mM N-hydroxysuccinimide (NHS) and 78.2 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC) at RT for 2 h. After coverslips were washed with H2O and dried under a stream of 
nitrogen, they were placed in 1 mg/ml Lipo-PEG in dimethylformamide at RT overnight. During the 
following reaction, NHS was removed and partially replaced by Lipo-PEG. Lipo-PEG would later serve 
as an anchor for tethering the lipid bilayer to the coverslip. The next day, coverslips were washed 
with chloroform and dried under a stream of nitrogen. 
Subsequently, silanes not linked to Lipo-PEG were conjugated to amino-terminated polyethylene 
glycol (alpha-methoxy-omega-amino poly(ethylene glycol)-750, Rapp Polymere; called PEG-NH2 
here). Therefore, coverslips were again treated with NHS/EDC solution. Then, OCT films were 
incubated in 10 mg/ml PEG-NH2 in Carbonate Buffer overnight to replace NHS by PEG-NH2. The 
resulting PEG-NH2 cushion passivated the glass surface in later experiments, creating a lipid bilayer 
lifted from the glass surface and simultaneously reducing nonspecific binding of proteins to the 
coverslips. After the overnight incubation, coverslips were cleaned using H2O and chloroform, dried 
under a stream of nitrogen, and finally, remaining solvents were removed by a 1 h incubation at RT 
and 40 mbar. Coated coverslips were stored at RT until use. 
In the second step of tethered bilayer preparation, passivated coverslips were coated with a 
phospholipid film. For this purpose, lipid stock solutions were mixed, and solvents were evaporated 
in a vacuum concentrator at 30 °C. Dried lipids were resuspended in isopropanol. The lipid solution 
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was then uniformly spread on the coverslips utilizing a spin coater. Subsequently, isopropanol was 
thoroughly evaporated by 150 min of incubation in a vacuum drying oven at 40 mbar at RT. Each 
lipid-coated coverslip was then inserted into a polymer slide containing a channel (µ-Slide I 0.8 Luer 
Uncoated, ibidi) via a rectangular opening milled out of the bottom of the slide (Figure 26). Coverslips 
were fixated using Microset 101RF Fluid silicone glue (Microset), and experimental chambers were 
stored in a desiccator at RT. Immediately before experimental use, chambers were carefully flushed 
with 25 ml of degassed Lipid Buffer 500 to rehydrate the dried lipid films.  
 
 
Figure 26 Polymer slides used for the preparation of tethered lipid bilayer samples. Tethered lipid bilayers were prepared 
with the help of prefabricated polymer slides containing an experimental channel. Prior to use, each polymer slide was 
modified by the removal of a rectangular piece of material from its base. Subsequently, a coverslip coated with a dried 
tethered bilayer film was inserted, and fixated using silicone glue. Eventually, the experimental channel was carefully 
flushed with degassed buffer in order to rehydrate the lipid film. 
 
FRAP Experiments and Calculation of Lateral Diffusion Constants 
Fluorescence Recovery after Photobleaching experiments (Figure 27) were performed with a Nikon 
A1R confocal microscope system using a 60x Nikon Apochromat oil immersion objective (NA 1.40) or 
a 100x oil immersion objective. Rhodamine DHPE contained in the bilayers was excited by 544 nm or 
561 nm laser light, bleaching was implemented with a 405 nm laser. Using the manufacturer´s 
software (NIS-Elements Advanced Research 4.00), in each field of view two regions of interest (ROI) 
were defined. For the Reference ROI solely the time course of fluorescence intensity was recorded. 
At the same time, the so-called Stimulation ROI was actually used for FRAP measurements: Following 
60 s of fluorescence intensity measurement, the majority of fluorophores within this region was 
bleached. Instantly after photobleaching, recovery of the fluorescence signal by lateral diffusion of 
non-bleached Rhodamine DHPE was monitored. Regions of interest always had a circular shape with 
radii ranging from 8 μm to 9 μm. 
Before FRAP of the Stimulation ROI was analyzed, a time-dependent correction factor α(t) was 
calculated which accounted for photobleaching inherent to the imaging process: 
 
𝛼(𝑡) =
𝐹𝑟𝑒𝑓(0)
𝐹𝑟𝑒𝑓(𝑡)
 
  
 (8) 
Here, Fref(t) denotes the fluorescence intensity of the Reference ROI at a time t. Fref(0) is the intensity at 
time t=0 s, i.e. at the beginning of the record. 
The correction factor α(t) was multiplied with the intensity data Fstim(t) obtained from the 
measurements of the Stimulation ROI: 
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 𝐹(𝑡) = 𝛼(𝑡) ∙ 𝐹𝑠𝑡𝑖𝑚(𝑡) (9) 
Thus, F(t) describes the time course of the corrected intensity curve of the Stimulation ROI. 
Curves F(t) were now subjected to an analysis derived from Axelrod et al. (1976) and 
Soumpasis (1983). Accordingly, intensity curves F(t) of FRAP experiments can be fitted by the 
following function: 
 
𝐹(𝑡) = 𝐹(∞) − [𝐹𝑏𝑒𝑓𝑜𝑟𝑒 − 𝐹𝑃𝐵] ∙ [1 − 𝑒
−
2𝜏𝐷
𝑡−𝑡𝑃𝐵 ∙ (𝐼
1(
2𝜏𝐷
𝑡−𝑡𝑃𝐵
)
+ 𝐼
0(
2𝜏𝐷
𝑡−𝑡𝑃𝐵
)
)] 
  
 (10) 
where F(∞) is the fluorescence intensity after termination of fluorescence recovery, Fbefore is the 
intensity before photobleaching, and FPB is the fluorescence intensity measured immediately after 
photobleaching. F(∞) and FPB were determined as average intensities of 15 s to 30 s intervals. The 
parameter tPB is the point in time where photobleaching is executed. The constant τD is the 
characteristic diffusion time and the parameter to be determined by fitting. I1 and I0 are modified 
Bessel functions. Fits were adapted to experimental data with the help of the solver Add-in in 
Microsoft Excel.  
Lateral diffusion constants D could then be calculated from τD and the ROI radius R: 
 
𝐷 =
𝜏𝐷
2
4𝑅
 
  
 (11) 
 
 
Figure 27 FRAP. In Fluorescence Recovery after Photobleaching experiments, bilayer fluidity was verified by bleaching 
bilayer-incorporated Rhodamine DHPE. Immediately after applying the bleaching laser to a defined circular ROI, a marked 
decrease in the fluorescence signal detected within this defined region was observed (1). Due to lateral diffusion of 
unbleached Rhodamine DHPE, the fluorescence signal recovered (2, 3) until finally almost reaching its initial level (4). 
Confocal images on the left show FRAP records of a supported bilayer composed of 73.0 mol% POPC, 26.0 mol% 
cholesterol, and 1.0 mol% Rhodamine DHPE. The diagram on the right depicts the corresponding intensity measurement of 
the selected ROI. Scale bars: 20 μm. 
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Binding of Myosin-XXI to Lipid Bilayers 
After ATPase activity and motility of FL-XXI had been tested in gliding filament assays on 
nitrocellulose surfaces, filament gliding was intended to be reproduced on lipid bilayers composed of 
bovine brain extract, or a combination of POPC or DOPC with other phospholipids. These other lipids 
were 9.5 mol% bovine brain extract, or 1.6 mol% to 9.7 mol% of a phosphoinositide (PI(4)P, PI(3,5)P2, 
or PI(4,5)P2). Bovine brain extract and the mentioned phosphoinositides were chosen as myosin-XXI 
binding to them had been demonstrated before (Batters et al., 2014). POPC/Rhodamine DHPE 
bilayers were used as negative controls.  
In addition to the investigation of the behavior of the actin-myosin-XXI complex, bilayer binding of 
myosin-XXI alone was tested with the help of FRAP experiments. 
 
1. Investigation of the F-Actin-Myosin-XXI Complex: 
In a first approach adapted from Zot et al. (1992), the procedure of gliding filament assays on 
nitrocellulose was transferred to supported lipid bilayers: at first 0.1 μM to 7.5 μM myosin-XXI in AB- 
was injected into a flow chambers in which an SLB had been prepared. Following this, 8.6 nM 
(monomer concentration) FITC-labeled F-actin in AB- or AB-/BSA was flushed into the flow cell. After 
Rigor Buffer was added and actin binding was verified by inspection with a TIRF microscope using a 
488 nm laser and a 100x oil immersion objective, Motility Buffer was injected and filament behavior 
was observed. In some experiments, the aforementioned procedure was complemented by blocking 
with AB-/BSA to prevent protein binding to the glass surface at areas not completely bilayer-covered. 
Furthermore, experiments omitting myosin-XXI addition were performed to assure actin´s inability to 
bind to lipid bilayers in the absence of myosin. 
The second method for binding F-actin-myosin-XXI complexes to planar lipid bilayers was adapted 
from Pyrpassopoulos et al. (2012). 0.5 μM to 7.5 μM myosin-XXI and 8.6 nM to 28.7 nM (monomer 
concentration) FITC-labeled F-actin were premixed in an ATP-supplemented buffer (Motility Buffer or 
KMg Activation Buffer) and incubated on ice for 3 min. The mixture was then added to a supported 
or a tethered lipid bilayer and the sample was observed using the TIRF microscope.  
 
2. Investigation of Myosin-XXI: 
In two additional set-ups, bilayer binding of FL-XXI in the absence of F-actin was studied. Here, the 
diffusive behavior of a fusion protein of FL-XXI and eGFP was investigated with the help of FRAP 
utilizing a 488 nm laser for imaging and a 405 nm laser or bleaching. Bilayers studied consisted of 
bovine brain extract and 1.2 mol% Rhodamine DHPE.  
In the first experimental set-up, myosin-XXI was added to readily formed SLB. 10 nM to 15 μM 
myosin-XXI in aqueous buffer (Rigor Buffer without BSA, Lipid Buffer 500, or Lipid Buffer 150) was 
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carefully injected into the flow cell and incubated at RT for at least 3 min. FRAP tests of the bilayer 
and of myosin-XXI were repeatedly performed over a time span of several hours. It was further 
investigated whether rinsing the flow chamber with buffer after incubation of myosin-XXI influenced 
myosin´s diffusive behavior. In addition to the procedure described so far, in some experiments the 
impact of blocking with AB-/2x BSA prior to myosin application was tested. 
To set-up the second type of experiment, 5 nM to 5 μM myosin-XXI and 0.1 mg/ml to 0.4 mg/ml lipid 
vesicles were mixed in buffer (Lipid Buffer 500 or Lipid Buffer 150), and the mixture was incubated at 
RT for 10 min. All vesicles used in this type of experiment had been treated with ultrasound at RT for 
10 min. Before myosin-lipid mixture was injected into a flow cell, the flow cell was rinsed with buffer. 
The sample was left to incubate at RT for at least 30 min. Bilayer formation was surveyed over a time 
period of several hours using the confocal microscope and a 100x oil immersion objective. In some 
experiments, bilayer formation was promoted by applying an osmotic shock to the vesicles by rinsing 
the flow chamber with H2O. 
 
 Co-Sedimentation Assays 3.5.4
Co-sedimentation assays were performed to test if proteins intended to be investigated in SLiC 
assays are capable of binding lipid vesicles.  
Experimental procedure was adapted from Spudich et al. (2007). In summary, 2 μM protein and 
0.2 mg/ml unilamellar vesicles were mixed in Lipid TBS, and incubated at RT for 10 min. Following 
this, samples were centrifuged at 4°C at 160,000 x g for 20 min. Supernatants were carefully removed 
from the samples, and pellets were resuspended in Lipid TBS. Supernatants and resuspended pellets 
were then subjected to SDS-PAGE. After imaging of gels with a gel imaging system, intensities of the 
protein bands were determined with the help of Image Lab 5.0 software (Bio-Rad). Vesicles used in 
co-sedimentation assays were identical to the ones utilized in SLiC assays, i.e. lipid composition and 
treatment prior to experimental use correspond to the descriptions given in the following subsection. 
 
 Single Liposome Curvature Assays 3.5.5
Once protein binding to vesicular bilayers had been verified in co-sedimentation assays, proteins 
were further investigated in Single Liposome Curvature assays to identify a potential curvature 
sensitivity of binding events (Figure 28). 
As negative control, SLiC assays with streptavidin conjugated to Alexa Fluor® 488 (Thermo Fisher 
Scientific) were performed (Hatzakis et al., 2009; Larsen et al., 2015). As positive control, 
experiments with eGFP-eNBAR fusion protein were carried out (Bhatia et al., 2009). Finally, lipid 
binding behavior of eGFP fusion proteins with FL-XXI and with myosin-XXI fragments was 
investigated.  
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Flow cells prepared for SLiC assays were always assembled using PEG-coated coverslips in order to 
minimize nonspecific protein binding to the glass surface and to avoid deformation of vesicles by 
immobilization (Bendix et al., 2009). In order to quantify diameters of the utilized unilamellar 
vesicles, size calibration was performed with the help of Stochastic Optical Reconstruction 
Microscopy (STORM).  
 
PEG Coating of Coverslips 
For the purpose of PEG coating, coverslips were silanized using VectabondTM reagent (Vector 
Laboratories) following manufacturer´s instructions. In the next step, a 100 mM NaHCO3 solution was 
freshly prepared to dissolve a mixture of 250 mg/ml PEG succinimidyl carbonate (alpha-methoxy-
omega-carboxylic acid succinimidyl ester poly(ethylene glycol)-5000, Iris Biotech; called PEG-NHS 
here) and 12.5 mg/ml biotinylated PEG (alpha-biotin-omega-carboxy succinimidyl ester poly(ethylene 
glycol)-5000, Iris Biotech; called Biotin-PEG here). Coverslips were then covered with the 
PEG-NHS/Biotin-PEG solution and incubated at RT for 3 h. Once incubation was finished, coverslips 
were washed in 100 mM NaHCO3 and H2O to remove unbound PEG. Coated coverslips were stored in 
a desiccator at RT until they were used for the construction of flow cells. 
 
Sample Preparation and Imaging 
For all SLiC assays, unilamellar vesicles composed of 97.2 mol% bovine brain extract, 1.2 mol% 
Rhodamine DHPE, and 1.6 mol% Biotin DHPE were prepared. Before resulting lipid solutions were 
used in SLiC assays, they were treated in an ultrasonic bath at RT for 10 min, and extruded through a 
polycarbonate membrane of 800 nm pore diameter 21 times. Biotin DHPE contained in the lipid 
mixture enabled vesicles to bind to Biotin-PEG molecules on the surface of coated coverslips via a 
biotin-streptavidin-biotin link. Sample preparation techniques were adapted from Bhatia et al. 
(2009). 
For all proteins except for Alexa Fluor® 488 streptavidin, 2 nM to 320 nM protein and 0.1 μg/ml 
vesicles were mixed in degassed Lipid TBS and left to incubate at RT for 1 h. Meanwhile, a flow cell 
with a PEG-coated coverslip was prepared. Immediately after construction, chambers were filled with 
15.1 μM BSA in Lipid TBS and left to incubate at RT for 15 min. Following this, flow chambers were 
rinsed with Lipid TBS, and 1.7 μM streptavidin in PBS was flushed in. After another 15 min of 
incubation, the flow cell was again rinsed with Lipid TBS, the protein-lipid mixture was added, and 
the chamber was sealed with vacuum grease. The sample was again incubated for 15 min to allow 
vesicles to bind to the PEG surface. This first method of sample preparation was also applied when 
assays solely with vesicles were performed, e.g. when samples for size calibration were prepared. In 
these cases, lipid concentrations ranged from 10 ng/ml to 1 μg/ml. 
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Figure 28 SLiC assay. With the help of Single Liposome Curvature assays, proteins were tested for their capability to sense 
bilayer curvature. For this purpose, the protein under investigation was incubated with a lipid solution composed of vesicles 
of various diameters. Further, protein and vesicles were labeled with distinguishable fluorophores. As vesicular bilayers 
contained Biotin DHPE, vesicles could be immobilized on a biotinylated PEG surface via biotin-streptavidin-biotin links. 
Using confocal microscopy, surface densities of vesicle-bound protein could then be determined. 
 
For SLiC assays with Alexa Fluor® 488 streptavidin, a modified procedure of sample preparation was 
applied. The reason for this was the fact that Alexa Fluor® 488 streptavidin bound to the vesicular 
bilayers by binding to Biotin DHPE. As Biotin DHPE also served as link between vesicles and the PEG 
surface, premixing of Alexa Fluor® 488 streptavidin and lipid solutions impeded vesicle 
immobilization on the PEG surface. Thus, once PEG surfaces were incubated with 15.1 μM BSA and 
16.7 μM streptavidin, flow chambers were three times flushed with Lipid TBS to remove unbound 
streptavidin, and 0.1 μg/ml unilamellar vesicles were injected. Samples were incubated at RT for 
15 min and rinsed with Lipid TBS afterwards. Then, 1 μM Alexa Fluor® 488 streptavidin in Lipid TBS 
was rinsed into the flow chambers, and samples were incubated for 30 min. Unbound Alexa Fluor® 
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488 streptavidin was removed by rinsing the flow cell with Lipid TBS three times, and chambers were 
sealed with vacuum grease.  
Imaging of samples was performed with the confocal microscope using the 100x oil immersion 
objective. Protein and lipid vesicles were recorded in two distinct channels. Rhodamine linked to 
DHPE was excited with a 544 nm laser, eGFP and Alexa Fluor® 488 fluorescence were excited by a 
488 nm laser.  
 
Data Analysis 
All images taken were processed and analyzed in a multi-step procedure modified from Bhatia et al. 
(2009). At first, image files were converted from ND2 format to TIF format using NIS-Elements 
Advanced Research 4.30 software. Analysis was then carried out in ImageJ 1.46r: the GaussFit 
OnSpot plugin was applied to fit 3D Gaussian profiles to all intensity peaks present in an image. Fit 
parameters, integrated intensities, and positions of the corresponding intensity maxima were 
automatically listed into text files. As binding of protein to a lipid vesicle was identified as a 
colocalization of the intensity peaks in the protein channel and in the lipid channel of one confocal 
image, positions of intensity maxima in associated TIF files were matched. For this purpose, a 
LabVIEW program was designed which calculated the distance between maxima positions in the two 
imaging channels. A maximum distance of √2 pixels was applied to identify binding events, and data 
of colocalizing intensity maxima were saved in another text file. In a second analysis step, positions of 
all intensity maxima in each TIF file were determined in ImageJ, and position and amplitude of every 
maximum were listed in a text file. Again using the above-mentioned LabView program, colocalizing 
peaks in the protein and the lipid channel were assigned and their data were saved. Finally, lists 
containing Gaussian profile parameters and lists containing intensity amplitudes were merged into 
one file using the LabVIEW program one more time. Identical binding events could be identified due 
to their identical positions of intensity maxima. 
With the help of the data contained in this merged file, each vesicle could now be assigned a 
fluorescence intensity IV of the vesicle itself and an intensity IP of the protein molecules bound to its 
surface. According to Kunding et al. (2008), the diameter d of a vesicle imaged by confocal 
microscopy can be calculated from: 
     𝑑 = 𝑐 ∙ √𝐼𝑉 (12) 
with c representing a constant calibration factor.  
As vesicular bilayers possess a spherical shape, their surface area AV is determined by the diameter d 
and thus can be calculated from the intensity IV: 
 𝐴𝑉 = 𝜋 ∙ 𝑑
2 = 𝜋 ∙ 𝑐2 ∙ 𝐼𝑉 (13) 
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Equation (13) describes the relation between the surface area of a uniformly labeled spherical shell 
and the fluorescence signal in confocal microscopy. 
Since proteins binding to immobilized vesicles form a spherical shell, (13) is equally valid for the 
fluorescence intensity signal IP originating from bound proteins: 
 𝐴𝑃 ∝ 𝐼𝑃 (14) 
In the above equation, AP denotes the surface area formed by the protein envelope.  
Assuming a uniform distribution of protein bound to a vesicular bilayer surface, the number NP of 
bound protein molecules satisfies the following relation: 
 𝑁𝑃 ∝ 𝐴𝑃 (15) 
In conclusion, NP is directly proportional to the fluorescence intensity IP: 
 𝑁𝑃 ∝ 𝐼𝑃 (16) 
As the surface density ρ of protein molecules bound to a vesicle is defined as the ratio of protein 
molecule number to vesicle surface area 
 
𝜌 =
𝑁𝑃
𝐴𝑉
 
  
 (17) 
the ratio ρR of fluorescence intensities IP to IV is a direct measure for this surface density: 
 
𝜌 ∝ 𝜌𝑅 =
𝐼𝑃
𝐼𝑉
 
  
 (18) 
The course of the intensity ratio ρR as a function of the vesicle diameter d illustrates the binding 
affinity of the tested protein for bilayers of different curvature and thus identifies proteins as 
curvature sensors or non-sensors. When the curve ρR(d) is normalized to a value ρR(d*) at a specific 
vesicle diameter d*, curvature sensitivity of different proteins can be compared. Therefore, curves 
ρR(d) obtained for the investigated proteins were normalized to the mean value ρR̅̅ ̅ of intensity ratios 
at vesicle diameters between 250 nm and 350 nm resulting in the calculation of normalized protein 
densities ρnorm(d): 
 𝜌𝑛𝑜𝑟𝑚(𝑑) =
𝜌𝑅(𝑑)
𝜌𝑅̅̅ ̅
    (19) 
Before curves ρnorm(d) were deduced from the data obtained from image analysis, data had to be 
filtered for noise. Noise could for example result from protein aggregation at areas of defective PEG 
coating. Hence, data were filtered by the following parameters: ratio 𝐴 = 𝜎𝑥 𝜎𝑦⁄  of Gaussian profile 
widths σx in x-dimension and σy in y-dimension, total Gaussian profile width σ, minimum integrated 
intensity, and minimum amplitude of intensity maxima. In addition, values ρR(d) deviating by more 
than a factor of 7.5 from the mean of their 8 adjoining data points were excluded. 
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Size Calibration of Unilamellar Vesicles 
To quantify diameters of unilamellar vesicles used in SLiC assays, calibration measurements were 
carried out. As stated in equation (12), the diameter d of a fluorophore-labeled vesicle equals the 
product of a constant calibration factor c and the square root of the intensity signal IV detected from 
that vesicle in confocal microscopy. Accordingly, a calibration factor can be determined when related 
intensity values Iv and diameters d can be assigned to each other. This assignment was implemented 
by consecutive imaging of identical fields of view of samples of immobilized unilamellar vesicles in 
confocal microscopy and in STORM.  
Intensity values IV were determined with the help of confocal microscopy as described above. 
Diameters d were determined by using a STORM system included in the Nikon A1R confocal 
microscopy set-up and a 100x oil immersion objective. For STORM, the 544 nm laser was utilized. The 
application of an additional laser of different wavelength for fluorophore deactivation was not 
required as rhodamine exhibited fluorescence intermittency, i.e. rhodamine switched between its 
emitting and its dark state while constantly irradiated by the 544 nm laser. To avoid overlapping of 
fluorescence signals from adjacent vesicles, unilamellar vesicles were imaged at a lipid concentration 
of 10 ng/ml. A reduction of photobleaching was achieved by a buffer exchange applied directly 
before imaging: Lipid TBS in the flow chambers was replaced by STORM Buffer which contained an 
oxygen scavenging system. 
Images recorded in STORM mode were analyzed in the following procedure: At first, fluorophore 
positions were reconstructed with the help of NIS-Elements Advanced Research 4.30 software. 
Coordinates of fluorophore positions were saved in a text file which was then processed in ImageJ 
1.46r. Employing a self-written macro, single fluorophores were assembled to 2D objects. In the next 
step, Gaussian Blur filter was applied, and ellipses were fitted to each 2D object with the help of 
automated particle analysis. Positions of the 2D objects (i.e. vesicle positions) and lengths of the 
major and minor axes of the correlating ellipses were saved in a text file. The diameter d of each 
vesicle could then be calculated as: 
 
𝑑 =
𝑎 + 𝑏
2
− 𝑟 
  
 (20) 
with a representing the length of the major ellipse axis and b the length of the minor axis. The 
variable r represents the approximate size of a single rhodamine molecule imaged by the STORM 
system. Subtraction of r was required as rhodamine molecules detected at the circumference of the 
xy-projection of a vesicle resulted in an apparent increase in vesicle size. As only intact lipid vesicles 
were intended to be included in the analysis, only objects with a maximum axis ratio a/b of 2.0 were 
taken into account.  
Vesicle positions in confocal and in STORM images were matched to generate a list of correlating 
intensities IV and diameters d. For each data pair (di,IVi), a calibration factor ci was calculated 
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according to equation (20), and the final calibration factor c was determined as the arithmetic mean 
of all calibration factors ci. 
75 
4 Results 
4.1 Cellular Localization of Myosin-XXI in Transfected Mammalian Cells 
In order to gain information about potential cellular functions of distinct myosin-XXI domains, 
transfection experiments with HeLa and COS-7 cells were performed.  
Myosin-XXI constructs investigated in in vivo experiments were designed considering the structural 
motifs and domains identified within myosin-XXI (Figure 29, Table C.1). 
 
 
Figure 29 Myosin-XXI constructs investigated in transfection experiments with HeLa and COS-7 cells. The table above lists 
all parts of the myosin-XXI DNA sequence that were transfected into mammalian cells (FL-XXI: full-length myosin-XXI of 
aa 1-1050, Trunc-XXI: motor truncation of aa 1-800, XXI-830 Tail: tail fragment of aa 830-1050, XXI-930 Tail: tail fragment of 
aa 930-1050). Myosin DNA was cloned into vectors already containing fluorophore DNA. The respective fusion proteins 
exhibited different cellular localizations within HeLa and COS-7: within the cytoplasm, fusion proteins were found to display 
a diffuse distribution frequently associated with staining of the nucleus. Additionally, FL-XXI and myosin-XXI fragments 
containing major parts of the motor domain accumulated in clusters in the vicinity of the nucleus and in spherical 
structures. FL-XXI and Trunc-XXI exhibited the most striking localization pattern forming protein populations along the 
plasma membrane and along the shafts and at the tips of filopodia. The schematic overview on the right illustrates the so 
far identified structural motifs encoded by the corresponding myosin-XXI constructs. 
 
According to previous studies of our research group (Batters et al., 2012, 2014), myosin-XXI 
possesses an N-terminal SH3-like domain (aa 11-37), followed by the catalytic motor domain 
(aa 65-747) including a converter region at aa 662-747. Starting at aa 705, i.e. already beginning 
within the converter domain, a PX domain (aa 705-752) and several other potential lipid binding 
domains have been identified. Furthermore, an IQ motif (aa 754-769), several potential 
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oligomerization sites and two UBA domains have been located in the neck and tail region of 
myosin-XXI. For the oligomerization site at aa 744-809, dimerization of full-length myosin-XXI has 
already been demonstrated. 
In experiments with immortal mammalian cells, in vivo localization of myosin-XXI and myosin-XXI 
fragments depending on the structural motifs contained in the respective constructs were examined. 
For this purpose, transfections with plasmids encoding a fusion protein of a fluorophore (ZsGreen1, 
eGFP, or DsRed2) and myosin-XXI or a myosin-XXI fragment were performed. A summary of all 
myosin-XXI constructs tested can be found in Figure 29. In addition to transfections with plasmids 
encoding myosin-XXI fusion proteins, control experiments were performed with plasmids just 
containing fluorophore DNA. 
 
 
Figure 30 Localization of FL-XXI and myosin-XXI fragments in transfected HeLa cells. In transfected mammalian cells, 
fusion proteins of a fluorophore and FL-XXI or a myosin-XXI fragment were detected at different cellular localizations 
depending on the structural motifs of myosin-XXI present in the protein. Above, representative confocal images of 
transfected HeLa cells are shown. (A) In control experiments with plasmids solely encoding a fluorophore (here: ZsGreen1), 
uniform staining of the cytoplasm with frequent staining of the nucleus was detected. (B) A diffuse cytoplasmic distribution 
was displayed by all myosin-XXI fusion proteins tested and was the only localization found for myosin-XXI tail constructs 
(here: aa 730-936). (C) Accumulations in clusters close to the nucleus were found for all constructs containing the major 
part of the myosin-XXI motor domain (here: FL-XXI) and were related to high expression levels of fusion proteins. (D) Fusion 
proteins containing the major part of the motor domain (here: FL-XXI) also formed spherical accumulations in the 
cytoplasm. (E, F) FL-XXI (E) and Trunc-XXI (F) were the only constructs capable of concentrating along the plasma membrane 
and within filopodia. Scale bars: 20 μm. 
 
When inspected by confocal microscopy, cells solely transfected with fluorophore encoding plasmids 
exhibited a uniform staining of the cytoplasm associated with a frequent staining of the nucleus. In 
fact, an identical staining pattern was observed for all plasmids encoding fusion proteins of the 
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myosin-XXI tail constructs (Figure 30, Figure 31). Tail fragments investigated were aa 730-1050, aa 
830-1050 (called XXI-830 Tail here), aa 930-1050 (called XXI-930 Tail here), aa 730-936, aa 730-836, 
and aa 830-936. 
For the other myosin-XXI constructs studied, apart from a diffuse cytoplasmic distribution, four 
additional cellular localizations were identified: clusters in the vicinity of the nucleus, spherical 
accumulations within the cell body, spherical accumulations along the plasma membrane, and 
accumulations within the shafts and inside the tips of filopodia. All of these cellular localizations were 
found in both, HeLa and COS-7 cells (Figure 30, Figure 31). Clusters in the vicinity of the nucleus were 
discovered to be a result of strong protein expression, with their incidence increasing with increasing 
concentrations of plasmid DNA applied during the transfection procedure. Further, clusters were 
only found in cells which also contained spherical myosin-XXI accumulations within the cytoplasm. 
 
 
Figure 31 Localization of FL-XXI and myosin-XXI fragments in transfected COS-7 cells. As in the case of HeLa cells, 
localization of fluorophore-fused FL-XXI and myosin-XXI fragments in transfected COS-7 cells was found to depend on the 
myosin-XXI structural motifs contained in the fusion proteins. Above, representative confocal images of transfected COS-7 
cells are shown. (A) In control experiments, expression of fluorophore (here: DsRed2) caused a uniform staining of the 
cytoplasm associated with nucleus staining. (B) Expression of myosin-XXI tail constructs (here: XXI-830 Tail) resulted in a 
homogenous cytoplasmic distribution of fluorescent protein as well. (C, D) Myosin-XXI constructs containing the major part 
of the motor were additionally detected in clusters in the vicinity of the nucleus (C, here: FL-XXI) and spherical 
accumulations within the cytoplasm (D, here: aa 1-704). (E, F) FL-XXI (E) and Trunc-XXI (F) were detected within filopodia 
and in accumulations along the plasma membrane. Scale bars: 20 μm. 
 
Myosin-XXI constructs located at one of the above-mentioned defined localizations 
comprised the full-length molecule (FL-XXI), and three motor truncations: Trunc-XXI (comprising 
aa 1-800) which also contained part of the myosin tail, the motor truncation of aa 1-754 which 
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terminated right after the converter, and the motor truncation of aa 1-704 which was truncated 
within the converter domain N-terminal of the PX domain. Furthermore, defined localization 
patterns were also observed when the first 45 amino acids, i.e. the SH3-like domain, were deleted 
from these four constructs.  
 
 
Figure 32 Staining of clathrin-coated vesicles, endoplasmic reticulum, early endosomes and Golgi apparatus in FL-XXI-
transfected HeLa cells. (A) Clathrin-coated vesicles (red) were stained by application of anti-clathrin heavy chain antibody 
and cyanine 3-conjugated secondary antibody. (B, C, D) Endoplasmic reticulum, early endosomes and Golgi apparatus (red) 
were stained in co-transfection experiments with baculoviruses encoding markers for the respective organelle. No 
colocalization of full-length myosin-XXI (green) with either one of the stained organelles was discovered. Scale bars: 15 μm. 
 
To summarize, while fluorophore-labeled myosin-XXI tail fragments displayed the identical cellular 
localization as mere fluorophores, the presence of a major part of the motor domain resulted in a 
more differentiated cellular distribution of fusion proteins. The respective part of the motor 
comprised almost the complete head domain and thus included the ATP binding loop, switch I, 
switch II, the relay loop, and half of the converter. 
While all motor-containing constructs were observed to accumulate in clusters and spherical 
structures within the cytoplasm, only FL-XXI and Trunc-XXI (i.e. a minimum construct of SH3-like 
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domain, motor and the neck and tail region from aa 748 to aa 800) additionally generated 
accumulations within filopodia and along the plasma membrane. 
Further investigation of filopodial protein accumulations by live imaging and statistical analysis of 
fixed cells, resulted in additional findings: in transfected HeLa cells, accumulations of FL-XXI and 
Trunc-XXI were present in both, substrate-attached and freely moving filopodia. Moreover, statistical 
analysis of 20 HeLa cells for each of these two constructs, i.e. of 1231 filopodia of FL-XXI-transfected 
cells and 1302 filopodia of Trunc-XXI-transfected cells respectively, revealed that myosin-XXI 
accumulations in filopodia tips were present in 54 % of filopodia of FL-XXI-transfected HeLa cells, and 
in 25 % of filopodia of Trunc-XXI-transfected HeLa cells. However, it needs to be noticed that despite 
equal transfection conditions, HeLa cells transfected with Trunc-XXI exhibited a lower average 
fluorescence intensity signal per area of cell body cross section (~900 a.u./μm2) than FL-XXI-
transfected ones (~1,500 a.u./μm2). Consequently, the average expression level in Trunc-XXI-
transfected HeLa cells was lower than in FL-XXI-transfected ones. Thus, in comparison to cells 
expressing FL-XXI, amounts of fusion protein available for the formation of filopodial accumulations 
were lower in cells expressing Trunc-XXI.  
 
 
Figure 33 F-actin staining with lifeact-RFP fusion protein within FL-XXI-transfected HeLa cells. Co-transfection of HeLa cells 
with plasmids encoding FL-XXI (green) and lifeact-RFP fusion protein (red) were performed to simultaneously visualize full-
length myosin-XXI and actin filaments. (A) No colocalization of FL-XXI and the actin cytoskeleton within the cell body was 
observed. (B) However, FL-XXI was detected within filopodia displaying striking accumulations at the filopodia tips. Scale 
bars: 20 μm, for magnified section: 5 μm. 
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Figure 34 F-actin staining with phalloidin-TRITC within FL-XXI- and Trunc-XXI-transfected HeLa and COS-7 cells. The actin 
cytoskeleton of FL-XXI- and Trunc-XXI-transfected (both green) HeLa and COS-7 cells was stained with TRITC-conjugated 
phalloidin (red) after transfection. (A) A COS-7 cell showing accumulations of Trunc-XXI within filopodia. Phalloidin-TRITC 
staining revealed that Trunc-XXI localized at the filopodia tips. (B) A HeLa cell expressing FL-XXI. Protein was detected along 
the shafts of filopodia and at the barbed ends of the intrafilopodial actin cores. Scale bars: 20 μm, for magnified sections: 
5 μm. 
 
In order to elucidate the exact localization of FL-XXI and Trunc-XXI in transfected COS-7 and HeLa 
cells, co-transfection experiments and different staining procedures were carried out.  
Co-transfections with baculoviruses encoding markers for early endosomes, endoplasmic reticulum, 
and Golgi apparatus did not reveal any colocalization of the myosin-XXI constructs with these cellular 
compartments. Immunostaining of clathrin-coated vesicles yielded the same result (Figure 32).  
Actin staining with phalloidin-TRITC and co-transfections with a plasmid encoding a fusion 
protein of RFP and lifeact, a peptide which binds to the actin cytoskeleton (Riedl et al., 2008), led to 
the finding that FL-XXI and Trunc-XXI did not colocalize with F-actin in the cell body but colocalized 
with actin filaments along the whole length of filopodia (Figure 33, Figure 34). 
To verify that the observations described above can be assigned to an expression of FL-XXI or 
Trunc-XXI fusion protein, western blots of lysates of transfected HeLa and COS-7 cells were 
performed (Figure 35). Application of anti-RCFP antibody confirmed the expression of ZsGreen1 
fusion proteins with the molecular weights expected for fusion constructs containing full-length 
myosin-XXI or the myosin-XXI motor truncation of aa 1-800 respectively. 
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Figure 35 Western blots of lysates of HeLa and COS-7 cells transfected with FL-XXI, Trunc-XXI, or ZsGreen1. To verify 
expression of the correct protein, transfected HeLa and COS-7 cells were lysed and subjected to western blotting. ZsGreen1 
and ZsGreen1 in FL-XXI and Trunc-XXI fusion proteins were detected with the help of anti-RCFP antibody. (A) Detection of 
FL-XXI and Trunc-XXI fusion protein. Observed bands correspond to the expected molecular weights (FL-XXI: ~140 kDa, 
Trunc-XXI: ~120 kDa). (B) Detection of ZsGreen1 (ZsGr.1). The resulting protein band is located at ~30 kDa, thus verifying 
ZsGreen1 expression. 
 
4.2 Dynamics of Myosin-XXI in Mammalian Cells 
Live imaging of HeLa cells co-transfected with plasmid encoding lifeact-RFP fusion protein and FL-XXI 
or Trunc-XXI construct was performed to gain insights into the dynamics of myosin-XXI within a 
cellular environment. 
In live records, two motile myosin-XXI populations were observed in transfected HeLa cells: spherical 
accumulations of myosin-XXI within the cell body and myosin-XXI-associated structures inside the 
shafts of filopodia. 
Intrafilopodial dynamics of FL-XXI and Trunc-XXI were subsequently subjected to a more detailed 
evaluation. Thereby, it was found that within filopodia, clusters of myosin-XXI frequently moved from 
the tip toward the cell body. These moving clusters could clearly be identified in temporally resolved 
intensity profiles covering the whole length of filopodia (Figure 36). Additionally, tracking algorithms 
could be applied to the clusters, resulting in speeds of 24.3±15.5 nm/s (mean ± s.d.; 20 tracks) for 
FL-XXI-transfected cells and 34.6±17.1 nm/s (46 tracks) for Trunc-XXI-transfected cells. Furthermore, 
it was detected that clusters of myosin moving rearward along the shafts of filopodia frequently 
elongated and occasionally split up. In contrast to myosin´s rearward movement toward the cell 
body, movement of myosin-XXI fusion protein toward the filopodia tips could not be resolved in live 
confocal microscopy. Nevertheless, rearward movement did not result in a permanent 
disappearance of the protein accumulations in filopodia tips. Instead, apart from decreases in the 
fluorescence intensity signals in the tips, significant intensity increases were detected (Figure 36). 
Furthermore, in addition to myosin-XXI movement within filopodia, stability of myosin-XXI 
accumulations within filopodia tips was monitored. It was observed that accumulations remained at 
the tips even throughout phases of filopodial length changes. Determination of the rates of length 
changes of filopodia with myosin-XXI tip accumulations led to the following results: for FL-XXI, 
average extension rate of 54 analyzed filopodia was 21.3±13.1 nm/s (mean ± s.d.), and average 
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retraction rate was 22.8±13.1 nm/s. For Trunc-XXI, changes in length of 113 evaluated filopodia were 
faster, with an average speed of 28.8±18.1 nm/s when extending, and 25.1±13.6 nm/s when 
retracting (Figure 37). 
 
 
Figure 36 Time course of fluorescence intensities in filopodia of Trunc-XXI-transfected HeLa cells. Fluorescence signals of 
motile Trunc-XXI populations were measured during phases of constant filopodia length. Illustrations symbolize 
corresponding movement of Trunc-XXI accumulations (green) along the filopodial actin core (red). The blue box depicts the 
region of intensity measurements of filopodia tips. (A, B) Representative Intensity signals detected in two filopodia tips of 
distinct HeLa cells. Following intensity decreases caused by Trunc-XXI travelling rearward to the cell body, intensity signals 
recovered thus proving forward movement of Trunc-XXI into the filopodia tips. Intensity values were normalized to the first 
data point. (C) Fluorescence intensity distribution along the whole length of a single filopodium. The position of 0 μm 
designates the distal end of the filopodium. At the beginning of the measurement (t=0 s), an accumulation of Trunc-XXI was 
present at the filopodium´s tip. This accumulation detached from the tip and moved rearward along the shaft of the 
filopodium. Data were normalized to the 1.05-fold of the maximum intensity value detected.  
 
4.3 Myosin-XXI Influenced Average Length and Density of Filopodia in 
Transfected HeLa and COS-7 Cells 
As FL-XXI and Trunc-XXI fusion proteins exhibited a pronounced accumulation at the tips of filopodia 
of transfected HeLa and COS-7 cells, and as it had been shown that myosin-X transfected into HeLa 
and COS-7 cells accumulated in filopodia tips and additionally influenced the average length and 
density of filopodia (Berg and Cheney, 2002; Zhang et al., 2004; Watanabe et al., 2010), an analysis of 
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length and density of filopodia of FL-XXI- and Trunc-XXI-transfected HeLa and COS-7 cells was 
performed in the present study. 
In the course of this analysis, COS-7 and HeLa cells transfected with plasmids encoding ZsGreen1, 
ZsGreen1-FL-XXI fusion protein, and ZsGreen1-Trunc-XXI fusion protein were evaluated. Identical 
transfection conditions were applied for all three constructs. Transfections with plasmid only 
encoding the ZsGreen1 fluorophore were performed to compensate for a potential effect of the 
treatments of the cells during the transfection procedure. As a result, the effect solely caused by 
FL-XXI or Trunc-XXI could be quantified. 
To ensure that transfected cells expressed the intended protein, lysates of transfected cells were 
subjected to western blotting (Figure 35), which revealed the expression of ZsGreen1 and ZsGreen1 
fusion proteins of the correct molecular weight.  
In the following subsections, a detailed description of the results of filopodia length and density 
analysis will be given. 
 
 
Figure 37 Filopodial length changes in FL-XXI- and Trunc-XXI-transfected HeLa cells. Dynamics of filopodia and persistence 
of myosin-XXI accumulations at filopodia tips were investigated with the help of live records of HeLa cells co-transfected 
with a plasmid encoding lifeact-RFP fusion protein and FL-XXI or Trunc-XXI respectively. (A) Extension and retraction rates of 
filopodia containing FL-XXI or Trunc-XXI tip accumulations. Cells expressing Trunc-XXI exhibited higher average length 
change rates than FL-XXI-expressing ones. (B) Image sequence of a filopodia tip containing Trunc-XXI. The protein 
accumulation remained at the tip even throughout a filopodial extension phase. Scale bar: 1.5 μm. 
 
 Transfection with FL-XXI or Trunc-XXI Resulted in an Increase in Filopodia Length 4.3.1
Filopodia length determination was performed for 6 HeLa and 10 COS-7 cells for each transfection 
construct respectively. In total, 319 (HeLa) and 276 (COS-7) filopodia were analyzed for the ZsGreen1 
control, 418 (HeLa) and 417 (COS-7) filopodia for Trunc-XXI, and 333 (HeLa) and 264 (COS-7) filopodia 
for FL-XXI.  
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Analysis yielded the result that for both, COS-7 and HeLa cells, the average filopodia length increased 
when cells were transfected with one of the myosin-XXI constructs.  
For COS-7 cells, in comparison to the control, a length increase of about 16.6 % for Trunc–XXI and 
approximately 22.2 % for FL-XXI (Figure 38) was revealed. This increase could be assigned to a more 
frequent occurrence of filopodia with a length of at least 2 μm in myosin-XXI-expressing cells 
(Figure 39).  
 
 
Figure 38 Increase in average filopodia length in FL-XXI- and Trunc-XXI-transfected HeLa and COS-7 cells. The average 
length of filopodia formed by cells expressing FL-XXI or Trunc-XXI fusion protein was determined. To eliminate a potential 
effect of the transfection procedure, cells expressing ZsGreen1 were used as negative control. (A, B) Box whisker plots of 
filopodia lengths of COS-7 (A) and HeLa cells (B). Middle lines of the boxes represent mean filopodia lengths, black circular 
markers show average lengths. Lower and upper line of the boxes depict 25
th
 and 75
th
 quartile. Upper and lower whiskers 
illustrate 10
th
 and 90
th
 percentile. For both cell lines, significant increases in average filopodia length were observed when 
cells were transfected with FL-XXI or Trunc-XXI. (C, D) Average filopodia lengths L of FL-XXI-, Trunc-XXI-, and ZsGreen1-
transfected COS-7 (C) and HeLa cells (D). ΔL denotes the average length increase observed for filopodia of FL-XXI- and 
Trunc-XXI-expressing cells relative to the control. 
 
Fluorescence intensities per area of cell body cross section were ~1,200 a.u./μm2 for FL-XXI-
transfected COS-7 cells, ~1,400 a.u. /μm2 for Trunc-XXI-transfected COS-7 cells, and ~7,900 a.u. /μm2 
for the ZsGreen1 control. Thus, FL-XXI- and Trunc-XXI-transfected cells exhibited lower expression 
levels than the control. The fact that average filopodia lengths were yet higher in FL-XXI- and 
Trunc-XXI-expressing COS-7 cells than in control cells further confirmed FL-XXI or Trunc-XXI 
expression as primary cause of filopodia elongation. In addition, expression levels in FL-XXI-
transfected COS-7 were lower than expression levels in Trunc-XXI-transfected cells. However, length 
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increase induced by FL-XXI was higher than the one induced by Trunc-XXI thereby indicating an 
impact of the expressed fusion protein on the extent of filopodia elongation. 
In transfected HeLa cells, average length increase of filopodia was 7.5 % for Trunc-XXI-expressing 
cells and 22.5 % for FL-XXI-expressing cells when compared to the control (Figure 38). In comparison 
to cells only transfected with ZsGreen1 construct, HeLa cells transfected with either myosin-XXI 
construct more often exhibited a length of 10 μm and above (Figure 39). 
In the case of HeLa cells, fluorescence intensities per area of cell body cross section were 
~1,700 a.u./μm2 for FL-XXI, ~1,100 a.u. /μm2 for Trunc-XXI, and ~1,300 a.u. /μm2 for ZsGreen1. 
Hence, similar to Trunc-XXI-expressing COS-7 cells, Trunc-XXI-expressing HeLa cells exhibited a lower 
expression level than the control. Nevertheless, Trunc-XXI again induced an elongation of filopodia in 
comparison to the control. FL-XXI-transfected HeLa cells, which showed a higher expression level of 
myosin-XXI fusion protein than Trunc-XXI-transfected cells, displayed an even higher increase in 
average length of filopodia. 
As HeLa cells were not analyzed in an automated approach, in addition to the evaluation of the 
average length of the entirety of filopodia of transfected cells, a distinction between filopodia with 
(FL-XXI: 179 filopodia; Trunc-XXI: 104 filopodia) and without (FL-XXI: 154 filopodia; Trunc-XXI: 314 
filopodia) protein accumulations at their tips could be made. According to this more detailed analysis 
(Figure 39), the increase in average filopodia length of FL-XXI- and Trunc-XXI-expressing HeLa cells 
resulted from an elongation of filopodia containing myosin-XXI tip accumulations: while protein 
accumulation-free filopodia exhibited an average length up to 7.5 % smaller than the average length 
of the control, filopodia containing FL-XXI or Trunc-XXI tip populations displayed a length increase of 
43 % (FL-XXI) to 53 % (Trunc-XXI). A comparison of length distributions of filopodia with and without 
myosin-XXI at their tips demonstrated that the length increase of filopodia containing FL-XXI or 
Trunc-XXI can be assigned to a reduced occurrence of filopodia of 2 μm of length or shorter. 
Overall, analysis of filopodia lengths of transfected mammalian cells demonstrated that the 
expression of either FL-XXI or Trunc-XXI resulted in an elevated average length of filopodia. In 
addition, analysis results indicated differing capabilities of both fusion proteins to induce an 
elongation of filopodia and provided hints that filopodial elongation was related to the presence of 
fusion protein accumulations within the distal ends of filopodia. 
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Figure 39 Filopodial length distributions of FL-XXI- and Trunc-XXI-transfected HeLa and COS-7 cells. The frequency of 
filopodia lengths was determined within length intervals of 2 μm. Filopodia of cells expressing FL-XXI or Trunc-XXI fusion 
protein were compared to those of cells solely expressing ZsGreen1. ZsGreen1-expressing cells were selected as control to 
compensate for a potential influence of the transfection procedure on filopodia formation. (A, B) Length distributions of 
filopodia of transfected COS-7 (A) and HeLa cells (B). In comparison to the control, transfection of COS-7 cells with either 
FL-XXI or Trunc-XXI resulted in an increased incidence of filopodia with a length of 2 μm or longer. In the case of HeLa cells, 
filopodia of FL-XXI- and Trunc-XXI-expressing cells more frequently exhibited a length of at least 10 μm when compared to 
filopodia of the control. (C, D, E) A more detailed analysis of filopodia lengths of transfected HeLa cells. In this analysis, 
filopodia of FL-XXI- and Trunc-XXI-expressing cells were classified into filopodia exhibiting and filopodia not exhibiting 
accumulations of fusion protein at their tips. Importantly, protein accumulations at the distal filopodia ends were not 
detected in ZsGreen1-expressing cells, thus length distribution and average length of control filopodia are identical in each 
diagram. (C, D) Length distributions of filopodia. In comparison to accumulation-free filopodia (D), a reduced occurrence of 
lengths of 2 μm and below was observed for filopodia containing protein tip populations (C). (E) Average lengths of 
filopodia normalized to the control. In consequence of the lower incidence of short filopodia, the average length of 
filopodia with (w/) FL-XXI or Trunc-XXI accumulations was found to exceed the average length of control filopodia by more 
than 40 %. In contrast, filopodia without (w/o) FL-XXI or Trunc-XXI tip populations were 7.5 % shorter than control filopodia. 
Accordingly, the overall increase in average filopodia lengths of FL-XXI- and Trunc-XXI-expressing HeLa cells is related to an 
elongation of filopodia containing FL-XXI or Trunc-XXI accumulations. 
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 Transfection with FL-XXI or Trunc-XXI Resulted in an Increase in Filopodia Density 4.3.2
Filopodia density, i.e. the number of filopodia per cell circumference, was determined for 20 HeLa 
and 10 COS-7 cells for each transfection plasmid respectively.  
For both cell types, density of filopodia increased upon transfection with FL-XXI or Trunc-XXI: for 
COS-7 cells density increases of 29 % (FL-XXI) and 100 % (Trunc-XXI) were observed (Figure 40). As 
mentioned before, detected fluorescence intensity signals of cell bodies were ~1,200 a.u./μm2 
(FL-XXI), ~1,400 a.u. /μm2 (Trunc-XXI), and ~7,900 a.u. /μm2 (ZsGreen1) respectively. As in the case of 
average filopodia length, an effect of myosin-XXI on filopodia was detected although average 
expression levels of COS-7 cells transfected with one of the myosin-XXI constructs were lower than 
the average ZsGreen1 expression level. The strongest impact on filopodia density was detected for 
Trunc-XXI, which on average was also expressed at a higher level than FL-XXI.  
 
 
Figure 40 Filopodial density increase in HeLa and COS-7 cells upon transfection with FL-XXI and Trunc-XXI. In the diagrams 
above, average numbers of filopodia per membrane circumference of cells expressing FL-XXI, Trunc-XXI, or ZsGreen1 are 
compared. ZsGreen1-transfected cells served as negative control. Determined densities were normalized to the filopodia 
density of the control. (A) Average density of filopodia of HeLa and COS-7 cells. For both myosin-XXI constructs and both 
cell lines, determined filopodia densities were increased by at least 25 % in comparison to the control. (B) A more detailed 
analysis of filopodia densities of FL-XXI- and Trunc-XXI-transfected HeLa cells. In this analysis, filopodia exhibiting 
accumulations of fusion protein at their tips were distinguished from accumulation-free filopodia. Importantly, protein tip 
populations were not observed in ZsGreen1-expressing cells, therefore only one constant value for the density of control 
filopodia was obtained. Evaluation revealed that relative to the control, filopodia number per membrane length was 
reduced by more than 7 % for both filopodia with (w/) and filopodia without (w/o) myosin-XXI accumulations. Hence, an 
increase in filopodia density was only observed when considering the entirety of filopodia of FL-XXI- or Trunc-XXI-expressing 
HeLa cells. 
 
In experiments with HeLa, cells displayed a filopodia density increase of 50 % (FL-XXI) and 25 % 
(Trunc-XXI) when transfected with one of the myosin constructs (Figure 40). For HeLa cells analyzed 
regarding filopodia density, average intensity levels of cell bodies were ~1,500 a.u. /μm2 (FL-XXI), 
~900 a.u. /μm2 (Trunc-XXI), and ~3,200 a.u. /μm2 (ZsGreen1). Again, an effect of myosin-XXI on 
filopodia density was observed even though average expression levels of FL-XXI- and Trunc-XXI-
transfected HeLa cells were lower than average expression level of ZsGreen1. A comparison of the 
data obtained for FL-XXI and Trunc-XXI showed that both the increase in filopodia density and the 
Results 
88 
average expression level of FL-XXI-expressing HeLa cells exceeded those of Trunc-XXI-expressing 
cells. 
A more detailed analysis of HeLa cells regarding the accumulation of myosin-XXI fusion protein at the 
tips of filopodia revealed that in FL-XXI- and Trunc-XXI-transfected cells, neither the density of 
filopodia without protein tip accumulations nor the density of filopodia containing these 
accumulations coincided with the overall filopodia density observed for ZsGreen1-expressing cells 
(Figure 40). Instead, the density of filopodia containing myosin-XXI as well as the density of 
accumulation-free filopodia was more than 7 % smaller than the average density of filopodia of 
ZsGreen1-transfected cells. An increase in filopodia density of FL-XXI- and Trunc-XXI-expressing HeLa 
in comparison to the control was only observed when considering all filopodia of these cells. 
Summarizing, evaluation of the densities of filopodia in transfected mammalian cells showed 
that both FL-XXI and Trunc-XXI induce an increase in the number of filopodia per membrane 
circumference. Unlike in the case of myosin-XXI-induced increases in filopodia length, no clear 
relation between elevated filopodia densities and the occurrence of fusion protein accumulations 
within the filopodia tips was found. 
 
4.4 Myosin-XXI Moved Towards the Plus End of Dual-Labeled Actin 
Filaments 
As described in section 4.2, motile populations of fluorophore-labeled full-length myosin-XXI were 
detected during live imaging of transfected HeLa cells. In subsequent gliding filament assays with 
dual-labeled F-actin, directionality of motor movement along filamentous actin was determined. 
In order to verify the applied method, directionality was first deduced for HMM and 
myosin-VI, i.e. for motor proteins of known direction of movement. For HMM, 70 dual-labeled 
filaments from 10 different samples were analyzed. 69 (98.6 %) of these filaments exhibited a leading 
pointed end, thus HMM was identified as plus end-directed motor. The evaluation of 80 filaments 
from 8 myosin-VI samples resulted in 93.8 %, i.e. 75, of the filaments exhibiting a leading barbed end 
(Figure 41). Therefore, myosin-VI motor movement was determined as minus end-directed. 
As these findings were in agreement with the literature (Huxley, 1969; Sheetz and Spudich, 1983; 
Wells et al., 1999), gliding filament assays with full-length myosin-XXI were performed. 6 samples 
were prepared and 76 filaments were analyzed. 73 of these filaments (96.1 %) showed a leading 
pointed end. Therefore, myosin-XXI was identified as a plus end-directed actin-associated motor 
protein (Figure 41).  
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Figure 41 Determination of motor directionality in gliding filament assays with dual-labeled F-actin. (A) Number of 
filaments indicating plus end- or minus end-directed movement of HMM, chicken myosin-VI, and L. donovani myosin-XXI. 
Identification of HMM as plus end-directed and of myosin-VI as minus end-directed motor verified the applied method. 
Myosin-XXI was found to be a plus end-directed actin-associated motor. (B) Sequential images of dual-labeled filamentous 
actin sliding on a surface covered with myosin-XXI: the leading FITC-labeled pointed filament end (green) demonstrates 
movement of myosin-XXI towards the TRITC-labeled barbed end (red). Scale bar: 0.5 μm. 
 
4.5 Myosin-XXI Binding to Planar Lipid Bilayers 
Previous research of our lab had demonstrated that myosin-XXI binds to various phospholipids. 
Moreover, when bound to vesicular lipid bilayers this motor protein can bind actin filaments and 
induce filament gliding (Batters et al., 2014). Therefore, the further investigation of the dynamic 
behavior of the bilayer-bound actin-myosin-XXI complex was one of the scientific objectives of the 
present study. 
In addition, as ZsGreen1-FL-XXI fusion protein was observed to accumulate along the plasma 
membrane of HeLa and COS-7 cells in present transfection experiments (see section 4.1), the 
question arose whether myosin-XXI is capable of binding to lipid constituents of the plasma 
membrane and thus whether myosin-XXI binds to planar lipid bilayers. 
In order to elucidate both aspects, the dynamics of the bilayer-associated actin-myosin-XXI complex 
and myosin-XXI´s capability of binding to lipid bilayers of planar geometry, gliding filament 
experiments on planar lipid bilayers were performed. In the investigation of the actin-myosin-XXI 
complex, usage of planar bilayer systems eliminated spatial constraints by the limited size of 
previously applied lipid vesicles. 
Prior to experiments involving myosin-XXI, applied bilayer preparation techniques were tested for 
the fluidity of the resulting bilayers. For this purpose, FRAP experiments were carried out and lateral 
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diffusion constants were determined. In the following step, it was tested whether myosin-XXI 
produced movement of F-actin when bound to planar lipid bilayers. As the investigations of the actin- 
myosin complex did not result in filament movement, bilayer binding of myosin-XXI alone was tested. 
 
 Lateral Diffusion Constants of Planar Lipid Bilayers 4.5.1
To verify that the applied preparation techniques resulted in the formation of lipid bilayers exhibiting 
reasonable fluidity, Fluorescence Recovery after Photobleaching was tested and lateral diffusion 
coefficients were computed (Figure 42).  
Tested lipid bilayer samples comprised supported lipid bilayers and one tethered lipid bilayer. SLB 
samples included 6 samples with a lipid composition of 97.3 mol% POPC, 1.5 mol% Biotin DHPE, 
1.2 mol% Rhodamine DHPE, and 5 samples composed of 73.0 mol% POPC, 26.0 mol% cholesterol, 
1.0 mol% Rhodamine DHPE. For each SLB, 24 measurements were performed and subsequently 
evaluated (Table D.1). In the case of tethered bilayer experiments, only one sample was prepared 
due to high material costs. The lipid mixture applied contained 94.0 mol% POPC, 4.8 mol% PI(3,5)P2, 
and 1.2 mol% Rhodamine DHPE. Here, 5 measurements were carried out and analyzed (Table D.1). 
 
 
Figure 42 FRAP measurement of a supported lipid bilayer and applied fit function. A supported lipid bilayer composed of 
73.0 mol% POPC, 26.0 mol% cholesterol, and 1.1 mol% Rhodamine DHPE was subjected to bleaching and recovery of the 
fluorescence signal was recorded. Experimental data depicted above are already corrected for photobleaching inherent to 
the imaging process. These corrected data were fitted by a function containing the characteristic diffusion time τD as fitting 
parameter. The lateral diffusion constant D was calculated from 𝐷 = 𝜏𝐷
2 ∙ (4𝑅)−1 with R representing the radius of the 
bleached area. Fitting resulted in D=1.49·10
-12
 m
2
·s
-1
. The average lateral diffusion constant determined from the results of 
24 measurements of 5 samples of this particular lipid composition was calculated as 1.21±0.33·10
-12
 m
2
·s
-1
 (mean ± s.d.). 
 
Analysis of FRAP experiments resulted in the following lateral diffusion coefficients D: for 
supported POPC/Biotin DHPE/Rhodamine DHPE bilayers, D was determined as 1.50±0.50·10-12 m2·s-1 
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(mean ± s.d.) resembling the diffusion coefficient of 1.42±0.13·10-12 m2·s-1 reported for a supported 
POPC bilayer containing 6.5·10-6 mol% TRITC-conjugated DHPE (Schmidt et al., 1996). In the case of 
supported POPC/cholesterol/Rhodamine DHPE bilayers, a diffusion coefficient of 
1.21±0.33·10-12 m2·s-1 was deduced agreeing with a value of D=1.20±0.50·10-12 m2·s-1 published for a 
supported bilayer of 79.5 mol% POPC, 20 mol% cholesterol, and 0.5 mol% 1-palmitoyl-2-(16-doxyl 
stearoyl)phosphatidylcholine. Furthermore, the reduced fluidity of POPC/cholesterol/Rhodamine 
DHPE bilayers in comparison to POPC/Biotin DHPE/Rhodamine DHPE bilayers corresponds to the 
membrane stiffening effect of cholesterol (Shin and Freed, 1989). FRAP measurements of the 
tethered POPC/PI(3,5)P2/Rhodamine DHPE bilayer resulted in D=1.45±0.19·10
-12 m2·s-1, which was 
found to be in good agreement with the publication of Daniel et al. (2007) stating that tethered 
bilayer systems display lateral fluidities similar to those of supported lipid bilayer systems.  
In summary, the applied preparation techniques were found to produce lipid bilayers suitable for 
utilization in further experiments. In addition, fluidity of all bilayers used in the assays described 
below was verified by the presence of a FRAP effect prior to experimental use. 
  
 Myosin-XXI Did Not Induce Filament Gliding on Planar Lipid Bilayers 4.5.2
To investigate whether full-length myosin-XXI binds to lipid bilayers and once bound maintains its 
ATPase activity and motility, FL-XXI was tested for its capability to induce actin filament movement 
on surfaces covered with planar lipid bilayers. 
Before gliding filament experiments were carried out, the following negative control assays were 
performed: to verify that FL-XXI attachment to the sample surface requires phospholipid binding, 
FL-XXI and actin filaments were incubated on POPC/Rhodamine DHPE bilayers, i.e. bilayers not 
containing any of the lipids previously shown to bind myosin-XXI (Batters et al., 2014). Further, SLB 
binding of actin alone was tested to exclude the possibility that actin itself binds to planar lipid 
bilayers. In both cases, no attachment of actin filaments to lipid bilayers was detected in TIRF 
microscopy. Thus, FL-XXI was not capable of binding to planar lipid bilayers in the absence of 
myosin-XXI binding lipids, and actin itself did not bind to planar lipid bilayers.  
In gliding filament experiments on bilayers containing phospholipids for which FL-XXI binding had 
been demonstrated in a previous study of our research group (Batters et al., 2014), actin filaments 
were found to attach to the sample surface. Thus, binding of FL-XXI to phospholipids enabled the 
attachment of the actomyosin complex to bilayer-covered surfaces. Unexpectedly, F-actin did not 
show any movement at all, neither directed gliding nor diffusive motion. Together with the fact that 
the presence of myosin-XXI was required for the binding of actin to surfaces of bilayer samples, this 
finding indicated that F-actin bound to FL-XXI, which in turn bound to immobile structures on the 
sample surface. In this configuration, myosin-XXI did not induce movement of filaments. 
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The observations described above were made for different experimental set-ups and modifications 
of the sample preparation procedure thereby repeatedly verifying the phospholipid-mediated 
attachment of FL-XXI to immobile structures. 
First, two different approaches for the attachment of the actomyosin complex to planar lipid bilayers 
were applied. In one approach, FL-XXI was incubated with a planar lipid bilayer and filamentous actin 
was subsequently added. In the other approach, FL-XXI and actin filaments were premixed, incubated 
and added to a lipid bilayer.  
Moreover, gliding filament experiments were performed using two different types of planar lipid 
bilayers: supported lipid bilayers, which were directly applied to the coverslip surface, and tethered 
lipid bilayers, which were separated from the glass surface by a PEG cushion, which reduced 
nonspecific binding of proteins to the coverslip. For SLB, additional passivation of the coverslip 
surface by BSA blocking was tested. In addition, various lipid compositions of bilayers were 
investigated in the present work: 
 DOPC/2.0 mol% PI(4,5)P2 
 DOPC/2.0 mol% PI(3,5)P2 
 POPC/PI(3,5)P2, with PI(3,5)P2 content ranging between 4.8 mol% and 9.7 mol% 
 POPC/PI(4)P, with PI(4)P content ranging between 1.6 mol% and 9.7 mol% 
 POPC/9.5 mol% bovine brain extract 
 bovine brain extract 
To allow for the verification of bilayer fluidity by FRAP tests, all of the lipid mixtures stated above 
were supplemented with Rhodamine DHPE. 
Finally, buffer conditions during bilayer preparation and gliding filament experiments were modified, 
and various concentrations of myosin-XXI and actin were tested. 
In summary, FL-XXI was shown to attach to immobile structures on the surfaces of planar lipid bilayer 
samples under various experimental conditions. When associated with these structures, myosin-XXI 
was incapable of driving actin filament movement. 
 
 Myosin-XXI Did Not Bind to Planar Lipid Bilayers 4.5.3
Subsequent to gliding filament tests, binding of myosin-XXI to planar lipid bilayers was further 
investigated in experiments with a fusion protein of FL-XXI and eGFP. 
In the first experimental set-up, fluorophore-labeled myosin-XXI was added to already formed SLB. In 
the second set-up, FL-XXI fusion protein was incubated with unilamellar vesicles, and after the 
mixture was injected into a flow cell, bilayer formation was monitored. In both cases, presence of a 
fluid lipid bilayer was tested by FRAP measurements. Additionally, FRAP signals of eGFP fused to 
myosin-XXI were measured to explore whether FL-XXI was bound to the SLB.  
Results 
93 
When myosin-XXI was added to readily prepared SLB, fluidity of the bilayers was preserved. 
Nevertheless, no FRAP signal was detected for eGFP indicating that myosin-XXI did not bind to SLB. 
Furthermore, rinsing of the bilayers with buffer resulted in a pronounced removal of FL-XXI-eGFP 
fusion protein from the sample. Fluorescence signal of the remaining fusion protein did not recover 
when bleaching was carried out and thus the remaining protein was immobile (Figure 43). These 
observations again demonstrated that myosin-XXI did not bind to planar lipid bilayers but instead 
attached to immobile structures on the sample surface. 
 
 
Figure 43 FRAP measurements of eGFP-FL-XXI fusion protein incubated with a supported lipid bilayer. Fusion protein of 
eGFP and FL-XXI was added to a readily prepared supported lipid bilayer composed of 98.8 mol% bovine brain extract and 
1.2 mol% Rhodamine DHPE. EGFP was bleached and time course of the fluorescence intensity was recorded. Experimental 
data depicted above are already corrected for photobleaching inherent to the imaging process. The first FRAP experiment 
(green curve) was performed after fusion protein had been incubated with the bilayer without further treatment. EGFP 
fluorescence signal only exhibited a small decrease and fluorescence recovery was not observed. Therefore, reduction of 
the fluorescence signal can be assigned to bleaching of immobilized fusion protein within the region of interest. The 
absence of a FRAP signal can be attributed to eGFP-FL-XXI fusion protein not binding to the bilayer. Fluorescence recovery 
due to the 3D diffusion of fusion protein in the solution above the bilayer was not temporally resolved by the microscope 
set-up utilized. The second FRAP measurement (red curve) was carried out after the sample was rinsed with buffer. Again, 
no fluorescence recovery was observed. Due to the removal of fusion protein in solution, eGFP signal was almost 
completely eliminated by a single application of the bleaching laser. 
 
When eGFP-labeled myosin-XXI and lipid vesicles were incubated and subsequently injected into a 
flow cell to generate a lipid bilayer with FL-XXI bound to it, formation of a fluid bilayer was only 
observed for the lowest myosin-XXI concentration (5 nM). For myosin-XXI concentrations of 50 nM 
and higher, bilayer formation was not observed. In agreement with this, no FRAP signal of lipids was 
detected. Independent from the formation of a fluid phospholipid bilayer, no fluorescence recovery 
was detected for eGFP when bleaching was applied. Thus, although formation of fluid bilayers from 
myosin-XXI-lipid mixtures occurred for appropriate lipid to FL-XXI molar ratios, myosin-XXI did not 
bind to the resulting SLB. 
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In addition, modifications of the sample preparation methods (e.g. application of different buffers, 
BSA blocking of bilayers prior to the addition of myosin-XXI) did not result in a binding of myosin-XXI-
eGFP fusion protein to the investigated lipid bilayers.  
Thus, myosin-XXI was not capable of binding to planar lipid bilayers. 
 
4.6 Myosin-XXI Produced Filament Gliding When Bound to Lipid Vesicles 
In a previous study of our lab, myosin-XXI was demonstrated to bind to lipid vesicles, i.e. curved lipid 
bilayers, and to exhibit motility in a lipid-bound state (Batters et al., 2014). 
To verify that the FL-XXI samples produced in the present study exhibited functional lipid binding and 
were motile when bound to lipids, gliding filament assays on vesicle-covered surfaces were carried 
out. For this purpose, unilamellar vesicles were attached to nitrocellulose-coated coverslips, and 
FL-XXI and F-actin were added. 
In negative control experiments, vesicles merely composed of POPC and Rhodamine DHPE were 
utilized. The lack of filament binding observed in control samples confirmed that in the absence of 
myosin-XXI binding lipids, FL-XXI did not bind to the areas of sample surfaces in the interstices 
between lipid vesicles (Figure 44). 
 
 
Figure 44 Gliding filament assays with myosin-XXI on lipid vesicle-covered surfaces. Unilamellar vesicles were immobilized 
on nitrocellulose-coated surfaces and subsequently, FL-XXI and FITC-labeled filamentous actin were added. Images display 
the FITC imaging channel. (A) Gliding filament assays on vesicles containing 94.0 mol% POPC, 1.2 mol% Rhodamine DHPE, 
and 4.8 mol% PI(3,5)P2. Observation of filament attachment and gliding verified the binding of myosin-XXI to vesicular 
bilayers and the motility of the motor protein in a lipid-bound state. (B) Negative control experiment utilizing vesicles 
composed of 98.9 mol% POPC and 1.1 mol% Rhodamine DHPE. The absence of bound actin filaments verified that FL-XXI 
did not bind to the sample surface in the interstices between vesicles. Scale bars: 10 μm. 
 
In assays with vesicles containing POPC, Rhodamine DHPE, and PI(4)P or PI(3,5)P2, gliding of actin 
filaments was observed (Figure 44). Phosphoinositide content of the tested lipid mixtures was 
4.8 mol% or 9.7 mol% and vesicle populations of different average size were prepared by extrusion 
through polycarbonate membranes of various pore diameters. For vesicles containing 
4.8 mol% PI(3,5)P2 extruded through a membrane of 100 nm pore diameter, filament movement was 
tracked and analysis resulted in an average gliding speed of 63.0±27.7 nm/s (mean ± s.d.; 255 
filaments from 7 samples). 
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Overall, gliding filament assays on unilamellar vesicles confirmed functional lipid binding by FL-XXI 
and motor motility of the lipid-bound protein. Furthermore, they indicated that myosin-XXI binding 
and thereby filament gliding only occurred on vesicular bilayers, i.e. on bilayers of positive curvature. 
 
4.7 Vesicle Binding by Fluorescently Labeled FL-XXI and Myosin-XXI 
Fragments 
In order to elucidate whether bilayer curvature influenced lipid binding by myosin-XXI, Single 
Liposome Curvature assays with FL-XXI and myosin-XXI fragments were performed.  
Before respective proteins were examined in SLiC assays, they were tested for their ability to bind to 
unilamellar vesicles in co-sedimentation assays. Centrifugation of protein-vesicle mixtures and 
subsequent analysis of the protein content of resulting pellets and supernatants allowed for the 
verification of protein binding via the quantification of the fraction of protein detected in the 
precipitate. 
Proteins examined comprised fusion proteins of eGFP and FL-XXI or a myosin-XXI fragment. 
Myosin-XXI fragments included Trunc-XXI, three tail constructs, and two converter domain 
constructs. Tail fragments analyzed were XXI-830 Tail (aa 830-1050), XXI-930 Tail (aa 930-1050), and 
XXI-809 Tail (aa 809-1050). Converter domain constructs consisted of aa 600 to 758 of the myosin-XXI 
sequence. One construct (XXI-Conv. WT) contained the wild-type sequence, the second one 
(XXI-Conv. M) was modified by a double-amino acid substitution in the PX domain replacing arginine 
and tyrosine (aa 705 and aa 706) by leucine and serine. This mutation had been demonstrated to 
reduce but not completely eliminate the phospholipid binding capacity of the myosin-XXI converter 
domain (Batters et al., 2014). Furthermore, co-sedimentation assays with a fusion protein of eGFP 
and the endophilin A1 N-BAR domain were carried out. The latter fusion protein was expressed and 
purified in order to be used as positive control in SLiC assays. 
For each protein tested, 5 co-sedimentation assays with vesicles consisting of 97.2 mol% bovine brain 
extract, 1.2 mol% Rhodamine DHPE, and 1.6 mol% Biotin DHPE were performed (Table E.2). 
Additionally, 3 negative controls were carried out (Table E.1). For the latter, solutions solely 
containing protein were subjected to the sedimentation procedure. Analysis of the protein content in 
supernatants and pellets revealed that in the negative controls, i.e. in the absence of lipids, on 
average less than 2 % of the protein contained in the solution was sedimented (Figure 45). 
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Figure 45 Negative control sedimentation assays of fusion proteins of eGFP and eNBAR, FL-XXI, and myosin-XXI 
fragments. Prior to co-sedimentation experiments with protein-vesicle mixtures, protein samples were ultracentrifuged in 
the absence of lipids. Resulting supernatants (S) and pellets (P) were analyzed by SDS-PAGE. (A) Results of the analyses of 
polyacrylamide gels. On average, less than 2 % of the amount of protein contained in the samples was detected in the 
sediment. Numbers are mean ± s.d. of 3 sedimentation assays. (B-E) Representative images showing polyacrylamide gels of 
sedimentation samples of eNBAR (B), FL-XXI and Trunc-XXI (C), XXI-930 Tail and XXI-830 Tail (D), XXI-809 Tail, XXI-Conv. WT 
and XXI-Conv. M (E). 
 
In the presence of lipids, the fraction of protein detected in the pellet increased for the following 
proteins indicating a capability of these proteins to bind to bovine brain extract vesicles (Figure 46): 
for eNBAR, which did not precipitate in negative control experiments, percentage of protein in the 
pellet increased to 82.9 % ± 4.0 % (mean ± s.d.). The capability of eNBAR to bind to the applied 
vesicles is in agreement with published data (Bhatia et al., 2009). FL-XXI protein content in the 
sediment increased from 1.6 % ± 1.5 % in negative controls to 22.4 % ± 5.0 %. In the case of 
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Trunc-XXI, fraction of precipitated protein increased by 10 % to 13.3 % ± 3.6 %. XXI-830 Tail and 
XXI-930 Tail, which did not show any precipitation in negative control experiments, exhibited 
proportions of sedimented protein of 67.0 % ± 4.6 % and 75.8 % ± 28.6 % respectively.  
 
 
Figure 46 Co-sedimentation assays of bovine brain extract vesicles with fusion proteins of eGFP and eNBAR, FL-XXI, and 
myosin-XXI fragments. To test the respective proteins for their capability to bind to unilamellar vesicles, proteins were 
incubated with bovine brain extract vesicles and subjected to ultracentrifugation. Resulting supernatants (S) and pellets (P) 
were analyzed by SDS-PAGE. (A) Results of the analyses of polyacrylamide gels. In comparison to negative control assays, 
where on average less than 2 % of the protein content of the samples was found to precipitate, significant fractions of 
eNBAR, FL-XXI, Trunc-XXI, XXI-930 Tail, and XXI-830 Tail sedimented in the presence of lipids. In contrast, no precipitation of 
XXI-809 Tail, XXI-Conv. WT, or XXI-Conv. M was observed. Numbers are mean ± s.d. of 5 co-sedimentation assays. (B-E) 
Representative images showing polyacrylamide gels of co-sedimentation samples of eNBAR (B), FL-XXI and Trunc-XXI (C), 
XXI-930 Tail and XXI-830 Tail (D), XXI-809 Tail, XXI-Conv. WT and XXI-Conv. M (E). 
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In addition to the verification of protein-vesicle binding, the extent of protein precipitation in the 
presence of lipids also permitted a comparison of the investigated proteins´ binding affinities for 
vesicular bovine brain extract bilayers: while eNBAR, XXI-830 Tail, and XXI-930 Tail fractions in the 
precipitate were comparably high, sedimentation of FL-XXI and Trunc-XXI was significantly less 
pronounced. Thus, binding affinities of eNBAR, XXI-830 Tail, and XXI-930 Tail for vesicular bovine 
brain extract bilayers were higher than those of FL-XXI and Trunc-XXI. 
In co-sedimentation assays with XXI-809 Tail, XXI-Conv. WT and XXI-Conv. M, no sedimentation of 
protein in the presence of lipids was discovered (Figure 46). Thus, these three myosin-XXI fragments 
did not bind bovine brain extract vesicles although each of the constructs contained at least one 
domain previously shown to be capable of phospholipid binding (Batters et al., 2014). 
 
4.8 Myosin-XXI Binding to Curved Lipid Bilayers 
As experiments studying the lipid bilayer binding capability of myosin-XXI yielded the result that 
FL-XXI did not bind to planar lipid bilayers but did bind to lipid vesicles, the question arose whether 
geometrical aspects influenced lipid binding by myosin-XXI. 
Research of past years has shown that several lipid binding motifs found in different proteins are 
sensors of membrane curvature and bind lipid bilayers in a curvature-dependent manner 
(e.g. Drin et al., 2007; Bhatia et al., 2009; Mehrotra et al., 2014; Snead et al., 2014; Prévost et al., 
2015). Accordingly, FL-XXI and myosin-XXI fragments were tested for their sensitivity for positively 
curved lipid bilayers. 
For this purpose, Single Liposome Curvature assays were performed: immobilized rhodamine-labeled 
unilamellar vesicles with eGFP- or Alexa Fluor® 488-labeled protein bound were imaged in 2-channel 
confocal microscopy. Densities of protein bound to the surface of vesicular bilayers were quantified 
by the intensity ratio 
 
𝜌𝑅 =
𝐼𝑃
𝐼𝑉
 
  
 (21) 
of fluorescence signals detected from vesicles (IV) and protein (IP). With the help of the average 
intensity ratio ρR̅̅ ̅ at vesicle diameters between 250 nm and 350 nm, normalized protein densities  
 𝜌𝑛𝑜𝑟𝑚(𝑑) =
𝜌𝑅(𝑑)
𝜌𝑅̅̅ ̅
    (22) 
were computed permitting comparison of results obtained for different proteins. In addition, 
diameters of vesicles were calculated from 
 𝑑 = 𝑐 ∙ √𝐼𝑉    (23) 
with c denoting a constant calibration factor. This calibration factor was determined by combined 
imaging of unilamellar vesicles by confocal microscopy and STORM. 
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In the following subsections, results of calibration measurements and of SLiC assays will be 
described. 
 
 Size Calibration of Unilamellar Vesicles 4.8.1
In order to assign diameters to unilamellar vesicles imaged in SLiC assays, 34 fields of view of 20 
samples of immobilized vesicles were consecutively imaged in confocal microscopy and STORM. To 
avoid overlapping of fluorescence signals in STORM, low phospholipid concentrations were applied 
for sample preparation.  
In total, image analysis resulted in the determination of calibration factors for 50 distinct vesicles 
(Figure 47) ranging from 1.2 nm/(a.u.)0.5 to 8.1 nm/(a.u.)0.5. By calculation of the arithmetic mean, the 
final calibration factor was determined as c=3.6±1.6 nm/(a.u.)0.5 (mean ± s.d.). 
 
 
Figure 47 Size calibration of unilamellar vesicles. To enable the assignment of specific diameters to vesicles utilized in SLiC 
assays, calibration measurements were performed. Identical fields of view of samples containing fluorescently labeled 
bovine brain extract vesicles were consecutively imaged by confocal microscopy and STORM. In the subsequent analysis, 
related intensity signals IV detected in confocal microscopy and diameters d determined with the help of STORM were 
assigned to each other and calibration factors were calculated from 𝑑 = 𝑐 ∙ √𝐼𝑉. As depicted in the above diagram, 
calibration factors for 50 distinct vesicles of different diameters were deduced. By calculation of the arithmetic mean, a 
final calibration factor of 3.6±1.6 nm/(a.u.)
0.5
 (mean ± s.d.) was determined. 
 
 Positive Curvature Promoted Binding of Myosin-XXI to Lipid Bilayers 4.8.2
In SLiC assays, impact of bilayer curvature on the bilayer binding capability of fusion proteins of eGFP 
and FL-XXI, Trunc-XXI, XXI-830 Tail, and XXI-930 Tail was tested. As positive control, SLiC assays with 
eGFP-eNBAR fusion protein were performed. In negative control assays, binding of Alexa Fluor® 488-
conjugated streptavidin to Biotin DHPE contained in the vesicular bilayers was examined. 
Prior to the investigation of the above-mentioned proteins, 2-channel confocal imaging of 
unilamellar vesicles dual-labeled with Rhodamine DHPE and DiO was carried out in order to verify the 
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image analysis method developed for assay evaluation. Vesicles examined were composed of 
94.7 mol% bovine brain extract, 1.6 mol% Biotin DHPE, 1.2 mol% Rhodamine DHPE, and 2.5 mol% 
DiO. Analysis followed the identical procedure as applied to images of SLiC assay samples, with DiO 
fluorescence replacing the protein signal. Evaluation of 4 samples (1,123 data points) resulted in a 
normalized DiO surface density curve ρnorm(d) displaying an increase in DiO density of a maximum 
factor of 8.2 for small vesicles relative to vesicles with diameters ranging from 250 nm to 350 nm 
(Figure 48). The magnitude of this increase is in agreement with published data of dual-labeled 
vesicular bilayers (Larsen et al., 2011). According to Larsen et al., increases in dye surface densities 
are related to the inhomogeneous distribution of lipid species and dyes inevitable in the vesicle 
preparation process. As the signal increase of the DiO surface density curve generated by the image 
analysis method developed in the present study lies within the range of the expected increase, the 
analysis method is suitable for the evaluation of SLiC assays. In addition, the curve ρnorm(d) obtained 
from vesicular bilayers dual-labeled with Rhodamine DHPE and DiO presented a useful reference to 
assess the reasonability of results received from the analysis of samples of vesicle-bound protein. 
In the following step, negative control experiments with Alexa Fluor® 488-conjugated 
streptavidin were executed. Normalized streptavidin densities deduced from 4 samples (296 data 
points) exhibited a 12.9-fold signal multiplication for protein bound to vesicles of small diameters 
(Figure 48). Accordingly, streptavidin results clearly resembled the curve of dual-labeled unilamellar 
vesicles validating the applied analysis procedure. 
 
 
Figure 48 Imaging of dual-labeled vesicles and SLiC assays of streptavidin. Diagrams show densities of DiO and Alexa 
Fluor® 488-conjugated streptavidin on the surfaces of vesicular bilayers normalized to the values obtained for vesicles of 
the reference size, i.e. of diameters from 250 nm to 350 nm. (A) Dual-labeled vesicles composed of bovine brain extract, 
Biotin DHPE, Rhodamine DHPE, and DiO were immobilized, imaged by confocal microscopy, and analyzed regarding surface 
density of DiO molecules. Relative to the reference size, an 8.2-fold increase in the DiO surface density was detected for 
small vesicles. This seeming curvature dependence of the DiO signal results from an inhomogeneous distribution of lipid 
species and dyes inherent to the vesicle production process. The magnitude of the signal increase lies within the expected 
range. (B) Analysis results of SLiC assays of Alexa Fluor® 488 streptavidin bound to vesicular bilayers of bovine brain extract 
supplemented with Rhodamine DHPE and Biotin DHPE. Streptavidin surface density exhibited an increase by a factor of 12.9 
for vesicles of small diameters thus resembling results obtained for dual-labeled vesicles. Therefore, SLiC assays of Alexa 
Fluor® 488 streptavidin presented a suitable negative control. 
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Subsequent to negative control assays, positive control experiments with 12 samples (406 data 
points) containing eNBAR fusion protein were carried out and evaluated. For small vesicles, 
normalized protein density was up to 130.4 times higher than for vesicles of the reference size 
(Figure 49). Thus, increase in protein signal of eNBAR significantly exceeded the signal increase 
observed for streptavidin. Consequently, eNBAR was identified as a sensor of positive bilayer 
curvature, which corresponds to findings published by Bhatia et al. (2009). 
SLiC assays with FL-XXI (14 samples, 115 data points) resulted in a curve ρnorm(d) with a protein density 
increase of up to a factor of 59.9 (Figure 49). As in the case of eNBAR, this increase was significantly 
higher than the protein density increase found for the negative control suggesting that full-length 
myosin-XXI bound to phospholipid bilayers in a curvature-dependent manner. In SLiC assays with 
FL-XXI, it was noticed that FL-XXI did not bind to bovine brain extract vesicles very efficiently leaving 
observable amounts of fusion protein in solution. The low efficiency of the FL-XXI-bovine brain 
extract binding reaction limited the number of data points obtainable from one sample. This effect 
could only be restrictedly compensated by increasing FL-XXI concentration as unbound FL-XXI fusion 
protein caused an elevation of noise level. 
On the contrary, in SLiC assay samples of Trunc-XXI, protein-vesicle binding was found to be 
remarkably efficient thereby generating a sufficient number of data points for a Trunc-XXI 
concentration (7 nM) almost 10-fold lower than the applied FL-XXI concentration (64 nM). Analysis of 
10 samples (181 data points) containing Trunc-XXI fusion protein showed that the number of protein 
molecules bound to the surface of small vesicles exceeded the average reference protein surface 
density by the 192.1-fold hence demonstrating the curvature sensitivity of Trunc-XXI (Figure 49). 
Notably, Trunc-XXI was not detected to be bound to vesicles of diameters above 350 nm. 
The investigation of eGFP fusion proteins of XXI-830 Tail and XXI-930 Tail showed that both of the tail 
fragments too were capable of sensing curvature of phospholipid bilayers. For XXI-830 Tail, 4 samples 
(240 data points) were evaluated yielding protein surface density increases of a maximum factor of 
131.7 for small vesicles (Figure 49). Analysis of 4 samples (318 data points) containing XXI-930 Tail 
fusion protein revealed that up to 110.7 times more protein molecules bound to lipid vesicles of 
diameters below 250 nm (Figure 49). 
Summarizing the results of SLiC assay experiments, myosin-XXI-lipid bilayer binding was promoted by 
positive bilayer curvature. In addition, fragments of myosin-XXI containing lipid binding motifs also 
exhibited curvature-dependent bilayer binding behavior. 
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Figure 49 SLiC assays of fusion proteins of eGFP and eNBAR, FL-XXI, Trunc-XXI, XXI-930 Tail, and XXI-830 Tail. Diagrams 
show normalized surface densities of proteins bound to vesicular bilayers composed of bovine brain extract, Rhodamine 
DHPE, and Biotin DHPE. As normalization factor, average protein density detected for vesicles in the diameter interval of 
250 nm to 350 nm was applied. (A) Density curve for Alexa Fluor® 488-conjugated streptavidin, which served as negative 
control. (B) When bound to vesicles of small size, eNBAR exhibited an up to 130.2-fold higher surface density. Thus, eNBAR 
was identified as a sensor of positive bilayer curvature. (C, D, E, F) Normalized surface density curves of FL-XXI (C), Trunc-XXI 
(D), XXI-930 Tail (E), and XXI-830 Tail (F). All myosin-XXI constructs exhibited a significant increase in the number of protein 
molecules bound per bilayer surface area for decreasing vesicle diameters. Surface densities increased by a factor of 
59.9 (FL-XXI), 192.1 (Trunc-XXI), 110.7 (XXI-930 Tail), and 131.7 (XXI-830 Tail) respectively. Accordingly, all of the tested 
myosin-XXI fusion proteins bind phospholipid bilayers dependent on positive curvature. 
 
103 
5 Discussion 
5.1 Cellular Localization Patterns and Dynamics of Myosin-XXI Constructs in 
Transfected HeLa and COS-7 Cells 
 General Discussion of Cellular Localization Patterns 5.1.1
Mammalian cell lines have frequently been used as model systems to investigate biochemical 
properties and cellular functions of different myosin motors (e.g. Tsakraklides et al., 1999; 
Les Erickson et al., 2003; Zhang et al., 2004; Belyantseva et al., 2005; Bohil et al., 2006; Kerber et al., 
2009; Watanabe et al., 2010). In the present study, plasmids encoding fusion proteins of a 
fluorophore and different myosin-XXI constructs were transfected into HeLa and COS-7 cells to 
examine myosin-XXI in vivo. 
For all myosin constructs investigated, a diffuse distribution of fusion protein in the cytoplasm 
frequently paired with staining of the nucleus was detected. This staining pattern was also observed 
when HeLa and COS-7 cells were transfected with plasmids solely encoding a fluorophore. Therefore, 
a homogeneous cytoplasmic localization most probably does not represent a cellular localization 
specific for myosin-XXI or myosin-XXI fragments. Noteworthily, a diffuse distribution in the cytoplasm 
was the only localization detected for myosin-XXI tail constructs, i.e. all myosin constructs merely 
containing amino acids C-terminal of aa 729. In contrast, transfection experiments of the Gupta 
research group had demonstrated that in L. donovani promastigotes a myosin-XXI tail construct of 
aa 751 to aa 1050 was capable of localizing at the same distinct cellular locations as FL-XXI 
(Katta et al., 2009). In addition, the tail domain had been identified as a prerequisite for the proper 
distribution of myosin-XXI within the promastigote. Thus, it can be concluded that in L. donovani, the 
tail domain mediates the transport of myosin-XXI via a cellular pathway that does not exist in HeLa 
and COS-7 cells (see subsection 5.1.2). 
Contrary to the myosin-XXI tail constructs, myosin-XXI fusion proteins containing the major part of 
the motor domain including the ATP binding loop, switch I, switch II, the relay loop, and half of the 
converter were detected at distinct cellular locations when expressed in HeLa and COS-7. These 
locations were related to structural motifs outside the motor domain that were present in the 
respective proteins. 
Motor-containing fusion proteins were found to accumulate in clusters and spherical structures 
within the cytoplasm of transfected cells. However, the nature of these myosin-XXI accumulating 
structures has to remain unclear as immunostaining for clathrin-coated vesicles and co-transfection 
experiments with baculoviruses encoding markers for early endosomes, Golgi apparatus, and 
endoplasmic reticulum did not reveal any colocalization of myosin-XXI with the respective organelles. 
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Since clusters were found to occur at high expression levels of fusion proteins and were only 
observed when cytoplasmic spherical myosin-XXI accumulations were present as well, clusters might 
result from fusion or incorporation of the smaller spherical myosin-XXI-related structures. Thus, 
clusters and spherical structures might potentially be part of the same cellular functional pathway. 
Remarkably, localization in clusters and spherical structures was independent of the presence of the 
myosin-XXI SH3-like or tail domain indicating that myosin binding to other cellular constituents than 
actin was not involved in this localization process. Therefore, myosin-XXI fusion proteins were most 
likely unspecifically enclosed in yet unidentified cellular compartments.  
In addition to the cytoplasmic accumulations described above, Trunc-XXI and FL-XXI exhibited cellular 
localizations not observed for any other myosin-XXI construct tested: both fusion proteins were 
detected along the plasma membrane and inside filopodia of COS-7 and HeLa cells. This localization 
pattern will be discussed in the subsequent subsection. 
 
 Accumulation of FL-XXI and Trunc-XXI along the Plasma Membrane and Inside 5.1.2
Filopodia 
Of all the myosin-XXI constructs studied, FL-XXI and Trunc-XXI exhibited the most striking localization 
pattern. In both, HeLa and COS-7 cells, FL-XXI and Trunc-XXI fusion proteins were observed to 
accumulate at the tips of filopodia and to be distributed along the filopodia shafts. In addition, both 
proteins were found to accumulate in a dot-like appearance along the plasma membrane. Possibly, 
these accumulations at the plasma membrane are areas of newly emerging filopodia thus resulting 
from the same processes that leads to filopodial localization. 
The localization of motor proteins inside the tips and along the shafts of filopodia of transfected 
mammalian cells has already been described for several myosins, including myosin-X (Berg and 
Cheney, 2002), myosin-Va (Tsakraklides et al., 1999), and myosin-IIIa (Les Erickson et al., 2003). As in 
the case of these myosins, for myosin-XXI presence of the motor domain is a prerequisite for the 
formation of filopodial myosin populations. Thus, identical to myosin-X, -Va, and -IIIa, myosin-XXI is 
likely to processively move toward the tips of filopodia under its own motor power. Further, active 
myosin-XXI movement along actin bundles inside filopodia agrees with myosin-XXI´s demonstrated 
plus end-directionality (see section 5.2), since within filopodia barbed ends of actin filaments point 
toward the cell periphery (Lewis and Bridgman, 1992). 
The present finding that myosin-XXI needs its motor domain to reach distinct cellular locations in 
HeLa and COS-7 cells is seemingly contradictory to the results of transfection experiments with 
L. donovani promastigotes reported by Katta et al. (2009), as the latter demonstrated that proper 
myosin-XXI distribution within the parasite is independent of the myosin head. However, it can be 
argued that due to the absence of a fully developed actin network in L. donovani, the capability of 
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myosin-XXI to processively move along filamentous actin might not be sufficient for the movement of 
this myosin to specific cellular locations within the parasite. Instead, as indicated by the observations 
made by Katta et al., other transport mechanisms evolved in the parasite to enable distribution of 
myosin-XXI. Moreover, the unspecific localization pattern of myosin-XXI tail constructs observed in 
the present transfection experiments with HeLa and COS-7 cells suggests that tail-mediated 
myosin-XXI transport in L. donovani is based on processes that might possibly be specific for 
Leishmania or lower eukaryotic species. As microtubules represent the main constituent of the 
trypanosomatid cytoskeleton (Gull, 1999) myosin-XXI might for example be transported with the help 
of a kinesin or dynein motor protein not found in HeLa or COS-7. 
 
 
Figure 50 Cellular localization patterns of PI(4,5)P2 and myosin-XXI. Confocal microscopy images of localization patterns of 
BODIPY-labeled PI(4,5)P2 (BODIPY: dipyrrometheneboron difluoride) (A) and ZsGreen1-labeled FL-XXI (B) in mammalian cells 
(both green). Actin cytoskeletons of the cells (red) were labeled with the help of phalloidin conjugated to ATTO 647 (A) or 
TRITC (B) respectively. Both PI(4,5)P2 and FL-XXI were found to localize along the shafts of filopodia and to form pronounced 
accumulations at the distal filopodia ends. (A) NIH-3T3 cell treated with artificial vesicles containing fluorescent conjugates 
of PI(4,5)P2 and phalloidin. Artificial vesicles were internalized by the cell via the endocytic pathway. Within early 
endosomes, vesicles dissociated and induced pore formation of the endosome membrane thereby causing the release of 
PI(4,5)P2 into the cytoplasm. Scale bars: 5 μm. Images taken from Chierico et al. (2014). (B) HeLa cell transfected with a 
ZsGreen1-FL-XXI fusion construct and subjected to staining of F-actin after fixation. The localization pattern observed for 
FL-XXI was identical to the one found for Trunc-XXI. Scale bars: 20 μm, for magnified section: 5 μm. 
 
Interestingly, the staining pattern of HeLa and COS-7 cells expressing a fusion protein of ZsGreen1 
and FL-XXI or Trunc-XXI strongly resembles the staining pattern of fluorescently labeled PI(4,5)P2 in 
NIH-3T3 cells (Mus musculus embryonic fibroblasts) observed by Chierico et al. (2014; Figure 50). The 
authors report that after fluorescent PI(4,5)P2 was internalized by the cells via endocytosis of 
synthetic vesicles, PI(4,5)P2 was found to form accumulations inside filopodia tips and domains along 
filopodia shafts. Considering the fact that the PI(4,5)P2 binding capability of FL-XXI and Trunc-XXI has 
been demonstrated in a previous study of our lab (Batters et al., 2014), myosin-XXI expressed by 
transfected HeLa and COS-7 cells might hence be bound to PI(4,5)P2 within filopodia. In addition, 
irrespective of a potential intrafilopodial PI(4,5)P2-myosin-XXI interaction, the striking similarity of 
PI(4,5)P2 and myosin-XXI localization patterns in mammalian cells indicates that myosin-XXI is 
localized at regulatory sites of filopodia formation, stabilization or elongation as PI(4,5)P2 is involved 
in the regulation of actin polymerization in filopodia (Lee et al., 2010; Chierico et al., 2014). In fact, 
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the assumption of myosin-XXI accumulation at such regulatory sites is further supported by the 
similarity of the FL-XXI and Trunc-XXI localization pattern with the reported cellular distribution of 
myosin-X: according to data published by Berg and Cheney (2002), myosin-X localized within 
filopodia of transfected COS-7, HEK-293 (human embryonic kidney epithelial cells) and NIH-3T3 cells, 
and furthermore influenced the length and density of filopodia in these cells.  
To elucidate an involvement of myosin-XXI in the formation or elongation of filopodia of transfected 
HeLa and COS-7 cells, length and density analyses of filopodia were performed. Respective results 
will be discussed in subsection 5.1.4. 
Comparison of cellular localizations of FL-XXI and Trunc-XXI with those of other myosin-XXI 
constructs also containing the motor domain reveals that the motor is not the only domain required 
for FL-XXI and Trunc-XXI to reach their filopodial destination. Additionally, the SH3-like domain and 
the neck and tail region from aa 748 to aa 800 have to be present in the protein. Within this region, 
an IQ motif, a dimerization site, and three lipid binding motifs have been identified. 
According to previously published work of our group (Batters et al., 2014), dimerization of 
myosin-XXI results in the formation of a non-motile state. Therefore, it can be concluded that dimer 
formation is not involved in the in vivo processive movement of myosin-XXI. This conclusion is further 
supported by the fact that dimer formation of Trunc-XXI could not be observed in vitro (Batters et al., 
2012). The requirement for a monomeric conformation implies that both FL-XXI and Trunc-XXI are 
capable of forming arrays of myosin molecules bound to cargo to enable processive motility in vivo. 
This again demonstrates cargo binding to be a mechanism enabling processive motor movement as 
for example already shown for myosin-VI (Iwaki et al., 2006). Furthermore, cargo-mediated 
processivity explains the necessity of the presence of a minimum myosin-XXI tail fragment for FL-XXI 
and Trunc-XXI to reach filopodia. It is worth mentioning that actin binding by a second actin binding 
site within the myosin tail is another mechanism discussed to play a role in processive movement of 
monomeric myosins (Les Erickson et al., 2003). However, Katta et al. (2010) verified the absence of 
an actin binding site C-terminal of the myosin-XXI motor domain. 
In order for myosin-XXI to retain a motile monomeric state, calmodulin binding is required 
(Batters et al., 2014) revealing that the IQ motif within the neck region of aa 754 to aa 769 is a 
prerequisite for FL-XXI and Trunc-XXI to move processively. In agreement with this, a myosin-XXI 
construct (aa 1-753) not containing the N-terminal part of the tail failed to reproduce the filopodial 
localization. However, unlike FL-XXI isolated Trunc-XXI was found to be incapable of binding 
calmodulin. Therefore, it is likely that cargo binding by Trunc-XXI causes a conformational change 
resulting in the accessibility of the calmodulin binding site. 
Transfection experiments with constructs (aa 46-800, aa 46-1050) obtained by a deletion of the 
SH3-like domain from FL-XXI and Trunc-XXI revealed that the SH3-like domain too is a prerequisite 
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for FL-XXI and Trunc-XXI to generate the observed staining pattern. SH3 domains are known to be 
important mediators of protein-protein interactions also regulating protein conformation and 
function by intramolecular binding to other domains (Cohen et al., 1995; Andreotti et al., 1997; 
Geli et al., 2000; Ago et al., 2003). In fact, studies of Dictyostelium discoideum myosin-II indicated 
that the N-terminal SH3-like domain of class-II myosins stabilizes the head domain thereby 
facilitating nucleotide binding, actin binding, and motility (Fujita-Becker et al., 2006). Thus, it is 
possible that the myosin-XXI SH3-like domain interacts with another structural motif within the 
motor domain, thereby maintaining FL-XXI and Trunc-XXI in a conformation enabling motility. 
In order to determine, whether FL-XXI and Trunc-XXI differ in their capability to localize inside 
filopodia, transfected HeLa cells were analyzed regarding the incidence of protein accumulations 
within filopodia tips. It was observed that FL-XXI was present in 54 % of the filopodia tips while 
Trunc-XXI was detected in 25 % of the tips. Hence, FL-XXI potentially localizes within filopodia more 
efficiently. This might be related to a higher cargo binding capability of the full-length myosin 
resulting in better motility or a more effective binding to molecular components of filopodia. 
However, it needs to be noticed that despite equal transfection conditions, higher average 
fluorescence intensities of the cell bodies of FL-XXI-transfected cells in comparison to Trunc-XXI-
transfected HeLa also indicate the possibility that the higher abundance of filopodial FL-XXI 
accumulations is related to a higher expression level of FL-XXI. 
 
 Dynamics of FL-XXI and Trunc-XXI in Transfected HeLa Cells 5.1.3
Since transfection experiments with COS-7 and HeLa cells yielded hints towards an involvement of 
FL-XXI and Trunc-XXI in specific cellular processes especially within filopodia, live imaging of HeLa 
cells transfected with FL-XXI or Trunc-XXI was performed. Records revealed that both spherical 
myosin-XXI accumulations in the cytoplasm and myosin-XXI populations within filopodia were motile.  
In filopodia, fluorescent puncta of protein were observed to move rearward from the cell 
periphery to the cell body, and tracking of these puncta resulted in average rearward speeds of 
24.3±15.5 nm/s (mean ± s.d.) for FL-XXI and 34.6±17.1 nm/s for Trunc-XXI. These values resemble 
speeds of rearward movement of fluorophore-labeled myosin-Va in HeLa (10-20 nm/s (Kerber et al., 
2009)), myosin-XVa in HeLa (~20 nm/s (Belyantseva et al., 2005)), and myosin-X in HeLa and COS-7 
(in HeLa: 15 nm/s (Berg and Cheney, 2002)), in COS-7: ~30 nm/s (Watanabe et al., 2010)). Moreover, 
it can be argued that rearward movement of myosin-XXI results from a coupling of myosin to the 
retrograde actin flow in filopodia as the speed of intrafilopodial retrograde actin flow in HeLa cells 
was determined to range between 0 nm/s and 55 nm/s (Mallavarapu and Mitchison, 1999). 
In a model described by Sousa and Cheney (2005; Figure 51), myosin-X moves toward the tips 
of filopodia using its own motor power and, once myosin-X stops moving actively, it is transported 
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back toward the cell body by coupling to rearward actin flow. During both processes, active 
movement and passive transport, myosin-X is involved into the delivery of cargo from the cell body 
to the filopodia tips and vice versa. Respective cargo is proposed to comprise integral membrane and 
cytoplasmic proteins which are related to the formation or stabilization of filopodia. Similar to 
myosin-X, active and passive forms of movement might be associated with the intrafilopodial motility 
of myosin-XXI in transfected HeLa and COS-7 cells. Furthermore, considering the fact that myosin-XXI 
increases the average length and density of filopodia in these cells, it is likely that similar to myosin-X, 
myosin-XXI transports components that are part of the filopodial architecture. 
 
 
Figure 51 Model of intrafilopodial movement of and cargo transport by myosin-X. This model proposed by Sousa and 
Cheney (2005) states that myosin-X (green) moves into the tips of filopodia by actively walking toward the barbed ends of 
actin filaments. At the distal end of the filopodial actin core, where actin monomers (red) attach to the filaments, myosin-X 
might regulate the polymerization process as constituent of a filopodial tip complex (blue). Retrograde movement of 
myosin-X results from a termination of active motor movement combined with a coupling to rearward actin flow. Potential 
cargo of intrafilopodial transport by myosin-X is hypothesized to comprise integral membrane and cytoplasmic proteins 
regulating filopodia formation or stabilization. In addition, myosin-X possibly links filopodial actin to substrate-attached 
integrins. Figure taken from Sousa and Cheney (2005). 
 
The assumption of active myosin-XXI movement to the tips of filopodia implies that in order to reach 
the filopodia tips, myosin-XXI has to be capable of moving faster than the rearward actin flow and 
faster than the elongation of filopodia by the polymerization of actin. A comparison of the speed of 
rearward actin flow in HeLa (0 nm/s to 55 nm/s) and of maximum actin assembly rates of 
approximately 30 nm/s in the tips of growth cone filopodia (Mallavarapu and Mitchison, 1999) with 
the average filament gliding speed of 63.0 nm/s observed in gliding filament assays with FL-XXI on 
vesicle-covered surfaces verifies that myosin-XXI is indeed capable of moving with the required 
speed. 
Interestingly, unlike retrograde movement of FL-XXI and Trunc-XXI, a tip-directed intrafilopodial 
motility of these fusion proteins was not detected in confocal live imaging. The occurrence of myosin 
accumulations in filopodia tips despite the absence of an observable movement toward the cell 
periphery was also reported for a myosin-XVa-GFP fusion protein expressed by COS-7 cells 
(Belyantseva et al., 2005). Belyantseva et al. concluded that myosin-XVa travels to the tips of 
filopodia as single molecule or in small groups. The same mechanism can be assumed for myosin-XXI, 
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especially since the time course of the fluorescence intensities of FL-XXI or Trunc-XXI accumulations 
in filopodia tips did not only exhibit significant decreases but also showed increases of up to 520 % 
hence clearly verifying a movement of fusion protein into the tips. Importantly, as processive 
translocation of myosin-XXI is most probably dependent on the formation of arrays of molecular 
motors (see subsection 5.1.2), FL-XXI and Trunc-XXI are likely to move toward the distal filopodia 
ends in small groups and not as single molecules. 
 
 
Figure 52 Model of intrafilopodial PI(4,5)P2 movement. In NIH-3T3 cells, PI(4,5)P2 was found to be associated with motile 
structures travelling toward the cell periphery (Chierico et al., 2014). Accordingly, Chierico et al. (2014) deduced a model 
proposing that PI(4,5)P2 (PIP2) is incorporated into organelles which are propelled to filopodia tips probably by the motor 
activity of myosins. Subsequently, organelles merge with the plasma membrane forming PI(4,5)P2 rich domains. These 
domains are transported back to the cell body via a coupling to rearward actin flow. Figure taken from Chierico et al. 
(2014). 
 
As already mentioned before, cellular localization patterns of FL-XXI and Trunc-XXI strongly resemble 
the distribution of PI(4,5)P2 in NIH-3T3 cells described by Chierico et al. (2014; Figure 50). 
Interestingly, PI(4,5)P2 was also found to be associated with motile structures travelling to the tips of 
filopodia. From the observed PI(4,5)P2 dynamics, Chierico et al. deduced a model stating that 
PI(4,5)P2 is incorporated into organelles which are propelled toward the cell periphery and merge 
with the plasma membrane at the filopodia tip, whereupon resulting PI(4,5)P2 rich membrane 
domains are transported back toward the cell body (Figure 52). In this model, vesicular PI(4,5)P2 
transport is proposed to possibly involve myosin activity, and rearward PI(4,5)P2 movement is 
assumed to be coupled to retrograde actin flow. In conclusion, PI(4,5)P2 and myosin-XXI movement 
in filopodia are likely to be associated with correlating transport mechanisms. Accordingly, 
myosin-XXI fusion proteins might be bound to PI(4,5)P2-enriched organelles travelling toward the tips 
of filopodia, and FL-XXI and Trunc-XXI rearward movement might be linked to PI(4,5)P2 transport 
back to the cell body. In the first case, a low surface density of organelle-bound FL-XXI and Trunc-XXI 
would explain why myosin-XXI movement toward filopodia tips was not detected in live imaging. In 
the case of rearward movement, PI(4,5)P2 and myosin-XXI might be propelled back to the cell body in 
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a multi-molecular complex which links curvature sensitive FL-XXI and Trunc-XXI (see subsection 5.3.4) 
to planar membrane domains via protein-protein interactions. Noteworthily, in L. donovani an 
involvement of myosin-XXI and PI(4,5)P2 in related transport processes within membrane protrusions 
might account for the suggested regulatory role of PI(4,5)P2 in flagellar development (Wei et al., 
2008). 
To further elucidate a potential role of myosin-XXI in the formation, elongation or stabilization of 
membrane protrusions, in addition to an evaluation of FL-XXI and Trunc-XXI populations moving 
along the shafts of filopodia, accumulations of myosin-XXI fusion proteins at the filopodia tips were 
analyzed. It was found that myosin-XXI presence at the distal filopodia ends persisted during phases 
of filopodial length changes, indicating two possible scenarios: firstly, FL-XXI and Trunc-XXI possibly 
remain at the barbed ends of filopodial actin bundles due to their active plus end-directed 
movement, which as described before can reach speeds faster than the in vivo actin assembly rate. 
Secondly, myosin-XXI fusion proteins might as well be bound to constituents of the plasma 
membrane. Owing to the sensitivity of FL-XXI and Trunc-XXI for positively curved bilayers, plasma 
membrane binding then has to be mediated by protein-protein interaction, e.g. by an interaction 
with integral membrane proteins. The latter is a binding mechanism already demonstrated for 
myosin-X, which was shown to bind to integrins in the filopodial plasma membrane (Zhang et al., 
2004). A protein-mediated attachment of myosin-XXI to the plasma membrane further represents a 
potential explanation how myosin-XXI is stably fixed at the proximal region of the L. donovani 
promastigote flagellum. 
The occurrence of stable myosin-XXI accumulations at filopodia tips further suggests that FL-XXI and 
Trunc-XXI could be capable of influencing actin polymerization, since distal ends of filopodia have 
been identified as sites of actin assembly (Okabe and Hirokawa, 1991). As the flagellum of 
L. donovani contains actin (Sahasrabuddhe et al., 2004), regulation of actin polymerization by 
myosin-XXI might play a role in myosin-XXI-dependent formation of a functional flagellum. 
To gain additional insight into a potential involvement of myosin-XXI in the modulation of 
intrafilopodial actin dynamics, length change rates of filopodia containing FL-XXI or Trunc-XXI 
respectively were determined. Analysis of the trajectories of permanent fusion protein 
accumulations at the tips of extending and retracting filopodia yielded average length change rates 
between 20 nm/s and 30 nm/s, with Trunc-XXI-expressing cells exhibiting higher average speeds of 
extension (approximate increase: 35 %) and retraction (approximate increase: 10 %) than FL-XXI-
expressing HeLa. This dependency of filopodial length change rates on the fusion protein expressed 
cannot be explained by a difference in the motor activity of the two proteins as past research of our 
lab had even demonstrated that Trunc-XXI exhibits a slightly reduced actin-activated ATPase rate in 
comparison to FL-XXI (Batters et al., 2012). Thus, the observed divergence indicates that myosin-XXI 
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actually influences actin dynamics within filopodia. Interestingly, similar observations were made for 
myosin-X in transfected COS-7 cells (Watanabe et al., 2010): variations in the length of filopodia of 
cells expressing the full-length protein proceeded slower than length changes in cells transfected 
with a truncated myosin-X construct lacking the C-terminal FERM domain. In this case, the absence of 
the FERM domain was suggested to result in the incapability of the myosin-X motor truncation to link 
the filopodial actin core to substrate-attached integrins in the plasma membrane. The fact that 
Trunc-XXI and FL-XXI too merely differ in their tail domains indicates that the detected shift in 
filopodial length change rates is as well related to an interaction with binding partners. However, this 
interaction might not be restricted to intrafilopodial transport processes. Instead, Kozlov and 
Bershadsky (2004) proposed that myosins might actively promote actin polymerization by exerting 
tensile forces on capping proteins at the barbed ends of actin bundles. Yet, further investigations on 
myosin-XXI binding partners will have to be carried out in order to elucidate how this motor protein 
regulates actin assembly or disassembly. 
In summary, analysis of live records of HeLa cells expressing FL-XXI or Trunc-XXI revealed that 
myosin-XXI is likely to be involved in processes regulating the assembly of membrane protrusions. 
Analyses of filopodia length and density of transfected HeLa and COS-7 cells, which are described in 
the next subsection, further confirmed this conclusion. 
 
 Induction of Filopodial Length and Density Increases in FL-XXI- and Trunc-XXI-5.1.4
Transfected HeLa and COS-7 Cells 
In order to gain further information on a potential involvement of myosin-XXI in the formation, 
stabilization, or elongation of membrane protrusions, HeLa and COS-7 cells transfected with FL-XXI 
and Trunc-XXI were analyzed regarding average filopodia length and density. 
The present work shows that myosin-XXI, similar to myosin-X in COS-7 cells (Berg and Cheney, 2002; 
Zhang et al., 2004; Bohil et al., 2006; Watanabe et al., 2010), is capable of changing the average 
length and density of filopodia. For myosin-X, it was shown that localization of myosin inside the tips 
of filopodia was not sufficient to increase filopodial number and length (Bohil et al., 2006). While tip 
localization only required head, neck and predicted coiled coil region of myosin-X, the MyTH4-FERM 
(MyTH4: myosin tail homology 4) domain cassette was essential for changes in length and density of 
filopodia (Berg and Cheney, 2002; Zhang et al., 2004; Bohil et al., 2006; Watanabe et al., 2010). In 
contrast, myosin-XXI localization in filopodia was always accompanied by an elevated average density 
and length of filopodia. This suggests that the myosin-XXI tail region C-terminal of aa 800 does not 
fulfill essential functions in the initiation and elongation of actin-based membrane protrusions.  
Nevertheless, FL-XXI-transfected cells were found to produce longer filopodia than Trunc-XXI-
transfected ones even in the case of COS-7 cells, which exhibited lower average FL-XXI expression 
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levels than Trunc-XXI expression levels. Therefore, it can be concluded that the C-terminal part of the 
myosin-XXI tail is not essential for filopodia elongation but might increase the efficiency of the 
underlying processes.  
Interestingly, a more detailed analysis of transfected HeLa cells revealed that filopodia not displaying 
myosin-XXI fusion protein accumulations in their tips exhibited an average length up to 7.5 % smaller 
than the average filopodia length of the control, i.e. of HeLa merely expressing ZsGreen1. In contrast, 
filopodia containing FL-XXI or Trunc-XXI populations within their tips, showed an increase in average 
length of up to 53 % relative to the control. Thus, FL-XXI and Trunc-XXI localization at the distal ends 
of filopodia is likely to be related to the elongation of filopodia indicating that myosin-XXI is capable 
of mediating processes promoting actin polymerization. As already described earlier (see 
subsection 5.1.3), potential roles of myosin-XXI therefore comprise the mechanical regulation of 
actin assembly by the exertion of a tensile force on capping proteins and the transport of cargo 
involved in the enhancement of actin polymerization comparable for example to intrafilopodial VASP 
transport by myosin-X (Tokuo and Ikebe, 2004). 
In fact, the involvement of myosin-XXI-cargo or -capping protein binding in the regulation of filopodia 
length might explain the more pronounced elongation effect of FL-XXI: as in the case of differing 
filopodial extension and retraction rates of FL-XXI- and Trunc-XXI-transfected HeLa cells, it can be 
argued that a truncation of the myosin-XXI tail domain reduces efficiency of interaction with binding 
partners. Thereby, mechanical regulation of capping proteins and transport mediated by myosin-XXI 
would be impaired. 
In addition to an elongation of already existing filopodia, interaction of FL-XXI and Trunc-XXI with 
binding partners might also play a role in elevating the filopodia density of HeLa and COS-7 cells: by 
forming a link between the filopodial actin core and integral membrane proteins, myosin-XXI could 
amplify the adhesion force between actin and the plasma membrane thus further reducing 
coalescence of neighboring filopodia. Noteworthily, mediation of cytoskeleton plasma membrane 
adhesion is proposed to be a critical function of myosins in the formation and maintenance of 
membrane protrusions (Tyska et al., 2005; Nambiar et al., 2010) and is assumed to be a potential 
function of myosin-X-integrin interaction within filopodia (Zhang et al., 2004). Furthermore, an 
involvement of myosin-XXI in the tethering of intrafilopodial actin bundles to the plasma membrane 
could provide an additional explanation for the resembling cellular localization patterns of FL-XXI, 
Trunc-XXI, and PI(4,5,)P2, which has been shown to be a crucial regulator of cytoskeleton-plasma 
membrane interaction (Raucher et al., 2000). 
Another myosin-XXI-related mechanism potentially influencing the density of filopodia is an actin 
bundling activity similar to that proposed for myosin-X (Figure 53; Tokuo et al., 2007): based on its 
plus end-directionality, dimeric myosin-X actively travels to the plasma membrane and subsequently 
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bundles adjacent actin filaments in a yet unknown process. Thereby, initiation sites for the formation 
of filopodia are created. In the case of FL-XXI and Trunc-XXI, actin bundling would be mediated by 
arrays of monomers as array formation is expected to be a prerequisite for processive movement of 
FL-XXI and Trunc-XXI (see subsection 5.1.2). In agreement with a contribution of myosin-XXI to the 
initiation of filopodia, FL-XXI and Trunc-XXI were found to accumulate along the plasma membrane of 
transfected mammalian cells.  
 
 
Figure 53 Model of filopodia initiation by myosin-X. In the model depicted above, Tokuo et al. (2007) hypothesize how 
myosin-X induces the formation of filopodia. 1: Myosin-X (MyoX) exists in a monomeric and a dimeric form. Monomers are 
distributed throughout the cytoplasm while dimers associate with actin filaments and perform processive movement.  
2: Once monomers have assembled to dimers, dimeric myosin-X walks toward the barbed ends of F-actin. 3: In a yet 
unspecified process, myosin-X motor power drives lateral movement of barbed actin filament ends. 4: Filament drift results 
in convergence of filament ends thereby creating initiation sites of filopodia formation. Figure taken from Tokuo et al. 
(2007). 
 
Moreover, both processes, tethering of actin to the plasma membrane and initiation of filopodia 
formation, coincide with the fact that no obvious relation between FL-XXI and Trunc-XXI 
accumulation within the filopodia tips and the increase in filopodia density was found. 
However, as both mechanisms described above involve the interaction of FL-XXI and Trunc-XXI with 
binding partners, at present it still remains unclear why the extent of the filopodial density increase 
was observed to be independent from the myosin-XXI construct and thereby independent from the 
myosin-XXI tail region C-terminal of aa 800: HeLa cells transfected with FL-XXI exhibited an almost 
twofold higher expression level than HeLa transfected with Trunc-XXI, and FL-XXI expression caused a 
two times higher filopodial density increase compared to Trunc-XXI expression. In contrast, despite 
comparable expression levels in COS-7 cells, FL-XXI caused a more than threefold smaller increase in 
the density of filopodia of COS-7 than Trunc-XXI. 
Overall, the impact of FL-XXI and Trunc-XXI on filopodia length and density clearly indicates that 
myosin-XXI is capable of promoting the elongation, initiation, and possibly even the stabilization of 
actin-based membrane protrusions. 
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 Conclusions on Functions of Myosin-XXI in L. donovani 5.1.5
Studies of the intracellular architecture of trypanosomatids revealed that microtubules represent the 
main cytoskeletal constituent in these parasites and form the flagellar axoneme (Gull, 1999). 
However, flagellar development and functionality are based on complex processes involving various 
proteins (Landfear and Ignatushchenko, 2001; Emmer et al., 2010; Maric et al., 2010) and in recent 
years, it was discovered that actin is not only present within the L. donovani cell body and flagellum 
(Sahasrabuddhe et al., 2004) but that actin polymerization and depolymerization are prerequisites 
for the formation of a functional flagellum (Tammana et al., 2008; Kumar et al., 2012). In addition, 
Katta et al. (2010) demonstrated that actin-based cargo transport by myosin-XXI too is essential for 
the development of the flagellum. Restriction of actomyosin-associated trafficking processes by a 
double gene knockout of the ADF/cofilin gene or a single gene knockout of the myosin-XXI gene 
resulted in a reduction of flagellar length and the elimination of L. donovani promastigote motility. 
Moreover, respective mutants exhibited defective endocytosis, exocytosis, and intracellular vesicle 
transport. Hence, the interplay between actin dynamics and actin-associated myosin-XXI transport is 
critical for the survival of L. donovani. 
In transfection experiments with mammalian cell lines HeLa and COS-7, FL-XXI and several 
myosin-XXI fragments were tested for their cellular localization to draw conclusions about potential 
in vivo functions of the full-length molecule and particular structural motifs.  
It was found that exclusively FL-XXI and Trunc-XXI colocalized with the actin core of filopodia and 
accumulated in filopodia tips, probably due to active movement powered by myosin-XXI motor 
activity. Thus, unlike in L. donovani promastigotes (Katta et al., 2009), the C-terminal myosin-XXI tail 
region is not required for the two constructs to reach their cellular destination in HeLa and COS-7. 
Further, results of analyses of filopodial length change rates and of average filopodia lengths of 
transfected mammalian cells indicate a regulatory function of FL-XXI and Trunc-XXI in the 
polymerization of actin. Hence, it can be concluded that even though myosin-XXI structural motifs 
N-terminal of aa 751 are not essential for myosin localization within L. donovani promastigotes, 
together with the N-terminal part of the myosin-XXI neck and tail region they are critical for a 
potential regulation of actin assembly by myosin in the parasite. Overall, the respective regulatory 
part of myosin-XXI comprises an SH3-like domain, the motor domain including the converter, an IQ 
motif, a PX domain, several other lipid binding domains, and a dimerization site are located. 
Intrafilopodial movement of FL-XXI and Trunc-XXI observed in live images of transfected HeLa 
cells and the increased average length of filopodia containing accumulations of either one of the 
myosin-XXI fusion proteins lead to the conclusion that regulation of actin dynamics by myosin-XXI 
might result from a transport of constituents involved in actin polymerization. Likewise, in L donovani 
myosin-XXI might transport components that regulate the assembly or analogically the disassembly 
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of filamentous actin. Interestingly, in addition to dynamic actin and actin-based myosin-XXI 
trafficking expression of the actin-depolymerizing factor ADF/cofilin has been shown to be another 
prerequisite for the formation of a functional flagellum (Tammana et al., 2008) possibly indicating an 
interaction of myosin-XXI, actin and ADF/cofilin in the process of flagellum formation. 
In addition to an involvement in transport processes, a potential role of FL-XXI and Trunc-XXI in the 
elongation of filopodia and other cellular processes dependent on dynamic actin is to interact with 
capping proteins thus facilitating actin assembly. However, in Leishmania no actin capping proteins 
have been identified so far (Gupta et al., 2015). 
The observation that FL-XXI and Trunc-XXI not only elongated filopodia of transfected HeLa and 
COS-7 cells but also increased filopodia density implies that myosin-XXI might contribute to the 
initiation and stabilization of filopodia. Initiation could be promoted by an actin bundling activity of 
myosin-XXI which might as well play a role in the formation of granular actin structures detected in 
the L. donovani flagellum and in other compartments of the promastigote (Sahasrabuddhe et al., 
2004). Filopodia stabilization might result from a binding of FL-XXI and Trunc-XXI to integral 
membrane proteins creating an adherent force between the plasma membrane and intrafilopodial 
actin thereby preventing coalescence of neighboring filopodia. As trypanosomatids only possess a 
single flagellum, prevention of the merging of membrane protrusions is not a potential function of 
myosin-XXI in L. donovani. Instead, by forming an interlink between actin and cellular membranes 
myosin-XXI might be involved in the actin-mediated tethering of subpellicular microtubules to the 
L. donovani plasma membrane proposed by Sahasrabuddhe et al. (2004). 
In fact, further indications on an interaction of myosin-XXI with membrane components are provided 
by the strong resemblance of the cellular localization patterns of FL-XXI and Trunc-XXI with the 
PI(4,5)P2 distribution in NIH-3T3 cells. Considering the fact that myosin-XXI as well as PI(4,5)P2 are 
critical factors in flagellar development, an interplay of these two constituents in L. donovani appears 
to be probable. 
To summarize, results of mammalian cell transfections imply that myosin-XXI is potentially involved 
in the regulation of actin polymerization in L. donovani and that this regulatory function is mediated 
by the N-terminal 800 amino acids of the motor protein i.e. by the aa sequence referred to as 
Trunc-XXI. In addition, myosin-XXI could possibly play a role in the formation of actin bundles and 
interact with cellular membranes. Membrane interaction might amongst others be mediated by 
PI(4,5)P2. 
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5.2 Determination of Myosin Directionality in Gliding Filament Assays with 
Dual-Labeled Actin Filaments 
In the course of this work, based on a protocol published by Herm-Götz et al. (2002) a method for the 
determination of the directionality of actin-based motor movement was developed. After the 
formation of TRITC-labeled actin seeds, actin polymerization was limited to the pointed ends of 
filaments by the application of gelsolin capping protein. This way, actin monomers newly added to 
the seeds selectively bound to the minus end, which was then specifically labeled with the help of 
phalloidin-FITC. This procedure resulted in the formation of filamentous actin exhibiting a polar 
fluorescent labeling.  
Analysis of gliding filament assays with myosin-VI and HMM identified myosin-VI as minus end-
directed and HMM as plus end-directed motor protein agreeing with the literature (Huxley, 1969; 
Sheetz and Spudich, 1983; Wells et al., 1999) and thus demonstrating that the developed actin 
staining protocol is a useful tool for the determination of myosin directionality.  
In the case of gliding filament assays with dual-labeled actin filaments driven by full-length 
myosin-XXI, evaluation of TIRF microscopy records revealed that myosin-XXI is a plus end-directed 
actin-based motor protein. This finding coincides with the current state of knowledge that myosin-VI 
is the only native myosin moving along filamentous actin in a minus end-directed fashion 
(O´Connell et al., 2007). 
It is noteworthy that in L. donovani, existence of a trypanosomatid actin species has been 
demonstrated but that this actin species was only found to form granules, patches, or filaments and 
bundles of small length (Sahasrabuddhe et al., 2004; Kapoor et al., 2008). The existence of a complex 
actin network as formed in higher eukaryotic cells has so far not been reported (Rodrigues et al., 
2014). Accordingly, directed movement along filamentous actin was demonstrated not to play a 
major role for myosin-XXI to reach its cellular localizations (Katta et al., 2009). In L. donovani 
promastigotes, myosin-XXI was found to be sparsely distributed in the cytoplasm and to be 
concentrated in the proximal region of the flagellum and along the proximal length of the 
paraflagellar rod (Katta et al., 2009). Myosin-XXI detected at the flagellar base was found to be stably 
attached to this region via its tail domain (Katta et al., 2009) most probably leaving the myosin head 
free to rotate. Hence, on the basis of their findings indicating the necessity of actomyosin-based 
transport for the formation of a flagellum, Katta et al. (2010) proposed a model in which this 
stationary myosin-XXI subpopulation propels actin-bound cargo into or out of the flagellum. In this 
scenario, the demonstrated plus end-directed movement of myosin-XXI along F-actin could possibly 
play a role in determining the direction of cargo transport. 
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5.3 Myosin-XXI Binding to Phospholipid Bilayers 
 Myosin-XXI Binding to Planar Lipid Bilayers 5.3.1
In a previous study of our research group (Batters et al., 2014), myosin-XXI was found to be capable 
of binding actin filaments and of driving filament movement when associated with vesicular lipid 
bilayers. Additionally, in present transfection experiments fusion proteins of ZsGreen1 and FL-XXI or 
Trunc-XXI accumulated along the plasma membrane of HeLa and COS-7 cells. Therefore, the 
association of myosin-XXI with lipid bilayers was further investigated in the present work. In this 
context, myosin-XXI´s capability to associate with planar lipid bilayers was examined and dynamics of 
the bilayer-bound actin-myosin-XXI complex was aimed to be further elucidated. 
In experiments on both supported lipid bilayers and tethered lipid bilayers, it was observed that 
FL-XXI only bound to the sample surface in the presence of phospholipids shown to bind myosin-XXI. 
Therefore, it can be concluded that lipid binding was involved in the attachment of myosin-XXI. 
However, in FRAP experiments with eGFP-FL-XXI fusion protein incubated with supported lipid 
bilayers no 2D lateral diffusive movement of fusion protein was detected implying that myosin-XXI 
did not bind to the intact fluid part of the bilayer. Instead, observations made when FL-XXI and 
F-actin were incubated with bilayers indicate that myosin-XXI bound to immobile structures on the 
surface of the sample. As binding of FL-XXI to vesicular bilayers has successfully been implemented in 
our lab (see sections 4.6 and 4.7; Batters et al., 2014), lipid binding of myosin-XXI is most likely 
influenced by bilayer geometry. Probably, myosin-XXI incubated with planar lipid bilayers bound to 
phospholipids at areas of bilayer discontinuities where positive bilayer curvature occurs (Figure 54). 
Noteworthily, several proteins like α-synuclein, apolipoprotein A-1, negative factor, and sorting nexin 
1 which bind to bilayers in a curvature-dependent manner have already been shown to be capable of 
deforming membranes (Wetterau and Jonas, 1982; Davidson et al., 1998; Kurten et al., 2001; 
Carlton et al., 2004; Gerlach et al., 2010; Varkey et al., 2010). Thus, it is possible that myosin-XXI does 
not passively bind to regions of positive bilayer curvature but actively induces these binding sites. In 
subsection 5.3.4 geometrical aspects of bilayer binding by myosin-XXI will be discussed in further 
detail.  
In agreement with the observations described above, formation of supported planar lipid bilayers 
from solutions containing vesicles and FL-XXI was not observed unless FL-XXI concentration was very 
low. Accordingly, bilayer formation only occurs when vesicles are associated with minor amounts of 
protein. This inhibitory effect of FL-XXI could result from a curvature stabilizing function of bilayer-
associated myosin comparable to the curvature stabilizing action of sorting nexin 1 (Carlton et al., 
2004), endophilin A1 (Farsad et al., 2001), or the syndapin 1 BAR domain (Ramesh et al., 2013). 
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However, it cannot be ruled out that the absence of bilayer formation was caused by the prevention 
of vesicle attachment to the glass surfaces of flow cells due to the presence of myosin-XXI. 
Interestingly, myosin-XXI immobilized on planar bilayer-covered surfaces despite being capable of 
binding F-actin does not induce gliding of filaments. Since FL-XXI was found to propel filamentous 
actin when bound to lipid vesicles (see section 4.6; Batters et al., 2014), absence of myosin-XXI 
motility in planar bilayer samples is most probably caused by steric hindrance. 
 
 
Figure 54 Illustration of discontinuities of supported and tethered planar lipid bilayers. At discontinuities of supported (A) 
and tethered (B) planar lipid bilayers, hydrophobic tails of the lipid molecules are shielded from the aqueous environment 
by the formation of curved bilayer edges. These curved regions might provide binding sites for curvature sensitive lipid 
binding proteins. 
 
 Myosin-XXI Binding to Vesicles 5.3.2
As described in the preceding subsection, the incapability of myosin-XXI to bind to planar lipid 
bilayers indicates that bilayer curvature might represent a crucial factor for the attachment of 
myosin-XXI. Consistently, studies of our research group have shown that FL-XXI binds vesicular 
bilayers of bovine brain extract and actually induces actin filament gliding in a vesicle-bound state 
(Batters et al., 2014). 
In the course of the present work, co-sedimentation assays and gliding filament assays on surfaces 
covered with unilamellar vesicles confirmed the previous finding of myosin-XXI binding to bovine 
brain extract, PI(4)P, and PI(3,5)P2, and verified the utilized FL-XXI samples to be functional in respect 
of lipid binding. The observed binding of FL-XXI to vesicle-incorporated PI(4)P and PI(3,5)P2 was in 
line with previously published findings obtained with the help of membrane lipid strips (Batters et al., 
2014). In addition, the present negative control experiments demonstrated that in the absence of 
myosin-XXI binding phospholipids, FL-XXI does not bind to vesicle-covered surfaces. Hence, filament 
gliding observed on vesicles containing myosin-XXI binding phospholipids was in fact driven by lipid-
bound FL-XXI. 
Overall, the verification of FL-XXI binding to vesicular lipid bilayers provides further evidence for a 
curvature dependence of the lipid bilayer binding capability of myosin-XXI. 
Additionally, vesicle-based gliding assays demonstrated that lipid-bound FL-XXI is capable of 
efficiently propelling filamentous actin and that the lipid-bound state of myosin-XXI seems to be of 
advantage for driving filament movement: in the present experiments, the average gliding speed of 
F-actin on vesicles containing 4.8 mol% PI(3,5)P2 was observed to be 3.5 times higher than the 
previously published speed of filament gliding on nitrocellulose-coated surfaces (18±3 nm/s (mean ± 
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s.d.; Batters et al., 2014)). Accordingly, the present finding coincides with the previously reported 
enhanced motility of myosin-XXI when bound to bovine brain extract vesicles. 
Furthermore, co-sedimentation assays with unilamellar vesicles composed of bovine brain extract, 
Rhodamine DHPE, and Biotin DHPE and fusion proteins of eGFP and several myosin-XXI constructs 
revealed differing capabilities of FL-XXI and the respective myosin-XXI fragments to bind vesicular 
bovine brain extract bilayers and thus indicated a potential influence of intermolecular interactions 
on myosin-XXI-lipid binding (Figure 55). 
In agreement with published results (Batters et al., 2014), FL-XXI, Trunc-XXI, XXI-830 Tail, and 
XXI-930 Tail were observed to bind to bovine brain extract vesicles in the present study. 
However, fusion constructs of the myosin-XXI converter domain (XXI-Conv. WT, XXI-Conv. M) did not 
exhibit any binding in the present experiments. As the myosin-XXI PX domain is the only lipid binding 
domain so far identified within the respective amino acid sequence (aa 600-758; Batters et al., 2014), 
this observation might imply that the binding of myosin-XXI to bovine brain extract does not involve 
the PX domain. Otherwise, similar to PX domains of other proteins, functionality of the myosin-XXI PX 
domain might depend on intramolecular or intermolecular interactions (Seaman and Williams, 2002; 
Ago et al., 2003) and these interactions might not be promoted by the converter constructs or the 
experimental settings. 
In previous binding tests using membrane lipid strips, unlabeled myosin-XXI converter constructs 
exhibited strong binding affinities for several phosphoinositides including PI(4)P (Batters et al., 2014). 
In addition, the wild-type construct was detected to bind phosphatidylserine in these tests. 
Accordingly, as bovine brain extract contains phosphatidylserine as its major constituent and further 
contains phosphatidylinositol including phosphorylated forms like PI(4)P (Low, 1990), detection of a 
binding reaction between bovine brain extract vesicles and XXI-Conv. WT or XXI-Conv. M might be 
expected. The absence of an association of the myosin-XXI converter constructs with bovine brain 
extract vesicles observed in the present study might therefore result from differences in the applied 
experimental approaches. In membrane lipid strip tests, unlabeled proteins were used while in the 
present experiments, fluorescently labeled converter constructs were investigated. As shown by our 
research group, presence of a fluorophore label can induce dimerization of myosin-XXI constructs, 
which in turn severely impairs lipid binding (Batters et al., 2014). Thus, the incapability of 
XXI-Conv. WT and XXI-Conv. M to bind to vesicular bovine brain extract bilayers in the present study 
might result from the presence of the eGFP label. 
It should be mentioned that the results of vesicle binding experiments and membrane lipid strip tests 
have been reported to occasionally differ. This variability is presumed to arise from the different 
geometrical arrangements of the binding partners in the two experimental set-ups (Cozier et al., 
2002; Zhan et al., 2002; Seet and Hong, 2006). 
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Figure 55 Lipid binding domains of myosin-XXI constructs tested in co-sedimentation and SLiC assays. The above scheme 
summarizes the lipid binding domains contained in the myosin-XXI constructs tested in the present co-sedimentation and 
SLiC assays. Respective lipid binding sites of myosin-XXI had been identified in a previous study of our lab (Batters et al., 
2014). They comprise a PX domain and several potential lipid binding motifs exhibiting a BHB sequence. BHB regions in the 
top row had been determined by calculation of a basic and hydrophobic score, BHB regions in the bottom row had been 
deduced from sequence analysis. In the present study, co-sedimentation assays were carried out to test all of the 
myosin-XXI constructs depicted above for their capability to bind to bovine brain extract vesicles. The asterisk above the 
scheme of the mutated myosin-XXI converter construct (XXI-Conv. M) indicates the position of the respective PX domain 
mutation. Co-sedimentation experiments showed that FL-XXI, Trunc-XXI, XXI-830 Tail, and XXI-930 Tail bound to the 
respective vesicles. With the help of SLiC assays, the latter fusion proteins were then investigated for curvature sensitive 
bilayer binding. 
 
Similar to XXI-Conv. WT and XXI-Conv. M, XXI-809 Tail did not display binding to bovine brain extract 
vesicles in the present study. Again, this might be caused by the presence of the fluorescent label. 
However, it is conceivable that XXI-809 Tail represents a myosin-XXI fragment incapable of binding to 
vesicular bilayers. Noteworthily, a dependency of the vesicle binding capability on the protein 
architecture flanking a lipid binding site has for example already been demonstrated for the 
centaurin β2 BAR domain (Peter et al., 2004) and the amphipathic helix motif of nucleoporin 133 
(Doucet et al., 2015): in the case of the centaurin β2 BAR domain, the presence of the adjacent PH 
domain significantly enhanced vesicle binding; in the case of the nucleoporin 133 amphipathic helix, 
the efficiency of vesicle binding was markedly reduced in the absence of the spatial constraint by the 
beta-propeller domain surrounding this motif. Accordingly, to be capable of binding to vesicular 
bilayers the XXI-809 Tail construct might require the presence of N-terminal structural myosin-XXI 
motifs. Since XXI-830 Tail was found to bind to bovine brain extract vesicles, in the absence of the 
N-terminal part of myosin-XXI the region of aa 809 to aa 829 possibly influences lipid binding sites 
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within the tail, for example by forming intramolecular bonds resulting in a change of the protein´s 
conformation. 
Overall, vesicle-based experiments performed in the present work clearly show that myosin-XXI and 
specific fragments of the motor protein are capable of associating with curved lipid bilayers. 
Together with the demonstrated incapability of myosin-XXI to bind to lipid bilayers of planar 
geometry, these findings strongly indicate a curvature-dependent bilayer association of myosin-XXI. 
Consequently, in the next step binding of myosin-XXI to curved bilayer surfaces was further 
investigated with the help of Single Liposome Curvature assays. 
 
 Investigation of Curvature Sensitivity in Single Liposome Curvature Assays 5.3.3
Single Liposome Curvature assays have been demonstrated to be a highly sensitive tool for the 
detection of a protein´s preference for curved bilayer geometries (Bhatia et al., 2009; Hatzakis et al., 
2009; Madsen et al., 2010; Larsen et al., 2015). 
In order to analyze SLiC assays, an image processing routine was established and verified with the 
help of samples of immobilized dual-labeled vesicles. Furthermore, size calibration measurements 
were performed to enable the determination of vesicle diameters. Subsequently, negative and 
positive control experiments were carried out. 
DiO surface densities derived from assays with dual-labeled vesicles and calculated calibration factors 
were found to display variations within an order of magnitude. Similarly, Larsen et al. (2011) had 
detected the surface density of a fluorescent dye in dual-labeled vesicular bilayers to exhibit 
variations of up to an order of magnitude and assigned this effect to an inhomogeneous distribution 
of lipid species and dyes inevitable in the vesicle preparation process. Accordingly, results of 
calibration measurements and control experiments with Rhodamine DHPE/DiO-labeled vesicles lie 
within a reasonable range thus verifying the suitability of the image analysis procedure developed in 
the course of this work. Importantly, the inhomogeneous distribution of lipids and dyes during 
vesicle preparation only causes an uncertainty in the size determination of lipid vesicles via 
fluorescence measurements by confocal microscopy but does not introduce any bias (Larsen et al., 
2011). Hence, the use of an average calibration factor for vesicle size determination is legitimate and 
used as standard method in the evaluation of SLiC assays (Kunding et al., 2008; Bhatia et al., 2009; 
Hatzakis et al., 2009; Madsen et al., 2010; Larsen et al., 2015). 
SLiC assays with Alexa Fluor® 488-conjugated streptavidin, which has been proven to represent a 
suitable negative control (Hatzakis et al., 2009; Larsen et al., 2015), yielded a protein surface density 
curve resembling the DiO density curve derived from assays with dual-labeled vesicles. The 
respective Alexa Fluor® 488 streptavidin surface density increase was found to be 12.9-fold, again 
lying within the range of signal fluctuation considered to be reasonable. Thus, usage of Alexa 
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Fluor® 488 streptavidin as a negative control was justified, and once again the developed analysis 
method was verified. 
Finally, as a positive control a fusion protein of eGFP and eNBAR was investigated in SLiC assays. In 
agreement with published data (Bhatia et al., 2009), eNBAR exhibited an increase in surface density 
of the order of two magnitudes. The divergence in signal increase between published results 
(approximately 100-fold; Bhatia et al., 2009) and data obtained in the present study (approximately 
130-fold) is most probably caused by differences in the image analysis procedure. 
 
 Curvature Sensitivity of FL-XXI and Myosin-XXI Fragments 5.3.4
As discussed before, experiments investigating the binding of myosin-XXI to planar and vesicular lipid 
bilayer systems repeatedly indicated a membrane curvature sensitivity of myosin-XXI. In order to 
elucidate this issue, SLiC assays with fusion constructs of eGFP and FL-XXI, Trunc-XXI, XXI-930 Tail, or 
XXI-830 Tail were performed (Figure 55). 
Trunc-XXI, XXI-930 Tail, and XXI-830 Tail were found to clearly exhibit MCS, preferentially binding 
vesicles of small diameter, i.e. of high positive curvature. With a surface density increase of a factor 
of approximately 190 upon binding to small vesicles, Trunc-XXI was identified as the strongest sensor 
of curvature among the fusion proteins tested. Signal increases observed for myosin-XXI tail 
constructs were approximately 110-fold (XXI-930 Tail) and 130-fold (XXI-830 Tail) respectively. In the 
case of FL-XXI, results only exhibited a tendency toward membrane curvature sensitivity. Due to the 
low efficiency of the FL-XXI-vesicle binding reaction, which was also observed in co-sedimentation 
assays (see section 4.7), analysis of SLiC assays with FL-XXI fusion protein generated only a limited 
number of data points. Nevertheless, a surface density increase of a factor of almost 60 when 
binding to vesicles of small diameter strongly indicates a capability of sensing curvature.  
Interestingly, analysis of SLiC assays with Trunc-XXI yielded a sufficient number of data points 
although Trunc-XXI concentration (7 nM) in SLiC assay samples was almost 10-fold lower than FL-XXI 
concentration (64 nM). Moreover, Trunc-XXI binding to bovine brain extract vesicles was observed to 
be even less efficient than FL-XXI binding in co-sedimentation assays (see section 4.7). This 
discrepancy might result from the effect of fractional binding: as described in Bhatia et al. (2009) and 
Madsen et al. (2010), due to a yet unidentified mechanism binding of certain proteins to vesicular 
bilayers exhibits a high temporal heterogeneity. Even for vesicles of the same diameter, binding of 
these proteins occurs at different points in time varying by several minutes to hours. Thus, 
depending on the incubation time a certain fraction of vesicles might not be associated with any 
protein. Since incubation times of protein-lipid mixtures in SLiC assays and in co-sedimentation 
assays varied sixfold, enhanced Trunc-XXI binding to bovine brain extract vesicles observed in SLiC 
assays might be caused by pronounced fractional binding.  
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Another interesting outcome of SLiC assays with Trunc-XXI fusion protein was that vesicles of a 
diameter larger than 350 nm did not bind this protein with surface densities above threshold level. 
Thus, due to the marked preference of Trunc-XXI for associating with small vesicles, interaction with 
vesicles of diameters above 350 nm was considerably limited. The fact that such a pronounced 
reduction in protein surface density at high vesicle diameters was not observed for any other of the 
fusion proteins investigated corresponds well with the identification of Trunc-XXI as the strongest 
sensor of bilayer curvature among the tested proteins. 
The curvature sensing capability of FL-XXI and myosin-XXI fragments demonstrated in the present 
work can be explained by the nature of the actual and potential lipid binding sites identified within 
the myosin-XXI sequence. According to previous research of our lab (Batters et al., 2014), myosin-XXI 
contains a PX domain and several basic-hydrophobic-basic regions, i.e. patches of hydrophobic amino 
acids surrounded by basic residues (Figure 55). Such BHB sequences, which potentially bind to lipid 
membranes by a combination of electrostatic attraction and bilayer penetration by hydrophobic side 
chains, are located within the Trunc-XXI construct as well as within XXI-930 Tail and XXI-830 Tail. 
According to a model proposed by Hatzakis et al. (2009), membrane binding by the insertion of 
hydrophobic moieties is always associated with a sensitivity for positive curvature, as bilayer 
penetration is dependent on the presence of lipid packing defects and the surface density of packing 
defects increases with increasing positive bilayer curvature. Therefore, bilayer binding by myosin-XXI 
via BHB motifs is expected to exhibit MCS. Noteworthily, structural and lipid binding studies of the PX 
domains of NADPH oxidase and Bem1p indicated that the interaction of at least certain PX domains 
with lipid membranes involves the insertion of hydrophobic amino acids as well (Bravo et al., 2001; 
Stahelin et al., 2003, 2007). Therefore, the myosin-XXI PX domain might also contribute to the 
regulation of bilayer association by geometric aspects. However, if the myosin-XXI PX domain does 
not exhibit curvature sensitivity, the additional presence of curvature-dependent BHB lipid binding 
sites might regulate PX domain-bilayer binding by imposing a geometric constraint thus further 
specifying target membranes of myosin-XXI. In fact, coincidence detection of distinct membrane 
properties like lipid composition, charge, or curvature by cooperating lipid binding motifs is a 
mechanism assumed to be employed by a variety of membrane binding proteins and has already 
been demonstrated to regulate the interaction of sorting nexin 1 with endosomal membranes 
(Carlton and Cullen, 2005; Carlton et al., 2004). 
The detection of curvature-dependent bilayer binding by Trunc-XXI as well as by XXI-830 Tail and 
XXI-930 Tail proves that myosin-XXI contains at least two distinct lipid binding motifs capable of MCS. 
In the case of myosin-Ia, Mazerik and Tyska (2012) identified two spatially separated BHB lipid 
binding sites involved in myosin-Ia enrichment at microvillar membranes, and hypothesized that the 
existence of multiple lipid binding domains might represent an adaptation to the myosin chemo-
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mechanical cycle. Depending on the respective conformational state of myosin-Ia, membrane 
association might primarily be mediated by either one of the two binding sites. Regarding 
myosin-XXI, observations made during gliding filament assays on vesicle-covered surfaces and 
published data (Batters et al., 2014) demonstrated that myosin-XXI is capable of exhibiting ATPase 
activity when bound to phospholipid vesicles. Thus, it is possible that the existence of multiple 
curvature sensitive lipid binding motifs in myosin-XXI too represents a mechanism to stably bind the 
motor protein to membranes throughout its ATPase cycle, in this case explicitly to membranes of 
positive curvature. 
In addition, MCS of myosin-XXI raises the question whether this motor protein by itself is capable of 
inducing curvature, i.e. of deforming lipid membranes, particularly as membrane shaping by myosins 
is so far assumed to result from pulling forces caused by the movement of membrane-bound motor 
proteins along the actin cytoskeleton (Farsad and De Camilli, 2003; Anitei and Hoflack, 2011). To 
date, even though several proteins have been reported to display coincident curvature sensing and 
induction (Wetterau and Jonas, 1982; Davidson et al., 1998; Kurten et al., 2001; Carlton et al., 2004; 
Gerlach et al, 2010; Varkey et al., 2010), the question if curvature sensitivity is always associated with 
a capability to deform membranes is still under debate (e.g. Zimmerberg and Kozlov, 2006; 
Arkhipov et al., 2009; Bhatia et al., 2009; Madsen et al., 2010). In the present experiments 
investigating whether FL-XXI binds to planar lipid bilayers, FL-XXI was found to be immobilized on 
bilayer-covered surfaces in the presence of myosin-XXI binding phospholipids thus indicating the 
possibility of membrane pore formation by myosin-XXI. However, as SLiC assays demonstrated that 
FL-XXI favors positively curved bilayers, pore formation by FL-XXI appears to be rather unlikely as it 
involves impression of the bilayer, i.e. generation of negative curvature. Hence, further investigations 
will be required to clarify if myosin-XXI is capable of modulating membrane shape.  
In transfection experiments, HeLa and COS-7 cells expressing a fusion protein of ZsGreen1 and FL-XXI 
or Trunc-XXI were found to display protein accumulations along the proximal part of the plasma 
membrane and at the distal ends of filopodia. Due to the preferred association of FL-XXI and 
Trunc-XXI with bilayers of positive curvature, i.e. with convex membrane surfaces, direct binding of 
FL-XXI and Trunc-XXI to the plasma membrane along the cell body or at filopodia tips is highly 
improbable as the respective membrane surfaces exhibit virtually no curvature (along the cell body) 
or a concave shape (at filopodia tips). In fact, atomistic simulation calculations have shown that the 
number and size of membrane defects required for hydrophobic insertion, which in the case of 
FL-XXI and Trunc-XXI is expected to be involved in membrane binding, severely decreases with 
decreasing membrane curvature thus strongly impeding membrane penetration (Cui et al., 2011). 
Therefore, localization of FL-XXI and Trunc-XXI in the vicinity of the plasma membrane might be 
mediated by an interaction of myosin-XXI with membrane-associated proteins or might not be 
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physically linked to the plasma membrane surface. Further, curvature dependency of the myosin-XXI-
bilayer binding reaction implies a high probability of FL-XXI and Trunc-XXI association with lipid 
vesicles, e.g. PI(4,5)P2-enriched vesicles travelling to the tips of filopodia. 
 
 Conclusions on Membrane Binding by Myosin-XXI in L. donovani 5.3.5
When lipid binding by myosin-XXI was first investigated in our lab (Batters et al., 2014), membrane 
lipid strip tests revealed that FL-XXI binds to various phospholipids including several 
phosphoinositides like PI(4)P, PI(4,5)P2, or PI(3,5)P2, and that FL-XXI does not display any specificity 
for a particular lipid. Consequently, the question arose how myosin-XXI is targeted to distinct cellular 
membranes within L. donovani.  
In the present study, SLiC assays with fusion proteins of eGFP and FL-XXI, Trunc-XXI, XXI-930 Tail, or 
XXI-830 Tail demonstrated a property of myosin-XXI which regulates the motor protein´s attachment 
to lipid bilayers according to bilayer geometry: membrane curvature sensitivity. Due to this 
sensitivity for membrane shape, myosin-XXI is directed to highly convex cellular membranes, e.g. 
vesicular compartments. In agreement with this, myosin-XXI was shown to be crucial for endocytosis, 
exocytosis, and intracellular trafficking in L. donovani promastigotes (Katta et al., 2010). In fact, MCS 
might even be a critical factor for the recruitment of myosin-XXI to sites of endocytosis and for the 
motor protein´s stable association with vesicular cargo.  
In addition to a geometrical constraint, MCS also allows for the regulation of myosin-XXI localization 
by variations in the lipid composition of membranes. Curvature-dependent bilayer binding by 
myosin-XXI is expected to be mediated by hydrophobic insertion, which is a process depending on 
the presence of lipid packing defects (Hatzakis et al., 2009) and hence can be modulated by the 
molecular shape of the lipids contained in the bilayer. Accordingly, lysophospholipids, which exhibit a 
conical shape with the cross-sectional area of the head exceeding the one of the hydrophobic tail 
region, reduce the occurrence of lipid packing defects thus impeding insertion of hydrophobic 
moieties. In fact, lysophospholipids have been shown to prevent folding of the amphipathic helix of 
phosphocholine cytidylyltransferase into the bilayer of synthetic vesicles (Davies et al., 2001). In 
L. donovani, preconditions for a lysophospholipid-mediated control of myosin-XXI localization 
potentially exist as lyso-PI has been shown to be a constituent of the parasite´s membranes 
(Kaneshiro et al., 1986). 
The observation that Trunc-XXI as well as XXI-930 Tail and XXI-830 Tail display curvature-dependent 
vesicle binding demonstrates that at least two spatially separated lipid binding sites capable of MCS 
exist within the myosin-XXI sequence. As gliding filament assays on vesicle-covered surfaces proved 
that FL-XXI efficiently propels F-actin in a membrane-bound state, it is conceivable that the presence 
of multiple lipid binding sites adapted to the attachment to convex membrane surfaces sustains the 
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stability of myosin-XXI association with vesicles during conformational changes throughout the 
myosin chemo-mechanical cycle. Such a stabilizing effect might actually be important for myosin-XXI-
mediated transport processes which have been shown to be critical for endocytosis, exocytosis, 
intracellular trafficking, and flagellum assembly in the parasite (Katta et al., 2010). 
However, independent from the underlying mechanism a stable membrane attachment of myosin-
XXI throughout its ATPase cycle, which was indicated by the observation of effective actin filament 
movement by vesicle-bound FL-XXI, could enable myosin-XXI to transport membrane patches to the 
flagellum during flagellar elongation as hypothesized by Katta et al. (2010). 
Summarizing, investigation of the bilayer binding behavior of FL-XXI and myosin-XXI fragments by 
demonstrating MCS of multiple lipid binding domains within the myosin-XXI sequence revealed how 
the localization of myosin-XXI might be regulated in the parasite and how stable membrane 
attachment of the motor throughout its chemo-mechanical cycle might potentially be achieved. 
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6 Summary, Conclusions and Future Perspectives 
The aim of the present study was to further elucidate the molecular bases of the physiological 
function of L. donovani myosin-XXI. This myosin plays an important role in the parasite as it is a 
multifunctional motor protein essential for survival. It mediates actin-based transport processes 
critical for endocytosis, exocytosis, vesicle transport, and flagellum formation (Katta et al., 2010). In 
the following chapter, general conclusions derived from in vivo and in vitro experiments will be 
summarized, and their importance for myosin-XXI functionality in L. donovani will be outlined. 
Additionally, potential future scientific perspectives will be proposed. 
 
6.1 Directionality of Myosin-XXI Translocation along F-Actin 
In the present work, using gliding filament assays the direction of myosin-XXI translocation along 
filamentous actin was determined for the first time. For this purpose, a novel protocol for the polar 
fluorescent labeling of F-actin was developed. Gliding filament assays with molecular motors of 
known directionality, namely HMM and myosin-VI, proved the developed labeling method to be 
suitable for the determination of myosin directionality, and thus to be favorable for future use in our 
laboratory. The application of dual-labeled F-actin in gliding filament assays based on myosin-XXI 
revealed that myosin-XXI is a plus end-directed cytoskeletal motor, a finding which coincides with the 
present state of knowledge that, with the exception of myosin-VI, myosins move along F-actin in a 
plus end-directed fashion (O´Connell et al., 2007). 
 
6.2 Functionality and Cellular Localization of Myosin-XXI 
In order to explore myosin-XXI functionality and cellular localization in in vivo systems devoid of 
endogenously expressed myosin-XXI, mammalian cell transfection experiments were performed. 
Cells were transfected with vectors encoding fusion constructs of a fluorophore and myosin-XXI or a 
myosin-XXI fragment to characterize the full-length motor protein as well as distinct protein 
domains. 
Overall, fluorescent myosin-XXI fusion proteins were detected at one or several of the following 
cellular localizations: homogeneously distributed throughout the cytoplasm with frequent nucleus 
staining, in clusters and spherical structures within the cytoplasm, in dot-like accumulations along 
the plasma membrane, and within filopodia. The most striking cellular distribution was observed for 
FL-XXI and Trunc-XXI as they were the only fusion proteins capable of localizing at the plasma 
membrane and in filopodia. Phalloidin-TRITC staining of the actin cytoskeleton revealed that FL-XXI 
and Trunc-XXI colocalized with the filopodial actin core. Both myosin-XXI constructs contain the 
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SH3-like domain, the complete motor domain, and the neck and tail region of aa 748 to aa 800. This 
region comprises an IQ motif, a dimerization site, and three lipid binding sites. 
The necessity of the full myosin head domain for FL-XXI and Trunc-XXI to reach the tips of filopodia 
led to the conclusion that these fusion proteins most probably employ their own motor power to 
actively move along the filopodial actin core. Consistently, vesicle-based gliding filament assays 
demonstrated that myosin-XXI is capable of translocating along F-actin with an average speed of 
63.0 nm/s, i.e. faster than rearward actin flow and filopodial actin assembly. Thus, myosin-XXI is 
capable of reaching the distal ends of filopodia and of maintaining its position at the filopodia tips. 
In order to actively translocate along actin filaments, myosin-XXI has to perform processive 
movement. The observation that FL-XXI and Trunc-XXI were the only tested myosin-XXI constructs 
containing the motor domain that localized within filopodia indicated that the SH3-like domain and 
the above-mentioned neck and tail region of aa 748 to aa 800 are necessary for processive motility of 
myosin-XXI. Considering the previously published finding of our lab (Batters et al., 2014) that 
dimerization forces myosin-XXI into an immotile state, dimer formation could be ruled out to be 
involved in processive movement. Instead, requirement of the neck and tail region of aa 748 to 
aa 800 can be explained by the previously demonstrated regulatory effect of the myosin-XXI IQ motif 
(aa 754-769), which inhibits dimerization of myosin-XXI by associating with calmodulin or calmodulin-
like proteins (Batters et al., 2014). The necessity of a monomeric myosin-XXI conformation implies 
that in order to move processively, FL-XXI and Trunc-XXI form arrays of myosin molecules bound to 
cargo. This hypothesis is in line with the present finding that a minimum tail segment is required for 
myosin-XXI constructs to reach the tips of filopodia. The observation that the N-terminal SH3-like 
domain is essential for the translocation of myosin-XXI fusion proteins as well, led to the conclusion 
that the SH3-like domain might mediate intramolecular interactions maintaining the motor proteins 
in a conformation suitable for processive motility. 
The filopodial localization pattern of FL-XXI and Trunc-XXI observed in the present study strongly 
resembles cellular localizations reported for PI(4,5)P2 and myosin-X (Berg and Cheney, 2002; 
Chierico et al., 2014), which are both proposed to be involved in processes regulating the generation, 
stabilization, or elongation of filopodia. According to this striking similarity, myosin-XXI is likely to 
have an impact on regulatory processes controlling the structure of filopodia. Indeed, live imaging of 
HeLa cells expressing either FL-XXI or Trunc-XXI revealed that both fusion proteins are capable of 
moving along intrafilopodial actin bundles, and of forming stable protein accumulations at the distal 
filopodia ends. In fact, translocation of FL-XXI and Trunc-XXI from the tips of these membrane 
protrusions to the cell body could clearly be observed by confocal microscopy. The evaluation of live 
images showed that FL-XXI and Trunc-XXI accumulations at filopodia tips, i.e. at sites of actin 
polymerization, were capable of persisting during phases of filopodia length changes. Further, 
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average filopodia extension and retraction rates of transfected HeLa cells were found to depend on 
the expressed fusion protein. Overall, these findings hint toward an influence of myosin-XXI on 
filopodial actin dynamics and thus on the assembly of actin-based membrane protrusions. 
The latter conclusion was subsequently further confirmed by the results obtained from the analyses 
of filopodia lengths and densities in HeLa and COS-7 cells transfected with FL-XXI or Trunc-XXI. 
Expression of either myosin-XXI fusion protein resulted in a significant increase in average filopodia 
length, and this increase was found to be related to the presence of fusion protein accumulations 
within the distal ends of membrane protrusions. Hence, it may be concluded that myosin-XXI 
promotes actin assembly at filopodia tips, for example by delivering cargo facilitating actin 
polymerization. The different extent of filopodial elongation induced by FL-XXI and Trunc-XXI 
demonstrated that the myosin-XXI tail region C-terminal of aa 800 is not critical for the elongation 
process yet it increases the efficiency of the underlying mechanism. In addition to an increase in 
average length, the average number of filopodia per membrane circumference was also found to be 
enhanced in FL-XXI- and Trunc-XXI-transfected mammalian cells. Thus, myosin-XXI either initiates 
filopodia formation, e.g. by bundling actin filaments, or stabilizes already existing membrane 
protrusions, for instance by contributing to adhesion forces between actin and constituents of the 
plasma membrane. Alternatively, cargo transport by myosin-XXI might support the supply with 
components required for filopodia generation or stabilization. 
In summary, the results of mammalian cell transfection experiments provide strong evidence for a 
significant impact of myosin-XXI and myosin-XXI-mediated transport on the assembly of actin within 
membrane protrusions. Further research may identify constituents that interact with myosin-XXI 
throughout the related cellular processes. 
 
6.3 Myosin-XXI Binding to Planar Lipid Bilayers 
As previous studies of our research group (Batters et al., 2014) had revealed the existence of multiple 
lipid binding sites within myosin-XXI and had proven the capability of vesicle-attached myosin-XXI to 
drive gliding of F-actin, the present study aimed to further investigate the dynamic behavior of the 
bilayer-bound actin-myosin-XXI complex. To circumvent spatial constraints due to the limited size of 
vesicles, the present experiments were performed using supported and tethered planar lipid bilayers. 
Additionally, investigation of actomyosin association with planar lipid bilayers was intended to clarify 
whether myosin-XXI was potentially capable of binding to the plasma membranes of transfected 
mammalian cells, thus providing a possible explanation for the observed dot-like accumulations of 
FL-XXI and Trunc-XXI along the plasma membranes of HeLa and COS-7. 
However, when incubated with planar lipid bilayers neither the actin-myosin-XXI complex nor 
myosin-XXI alone attached to the intact fluid part of the applied bilayers. This effect was independent 
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of lipid composition and buffer conditions. Conversely, when myosin-XXI functionality was examined 
in gliding filament assays on vesicle-covered surfaces, myosin-XXI could successfully be bound to 
vesicular lipid bilayers and furthermore propelled subsequently added filamentous actin. These 
observations led to the presumption that bilayer curvature might be a regulatory factor in 
myosin-XXI-membrane association. In order to test this hypothesis, fluorescently labeled full-length 
myosin-XXI and myosin-XXI fragments were subjected to SLiC assays, once their capability to bind to 
bovine brain extract vesicles had been tested in co-sedimentation assays. 
 
6.4 Myosin-XXI Binding to Curved Lipid Bilayers 
In agreement with previous findings (Batters et al., 2014), co-sedimentation assays performed in the 
present study demonstrated that fluorescently labeled FL-XXI, Trunc-XXI, XXI-930 Tail, and 
XXI-830 Tail associated with vesicles prepared from bovine brain extract. In contrast, fluorescent 
XXI-Conv. WT and XXI-Conv. M were found not to attach to the applied vesicles despite the fact that 
the unlabeled myosin-XXI converter constructs had previously been shown to bind lipid constituents 
of bovine brain extract. Hence, it is very likely that the eGFP label of the converter constructs used in 
the present experiments inhibited lipid binding. In fact, fluorophore-related inhibition of lipid binding 
had previously been observed for an RFP-labeled myosin-XXI tail construct and could be assigned to 
the induction of dimer formation (Batters et al., 2014). In co-sedimentation assays with XXI-809 Tail, 
no attachment of fusion protein to vesicles was detected. Apart from a potential influence of the 
fluorescent label, it might be assumed that the presence of the aa stretch of residues 809 to 829 
hindered the association with vesicular bilayers. Considering the demonstrated vesicle binding 
capability of XXI-830 Tail, it is conceivable that in the absence of the N-terminal parts of myosin-XXI, 
aa 809 to aa 829 affect tail-located lipid binding sites, for example due to intramolecular interactions. 
In SLiC assays, FL-XXI, Trunc-XXI, XXI-930 Tail, and XXI-830 Tail were entirely identified as 
sensors of positive bilayer curvature. Thereby, myosin-XXI is the first myosin demonstrated to exhibit 
a capability to sense the curvature of lipid bilayers. Surface densities of vesicle-bound myosin-XXI 
constructs were found to display ~60-fold (FL-XXI), ~190-fold (Trunc-XXI), ~110-fold (XXI-930 Tail), 
and ~130-fold (XXI-830 Tail) increases for small, i.e. highly curved, vesicles relative to vesicles of the 
reference size. It should be mentioned that for assays with FL-XXI, the low efficiency of the FL-XXI-
vesicle binding reaction resulted in the generation of a comparably small number of data points, 
which in turn potentially masks the full extent of the curvature sensitivity of full-length myosin-XXI. 
The present observation of curvature-dependent bilayer association of FL-XXI and the myosin-XXI 
fragments agrees with the types of lipid binding sites so far identified within the myosin-XXI 
sequence, namely a PX domain and multiple basic-hydrophobic-basic regions (Batters et al., 2014). 
For representatives of both classes of lipid binding motifs, experimental studies have shown that 
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membrane binding involves the insertion of hydrophobic residues into the lipid bilayer core 
(Stahelin et al., 2003, 2007; McLaughlin and Murray, 2005), a mechanism which is proposed to 
require positive membrane curvature (Hatzakis et al., 2009; Madsen et al., 2010; Cui et al., 2011). 
The demonstrated preference of myosin-XXI for bilayers of positive curvature also explains the motor 
protein´s incapability to bind to the applied supported and tethered planar bilayers. Additionally, it 
negates the possibility of a direct association of FL-XXI or Trunc-XXI with lipids contained in planar or 
concave cellular membranes. Thus, FL-XXI and Trunc-XXI detected in accumulations along the plasma 
membrane and in the filopodia tips of transfected mammalian cells were not bound to lipid 
constituents of the plasma membrane. Instead, these myosin-XXI constructs might associate with 
membrane proteins. The evident capability of Trunc-XXI and the tested myosin-XXI tail constructs to 
sense bilayer curvature proves that a minimum of two distinct curvature sensitive lipid binding 
domains exists within myosin-XXI. Since myosin-XXI drives filament movement in a vesicle-bound 
state, the presence of at least two such domains might guarantee the stability of the motor protein´s 
attachment to convex bilayer surfaces during the conformational changes inherent to the myosin 
chemo-mechanical cycle. 
Further clarification of the mechanisms regulating bilayer association of each individual lipid binding 
motif of myosin-XXI represents a promising future research objective possibly yielding information on 
how this motor protein is recruited to distinct cellular targets. In this context, a potential role of 
coincidence detection of distinct membrane properties like curvature and charge by separate lipid 
binding domains might be an interesting research focus. Additionally, as a relation between the 
sensing and the induction of bilayer curvature has been observed for several proteins 
(e.g. Kurten et al., 2001; Carlton et al., 2004; Gerlach et al., 2010), and as a functional coupling of 
these two processes is actually taken into consideration for certain lipid binding motifs 
(e.g. Zimmerberg and Kozlov, 2006; Madsen et al., 2010), a closer inspection of a potential 
membrane deforming activity of myosin-XXI is of great interest for future investigations. 
 
6.5 Functionality of Myosin-XXI in L. donovani 
In the present study, mammalian cell transfection experiments provided further insight into the 
function of myosin-XXI under physiological conditions. Unlike in L. donovani promastigotes, where 
myosin-XXI localization had been demonstrated to be exclusively mediated by the tail domain 
(Katta et al., 2009), targeting of myosin-XXI to distinct cellular locations in mammalian cells was 
shown to require the presence of the N-terminal parts of the motor protein (aa 1-800). Moreover, 
results of the present work indicate that the distribution of myosin-XXI within mammalian cells is 
related to processive actin-based movement of the molecular motor. Therefore, tail dependency of 
myosin-XXI localization within L. donovani cannot be assigned to a lack of processivity. Conversely, 
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the apparent absence of a complex actin cytoskeleton within the parasite (Rodrigues et al., 2014) can 
be concluded to be associated with the necessity of an alternative transport mechanism in which the 
tail domain links myosin-XXI to respective binding partners. Such a mechanism might involve 
microtubule-dependent kinesins or dyneins. 
The present transfection experiments further revealed that the respective N-terminal parts of 
myosin-XXI enable the motor protein to influence the structure of filopodia in mammalian cells. 
Analyses of live confocal images and of average filopodia lengths and densities indicated a regulatory 
function of the motor protein in the actin polymerization process at the distal ends of membrane 
protrusions. Hence, as actin represents a constituent of the L. donovani flagellum 
(Sahasrabuddhe et al., 2004), myosin-XXI-mediated flagellar assembly might involve the regulation of 
actin polymerization. 
In vitro approaches applied in the present study provided valuable insights into the lipid bilayer 
association of myosin-XXI. Positive bilayer curvature was revealed as a key factor in myosin-XXI-
bilayer attachment, and thus membrane shape is likely to play a role in the control of myosin-XXI 
distribution within L. donovani. Therefore, membrane geometry potentially contributes to the 
recruitment of the motor protein to its cellular sites of action, e.g. to sites of endocytosis or to 
vesicular cargo. Furthermore, curvature sensitivity of myosin-XXI could enable regulation of myosin 
localization in L. donovani by bilayer-incorporated lysophospholipids. Owing to their molecular 
shape, these phospholipids are capable of impeding the association of convex membrane surfaces 
with proteins sensing positive curvature (Davies et al., 2001). 
SLiC assays additionally revealed the existence of at least two separate curvature sensitive lipid 
binding motifs within myosin-XXI, a structural property that might ensure the stable attachment of 
myosin-XXI to convex membranes (e.g. vesicles) throughout the motor protein´s ATPase cycle. In 
turn, stable membrane attachment might be essential for myosin-XXI-mediated transport processes 
required for functional endocytosis, exocytosis, vesicular trafficking, and flagellum formation in 
L. donovani. 
 
In summary, the present study provides significant new knowledge on the molecular bases of the 
physiological roles of L. donovani myosin-XXI and thereby also gives general information on motor 
proteins of the myosin superfamily. The demonstrated regulatory role of myosin-XXI in the assembly 
of actin-based cellular structures once more illustrates the importance of the interplay between actin 
and myosins even in organisms like L. donovani, which exhibit a primarily microtubule-based 
cytoskeleton. Moreover, by demonstrating for the first time that membrane association of myosins 
can be controlled by the shape of the lipid bilayer, the present work revealed an interesting novel 
aspect of the targeting and thus the functionality of myosins. 
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xi 
Appendix A – Molecular Cloning 
In this appendix, an overview of the recombinant DNA constructs produced throughout the course of 
the present study is given. DNA templates encoding the respective proteins were amplified by 
polymerase chain reaction. In order to create recombinant DNA, templates and respective plasmid 
vectors were subjected to restriction enzyme digestion, and subsequently ligated. An overview of the 
utilized primers, DNA templates, plasmid vectors, and restriction enzymes is given in Table A.1 and 
Table A.2. Nucleic acid sequences of primers are summarized in Table A.3. 
 
Table A.1 Recombinant plasmids for protein expression. The table below lists all recombinant plasmids created for the 
purpose of protein expression in the present study. DNA templates encoding the respective proteins were amplified by PCR 
utilizing the primers listed below. Templates denoted as XXI and VI contain the complete or partial sequences of L. donovani 
myosin-XXI and chicken myosin-VI respectively. CaMX refers to Xenopus laevis calmodulin. “FL” designates full-length DNA 
sequences. Ligation of DNA templates and plasmid vector was prepared by restriction enzyme digestion using the indicated 
enzymes. The table further summarizes the fluorophore and the antibiotic resistance encoded by each vector. 1: The 
pet28a(+)-eGFP vector is a modified version of the pet28a(+) vector additionally containing the DNA sequence of eGFP. 
EGFP DNA was amplified by PCR (primers: mGFP-HindIII-FP, mGFP-NotI-RP), and pet28a(+) and the eGFP sequence were 
subjected to restriction enzyme digestion with NotI and HindIII to enable ligation. 2: This myosin-XXI construct contains a 
double-amino acid substitution (Arg705Leu, Tyr706Ser). Site-directed mutagenesis of the original recombinant 
pet-28(a)-eGFP-XXI aa 600-758 plasmid was implemented in two subsequent steps of PCR (primers: XXI-SDM-FP1 and 
XXI-SDM-RP1 in the first reaction, XXI-SDM-FP2 and XXI-SDM-RP2 in the second reaction). After PCR was finished, original 
pet-28(a)-eGFP-XXI aa 600-758 plasmid was digested by DpnI restriction enzyme (New England Biolabs) according to 
manufacturer´s instructions. 3: Recombinant plasmids encoding fusion constructs of eGFP and FL-XXI (aa 1-1050) or 
Trunc-XXI (aa 1-800) respectively were created by insertion of the eGFP sequence at the BamHI restriction site of the 
recombinant pFastBac™HT B-XXI aa 1-1050 or pFastBac™HT B-XXI aa 1-800 plasmids. PCR of eGFP DNA was carried out 
applying XXInGFPTR1 and XXInGFPTR2 primers. 4: This readily prepared recombinant plasmid was kindly provided by James 
R. Sellers (National Institutes of Health, Bethesda, Maryland). 
 
Vector DNA Template 
Restriction 
Enzymes Name 
Antibiotic 
Resistance 
Fluorophore 
Amino Acid 
Sequence 
Primers (PCR) 
pet-28a(+)-eGFP
1
 
(modified from 
pet-28a(+) 
(Merck)) 
Kanamycin eGFP 
Endophilin aa 1-247 eNBAR-FP, eNBAR-RP BamHI, HindIII 
XXI aa 809-1050 
XXI-809tail-BamHI-FP,  
XXI-1050-HindIII-RP 
BamHI, HindIII 
XXI aa 930-1050 
XXI-930tail-BamHI-FP,  
XXI-1050-HindIII-RP 
BamHI, HindIII 
XXI aa 830-1050 
XXI-830tail-BamHI-FP,  
XXI-1050-HindIII-RP 
BamHI, HindIII 
XXI aa 600-758 
XXICON-Bam-FP,  
XXICON-Hind-RP 
BamHI, HindIII 
XXI aa 600-758 
(R705L/Y706S)
2
 
- - 
pFastBac™HT B 
(Thermo Fisher 
Scientific) 
Ampicillin - 
XXI aa 1-1050 (FL) XXIFP6, XXIRP2 BamHI, NotI 
XXI aa 1-800 XXIFP6, XXITR3 BamHI, NotI 
VI aa 1-1277 (FL) CVI-SalI-FP, CVI-XhoI-RP SalI, XhoI 
eGFP-XXI aa 1-1050
3
 - - 
eGFP-XXI aa 1-800
3
 - - 
pFastBac™1
4
 Ampicillin none CaMX aa 1-149
7
 (FL) - - 
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Table A.2 Recombinant plasmids for mammalian cell transfections. In the table below, recombinant plasmids used in the 
present mammalian cell transfection experiments are summarized. In addition to the respective DNA templates and 
plasmid vectors, primers used for template amplification and restriction enzymes applied to enable ligation of templates 
and vectors are listed. Template sequences termed XXI refer to myosin-XXI DNA constructs. Amino acid sequences 
designated as “FL” encode a full-length protein. Fluorophore sequences already contained in the vectors and the antibiotic 
resistance encoded by each vector are also specified. Importantly, control transfection experiments were performed with 
plasmids solely containing fluorophore DNA. Respective plasmids are indicated as “Control”. 1: Vectors pmEGFP-C3 and 
pmRFP-C3-MCS were created and kindly provided by former lab member Natali Fili. 2: The complete recombinant plasmid 
already containing the lifeact DNA sequence was kindly provided by Roland Wedlich-Söldner (Westfälische Wilhelms-
Universität Münster). 
 
Vector DNA Template 
Restriction 
Enzymes Name 
Antibiotic 
Resistance 
Fluorophore 
Amino Acid 
Sequence 
Primers (PCR) 
pZsGreen1-N1 
(Clontech) 
Kanamycin ZsGreen1 
- (Control) - - 
XXI aa 1-1050 (FL) XXI-ZsG-FP, XXI-Zs-RP HindIII, BamHI 
XXI aa 1-800 XXI-ZsG-FP, XXITr-Zs-RP HindIII, BamHI 
pmEGFP-C3
1
 Kanamycin eGFP 
- (Control) - - 
XXI aa 1-753 
XXI-MAM-FP, 
XXI-MAM+PX-RP 
XhoI, BamHI 
XXI aa 1-704 
XXI-MAM-FP,  
XXI-MAM-PX-RP 
XhoI, BamHI 
pEGFP-C3 
(Clontech) 
Kanamycin eGFP 
XXI aa 46-1050 XXI-SH3-FP, XXI-RP-FL XhoI, BamHI 
XXI aa 46-800 XXI-SH3-FP, XXI-RP-800 XhoI, BamHI 
XXI aa 46-753 
XXI-SH3-FP,  
XXI-MAM+PX-RP 
XhoI, BamHI 
XXI aa 46-704 XXI-SH3-FP, XXI-MAM-PX-RP XhoI, BamHI 
pmRFP-C3-MCS
1
 Kanamycin DsRed2 
- (Control) - - 
XXI aa 730-1050 
XXI730FP-MAM,  
XXI-ENDRP-MAM 
HindIII, BamHI 
XXI aa 830-1050 
XXI830FP-MAM,  
XXI-ENDRP-MAM 
HindIII, BamHI 
XXI aa 930-1050 
XXI930FP-MAM,  
XXI-ENDRP-MAM 
HindIII, BamHI 
XXI aa 730-936 
XXI730FP-MAM,  
XXI930RP-MAM 
HindIII, BamHI 
XXI aa 830-936 
XXI830FP-MAM,  
XXI930RP-MAM 
HindIII, BamHI 
XXI aa 730-836 
XXI730FP-MAM,  
XXI830RP-MAM 
HindIII, BamHI 
mRFPRuby-N1
2
 Kanamycin RFP Lifeact aa 1-17
3
 (FL) - - 
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Table A.3 Nucleic acid sequences of primers utilized for the amplification of DNA templates. Sequences are listed in the 
5’ to 3’ direction. Bold letters indicate sites of restriction enzyme digestion. If not indicated, no restriction sites are present. 
Colored letters designate amino acid substitutions. 
 
Primer Name Nucleic Acid Sequence Restriction Site 
CVI-SalI-FP AAA GTC GAC AAT GGA GGA CGG GAA GCC CGT TTG  SalI 
CVI-XhoI-RP ACT CGA GCT ATT TCA ACA GGT TCT GCA GC  XhoI 
eNBAR-FP GGG GGA TCC ATG AGT GTT GCA GGC CTG AAA AAA BamHI 
eNBAR-RP AAA AAG CTT AGC CTG GCG GAT ACG TTC TTC CAG HindIII 
mGFP-HindIII-FP CCA AGC TTG CAT GGT GAG CAA GGG CGA GGA GC HindIII 
mGFP-NotI-RP TCT TGC GGC CGC CTT GTA CAG CTC GTC CAT GCC NotI 
XXI-1050-HindIII-RP AAA AAG CTT GCT CAC CTT GAA CAG CA HindIII 
XXI-809tail-BamHI-FP GGG GGA TCC CTG CAG TGG GTG GAG GAG GCG BamHI 
XXI-830tail-BamHI-FP GGG GGA TCC GCC GTC GAG GCG GAC ACG CGC G BamHI 
XXI-930tail-BamHI-FP GGG GGA TCC GGC ACG GAC AGC GAA TAT GCC BamHI 
XXI-ENDRP-MAM AAA AAA GGA TCC CTA GCT CAC CTT GAA CAG C BamHI 
XXI-MAM-FP AAA ACT CGA GAT GCC GGA GCG TGT GTC TG XhoI 
XXI-MAM-PX-RP TTT TTT GGA TCC TTA CCC TTG CTT GAA CAA GGA GG BamHI 
XXI-MAM+PX-RP TTT TTT GGA TCC TTA CGC GCG GCG ACG AAG CAC C BamHI 
XXI-RP-800 TTT TTT GGA TCC TTA GTC GGC GGC CTT GGC CTC CC BamHI 
XXI-RP-FL TTT TTT GGA TCC CTA GCT CAC CTT GAA CAG C BamHI 
XXI-SDM-FP1 CCT TGT TCA AGC AAG GGC TGT ACA GCG ACG CGT CCC - 
XXI-SDM-FP2 CCT TGT TCA AGC AAG GGC TGT CCA GCG ACG CGT CCC AGG - 
XXI-SDM-RP1 GGG ACG CGT CGC TGT ACA GCC CTT GCT TGA ACA AGG - 
XXI-SDM-RP2 CCT GGG ACG CGT CGC TGG ACA GCC CTT GCT TGA ACA AGG - 
XXI-SH3-FP AAA ACT CGA GGC GGC CGA TAA TGT GCA CGG XhoI 
XXI-ZsG-FP GTG AAG CTT ATG CCG GAG CGT GTG TCT GTG HindIII 
XXI-Zs-RP GGG ATC CGC CGC TCA CCT TGA ACA GC BamHI 
XXI730FP-MAM GGG AAG CTT GGC AAG ACG AAG GTG TTC CTC C HindIII 
XXI830FP-MAM GGG AAG CTT GCC GTC GAG GCG GAC ACG CGC G HindIII 
XXI830RP-MAM AAA AAA GGA TCC CTA GCG CGT GTC CGC CTC GAC GGC BamHI 
XXI930FP-MAM GGG AAG CTT GGC ACG GAC AGC GAA TAT GCC HindIII 
XXI930RP-MAM AAA AAA GGA TCC CTA GGC ATA TTC GCT GTC CGT GCC BamHI 
XXICON-Bam-FP TCT TCT GGA TCC TCG CAG CTT GAG TCC GCT GG BamHI 
XXICON-Hind-RP TCT TCT AAG CTT ACC ACC TCC GCA GCG GTG CAG CAG CTG CG HindIII 
XXIFP6 AGG ATC CAT GCC GGA GCG TGT GTC TGT G BamHI 
XXInGFPTR1 GGG ATC CAT TGG CGG CGT CGG CGG CCT TGG C BamHI 
XXInGFPTR2 GGG ATC CTT TCT CCG CCG GCA CCA TTG GC BamHI 
XXIRP2 AAA AGC GGC CGC CTA GCT CAC CTT GAA CAG C NotI 
XXITr-Zs-RP GGG ATC CAT TGG CGG CGT CGG CGG CCT TGG C BamHI 
XXITR3 AAA AGC GGC CGC CTA ATT GGC GGC GTC GGC GGC NotI 
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Appendix B – Myosin-XXI Sequence 
The following nucleic acid sequence encodes L. donovani myosin-XXI. The sequence is given in the 5’ 
to 3’ direction:  
ATGCCGGAGCGTGTGTCTGTGAATCAGGAGGTGTACTACTTCGACACCAAGAGCGGGTGGCTGCGTGGCACCGTGAAGGAGG
TCGATGGCGCCAAGGTGACGGTAGAGGACAATGCCTCGCAGAGTGCCGTGAAAGTGGCGGCCGATAATGTGCACGGCTACAT
GTCGGAGAGCTACGATATCGAGGACGCGGACCTCTTCCACGTGAGCGATCTGCACGTGGCCACTCTCTTGCACTGCGTCAAG
GACCGTTTTGAGAAGCTGCACAAGCAGTACTCGCTCATGGGGGAGATGGTGCTCTCCGTCAACCCATTTCGCCTCATGCCCT
TCAACAGCGAAGAGGAGCGTAAAGAGTATCTGGCCCTGCCGGACCCCCGCATGCTGCCCCCGCACATCTGGCAGGTGGCGCA
CAAGGCCTTCAACGCGGTCTTCGTTCAGGGTCAGGGCAACCAGTCCATCGTCATCTCCGGCGAGTCCGGTTCCGGAAAAACC
GAGAACGCCAAGATGCTCATCGCGTACCTGGGCCAACTCAGCTACATGCACAGCAAGAACACCTCGCAGCGCAGCATCGCGG
ACAAGATCGACGAGAACCTAACCTGGAGCAACCCCGTCATGGAGTCGTTCGGCAACGCCCGCACCGTGCGCAACGACAACTC
TTCGCGCTTCGGCAAGTACATCAAGCTCTACTTTGATCCTGTATCTGGCGTCATGGTGGGGGGCCAGACCGTCACCTACTTG
CTGGAGAGGAGCCGCATCATCATGCAGTCTCCTGGCGAGCGCAACTACCACATCTTCTACGAGATGCTGGCGGGCCTGTCGC
CGACAGAGAAGCAGCAGCTTGGCGGGCTCAAGACTGCCCAGGACTACAAGTGCCTGAACGGCGGTAACACCTTCATCCGCCG
CGGCGTGGATGGCAAGCCGCTCGACGACGCGCACGAGTTTCAGATGGTGCGCCGCGCGCTTTCCATGATCGGTGTGCCGCTG
GAGACGCAGAACTGCATGTTGCGCGTGCTGGCGGCCATCCTGCACCTGATGGAGGTCGAGTTCGAGCCCGACAACAACGACA
AGGCACAGATCGCAAACGGGACACCGCTCGCGACGGCCTGCGCGCTGCTCTGCCTGGATGAGGCCAAGGTGCGCGAGTGCTT
TCTCGTGAGGAGCAAGACGTCGCTTGTCACGATCCTCGCCTCCAAGACGGAGGCGGAGGGCCTGCGCAACGCCTTCTGCAAG
GGACTTTACGTTGGCATGTTCGACCGGCTGGTCGAGTTTGTGAACGCCGCCATTCAGCCCCGGGTGGACTGCAGCGACTGCA
AGTACGTCGGCCTGCTCGATATTTTCGGCTTTGAAAACTTCACGCGCAACAGCTTCGAGCAGATCTGCATCAATTACGCGAA
CGAGTCGCTGCAAAACCACTACAACAAGTACACGTTCATCAACGACGAAGAGGAGTGCCGCCGCGAGGGTATCCAGACCCCG
AATATCGAGTTCCCAGACAACTCCGAGTGCGTCAACATGCTCGATGCGAAGCGCGTCGGCATCTTCTCGATGCTGGATGAGG
AGTGCAACTTCAAGGGCGGCAACACAGACCGCTTCACCACGAACCTTTGGGAGGAGTGGGCTGGCAGGAACCCGTACTTTGT
GAAGCCGAAGAGCACGATCCCGAACCAGTTCGGCGTGAACCACTACGCTGCCTTCGTCAACTACAACACGGCGGACTGGTTG
GAGAAGAACACGGACGCACTCAAGGAAGACATGTATGAGTGCGTGAGTGAGTCCACCGACGAGTTCATTCGGACCCTTCTCT
CGACGGAGAAGAGCGAGGCACGCCGCAAGCAGACCGTTGCCATCCGCTTCCAGCGCCAGCTCACGGACCTGCGCTCCGAGCT
GGAGTCCACCGAGACACGGTTCATTCGCTGCATCAAGCCAAATATGGAGGCAAGCCCCTCGTTCCTCGAAAACCTTCTCGTC
GGCTCGCAGCTTGAGTCCGCTGGTGTGCTGCAGACCATCTCCCTCAAGCGTCAGGGCTACCCGGTGCGCCGTCCGCTGGAGC
AGTTTTGCAGGTACTTCTACCTTGTCATGTCCCGCACCACCGCCTCCTTGTTCAAGCAAGGGCGGTACAGCGACGCGTCCCA
GGACTTTCTGCAGCGACACCAGCGCCTCTACAGCTGGGCGGAGCCCAACTACGCCGTTGGCAAGACGAAGGTGTTCCTCCGG
GCTGAGGTGTGGTCGGCGCTGGAGCGGCTGGTGCTTCGTCGCCGCGCGCAGCTGCTGCACCGCTGCAAGCCCTACCTGCGCC
GCTGGATCGACGAGCTCCGCGAGCGCAGGCGTATCGAGGAGCAGAAGCGGCTGGAGGCAGCGCGCAAGCTGCGCGAGGCGCG
GGAGGCCAAGGCCGCCGACGCCGCCAATGGTGTGCCGGCGGAGAAACTGCAGTGGGTGGAGGAGGCGTCGAACATGTTCCCA
GACTTCGACACGGACACGCTGCTCGACGTTGCCGTCGAGGCGGACACGCGCGAGGAGGCTCTCAGCGCCATCCTTGCCATCC
AGGCTGACCGCCTTGACAAGCAGACAGCCTCTGGATTCATGGAAGTGATGGCGGCTGCGAACGTGCGCCGTGGCGTCATCAA
CAACTTTATCTCGGCGGACATCAAGACGGTGTCGGCGCTGTCGAGGCTGCAGCCGGAGGATATGAAGAGCCTCGGCGCCAGT
GAGATGGAGGTGGTGGCGATCACGAAGAAGCTGGCGGAGCAGCAGGGGCAGCGCGTCAAGTACCAGCGCCTCGCCGAGGCCA
TCGGCACGGACAGCGAATATGCCGCCGCTGGCGCCGTCCAACGCGCCGAGGTGGCTCGCCACCAGGAAGACTTCGACGCCAA
AGTGCAGACCCTTGCCAGCATGGGCTTTGATGAGCCCACCGGCCGCCTCGTGCTGGCGCACTACAACGGCGACGTGCAGCGC
ACGGCGGCGCGCCTGCTTTATGGCGTGGACAGCCGGAAGATGAGGAACAACGCGCGCAAGCACAAGAACTTCAACACAACGG
ACCCCAACGTGCAGCAGCTCATCTCTCTCGGTGCGACGAAGCAGGATGCAAAGATGGCACTACGTCGCAACAACGGAGACGC
GAACGCCGCCGTTAAGATGCTGTTCAAGGTGAGCTAG 
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Appendix C – Structural Motifs of Myosin-XXI 
In this appendix, the types and intramolecular positions of the structural motifs so far identified 
within L. donovani myosin-XXI are summarized. 
 
Table C.1 Structural motifs of L. donovani myosin-XXI. This table lists the myosin-XXI structural motifs known at present 
and states their position within the aa sequence of the motor protein. Full-length myosin-XXI comprises 1050 aa. Data have 
partially been reported in a previous publication of our research group (Batters et al., 2014). In the respective study, BHB 
domains were predicted by basic and hydrophobic score calculation (1) and sequence analysis (2). 
 
Structural Motif Start at aa End at aa 
SH3-like domain 11 37 
motor domain 65 747 
 ATP/ADP binding pocket 103 166 
 switch I 219 222 
 switch II 445 451 
 relay Loop 473 496 
 converter 662 747 
IQ motif 754 769 
predicted coiled coils 744 809 
 828 856 
 878 961 
 1016 1046 
PX domain 705 752 
predicted BHB domains (1) 765 776 
 781 793 
 796 808 
 897 912 
 996 1006 
 1033 1044 
predicted BHB domains (2) 752 770 
 999 1006 
UBA Domains 950 992 
 1013 1046 
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Appendix D – Lateral Diffusion Coefficients of 
Planar Lipid Bilayers 
In Fluorescence Recovery after Photobleaching experiments, planar lipid bilayers were tested for 
their fluidity. Analysis of FRAP measurements resulted in the determination of lateral diffusion 
constants. By comparison of the respective diffusion constants with published data, quality of the 
prepared bilayer samples could be verified. Here, the diffusion coefficients obtained from each 
individual measurement are listed. 
 
Table D.1 Lateral diffusion coefficients determined by FRAP measurements. In FRAP experiments, tethered and 
supported planar bilayers of different lipid composition were investigated. From each individual measurement, a diffusion 
coefficient Di was determined. Subsequently, average lateral diffusion constants D were calculated, which are stated as 
mean ± standard deviation. The tethered bilayer sample is labeled as “TB”, and the number of evaluated samples of each 
bilayer type is stated. 
 
Di [10
-12 m2·s-1] for bilayers composed of 
97.3 mol% POP 
1.5 mol% Biotin DHPE 
1.2 mol% Rhodamine DHPE 
(6 samples) 
73.0 mol% POPC 
26.0 mol% cholesterol 
1.0 mol% Rhodamine DHPE 
(5 samples) 
94.0 mol% POPC 
4.8 mol% PI(3,5)P2 
1.2 mol% Rhodamine DHPE 
(TB, 1 sample) 
0.74 0.81 1.18 
0.99 0.85 1.39 
1.00 0.89 1.48 
1.03 0.97 1.49 
1.08 0.97 1.70 
1.13 0.99  
1.14 1.01  
1.18 1.02  
1.23 1.07  
1.25 1.09  
1.26 1.10  
1.35 1.12  
1.39 1.14  
1.41 1.16  
1.46 1.16  
1.55 1.19  
1.60 1.23  
1.76 1.27  
1.98 1.31  
2.05 1.35  
2.18 1.49  
2.20 1.60  
2.47 2.03  
2.59 2.16  
average lateral diffusion constant D [10-12 m2·s-1] 
1.50±0.50 1.21±0.33 1.45±0.19 
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Appendix E – Protein-Vesicle Co-Sedimentation 
Co-sedimentation assays were carried out prior to the investigation of the bilayer binding behavior of 
proteins in Single Liposome Curvature assays. In order to test the respective proteins for their 
capability to bind to bovine brain extract vesicles, protein-vesicle mixtures were prepared and 
subjected to ultracentrifugation. Sedimentation of protein indicated vesicle binding. To rule out 
significant vesicle-independent precipitation of protein, negative control sedimentation assays with 
solutions solely containing protein were performed. In this appendix, results of all co-sedimentation 
experiments and negative control assays are stated.  
 
Table E.1 Results of negative control sedimentation assays. For each protein, 3 negative control assays, i.e. sedimentation 
assays in the absence of vesicles, were performed. Below, the fraction of sedimented protein detected in each individual 
assay is listed. The resulting average values are given as mean ± standard deviation. 
 
Protein 
Fraction of Protein in the Precipitate 
Assay 1 Assay 2 Assay 3 Average 
eNBAR 0.0 0.0 0.0 0.0±0.0 
FL-XXI 2.9 0.0 2.2 1.6±1.5 
Trunc-XXI 0.0 0.0 4.1 1.3±2.4 
XXI-930 Tail 0.0 0.0 0.0 0.0±0.0 
XXI-830 Tail 0.0 0.0 0.0 0.0±0.0 
XXI-809 Tail 0.0 0.0 0.0 0.0±0.0 
XXI-Conv. WT 0.0 0.0 0.0 0.0±0.0 
XXI-Conv. M 0.0 0.0 0.0 0.0±0.0 
 
Table E.2 Results of co-sedimentation assays with bovine brain extract vesicles. For each protein, 5 co-sedimentation 
assays were carried out. In the table below, the fraction of precipitated protein detected in each assay is given. The 
resulting average values are stated as mean ± standard deviation. 
 
Protein 
Fraction of Protein in the Precipitate 
Assay 1 Assay 2 Assay 3 Assay 4 Assay 5 Average 
eNBAR 79.3 82.7 85.3 88.3 79.1 82.9±4.0 
FL-XXI 29.5 15.7 22.5 23.8 20.9 22.4±5.0 
Trunc-XXI 9.6 16.5 11.7 17.6 11.1 13.3±3.6 
XXI-930 Tail 80.4 53.6 35.7 100.0 100.0 75.8±28.6 
XXI-830 Tail 71.4 63.7 66.1 62.8 73.1 67.0±4.6 
XXI-809 Tail 0.0 0.0 0.0 0.0 0.0 0.0±0.0 
XXI-Conv. WT 0.0 0.0 0.0 0.0 0.0 0.0±0.0 
XXI-Conv. M 0.0 0.0 0.0 0.0 0.0 0.0±0.0 
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